ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0048732,gland development,26/90,441/18614,1.90E-21,6.02E-18,2.95E-18,5290/595/80139/2625/999/207/55294/1030/6926/675/4763/1956/2099/3169/4853/208/7494/5156/2263/4089/472/1027/4851/6794/171023/673,26
GO:1901987,regulation of cell cycle phase transition,26/90,457/18614,4.67E-21,7.39E-18,3.62E-18,7157/595/5728/5925/57492/1029/207/55294/8289/896/4193/1030/675/1956/1021/672/545/472/1027/6597/677/324/4221/4436/55193/701,26
GO:0044843,cell cycle G1/S phase transition,22/90,281/18614,8.02E-21,8.46E-18,4.14E-18,7157/4609/595/5728/5925/57492/1029/207/55294/8289/896/4193/898/1030/1956/1021/472/1027/6597/324/4221/55193,22
GO:1902105,regulation of leukocyte differentiation,22/90,319/18614,1.27E-19,1.00E-16,4.90E-17,4609/2064/2625/5925/57492/55294/8289/865/4763/5295/1021/4853/27086/861/7494/387/6597/677/841/55193/673/639,22
GO:0050678,regulation of epithelial cell proliferation,24/90,419/18614,1.68E-19,1.06E-16,5.19E-17,4609/595/2064/80139/2260/2625/5925/207/55294/1030/675/4763/1956/1021/4853/7494/2263/1027/4851/677/4221/4893/6794/3265,24
GO:0050673,epithelial cell proliferation,25/90,488/18614,3.80E-19,1.75E-16,8.56E-17,4609/595/2064/80139/2260/2625/5925/207/55294/1030/675/4763/1956/2099/1021/4853/7494/2263/1027/4851/677/4221/4893/6794/3265,25
GO:0000082,G1/S transition of mitotic cell cycle,20/90,251/18614,4.06E-19,1.75E-16,8.56E-17,7157/4609/595/5728/5925/57492/1029/207/8289/896/4193/898/1030/1956/1021/472/1027/6597/324/55193,20
GO:1902806,regulation of cell cycle G1/S phase transition,19/90,214/18614,4.42E-19,1.75E-16,8.56E-17,7157/595/5728/5925/57492/1029/207/55294/8289/896/4193/1030/1956/472/1027/6597/324/4221/55193,19
GO:0009314,response to radiation,24/90,452/18614,9.69E-19,3.41E-16,1.67E-16,7157/4609/595/2625/207/4193/675/4763/5295/1956/3845/208/672/1387/1788/545/472/4221/4436/6794/673/2072/3265/639,24
GO:0071214,cellular response to abiotic stimulus,21/90,339/18614,8.60E-18,2.47E-15,1.21E-15,7157/5290/4609/5728/2625/4214/6416/4193/3480/675/5295/208/672/1387/545/472/677/841/6794/2072/3265,21
GO:0104004,cellular response to environmental stimulus,21/90,339/18614,8.60E-18,2.47E-15,1.21E-15,7157/5290/4609/5728/2625/4214/6416/4193/3480/675/5295/208/672/1387/545/472/677/841/6794/2072/3265,21
GO:2000045,regulation of G1/S transition of mitotic cell cycle,17/90,186/18614,2.33E-17,6.01E-15,2.94E-15,7157/595/5728/5925/57492/1029/207/8289/896/4193/1030/1956/472/1027/6597/324/55193,17
GO:1901990,regulation of mitotic cell cycle phase transition,21/90,357/18614,2.47E-17,6.01E-15,2.94E-15,7157/595/5728/5925/57492/1029/207/8289/896/4193/1030/1956/1021/672/472/1027/6597/677/324/55193/701,21
GO:0044772,mitotic cell cycle phase transition,23/90,467/18614,3.01E-17,6.80E-15,3.33E-15,7157/4609/595/5728/5925/57492/1029/207/8289/896/4193/898/1030/1956/1021/672/472/1027/6597/677/324/55193/701,23
GO:1903706,regulation of hemopoiesis,22/90,415/18614,3.49E-17,7.37E-15,3.61E-15,4609/2064/2625/5925/57492/55294/8289/865/4763/5295/1021/4853/27086/861/7494/387/6597/677/841/55193/673/639,22
GO:1903131,mononuclear cell differentiation,23/90,474/18614,4.17E-17,8.24E-15,4.03E-15,7157/4609/2064/2625/57492/8289/865/5295/1021/4853/27086/861/7494/387/472/6597/677/4221/4436/55193/6794/673/639,23
GO:0030098,lymphocyte differentiation,22/90,422/18614,4.97E-17,9.25E-15,4.53E-15,7157/2064/2625/57492/8289/865/5295/1021/4853/27086/861/7494/387/472/6597/677/4221/4436/55193/6794/673/639,22
GO:0001701,in utero embryonic development,21/90,398/18614,2.22E-16,3.91E-14,1.91E-14,7157/2625/207/6926/675/1956/4853/29072/5156/2263/79728/4089/8312/54880/4851/84295/677/841/4849/4436/639,21
GO:0030217,T cell differentiation,19/90,300/18614,2.52E-16,4.19E-14,2.05E-14,7157/2064/2625/57492/8289/865/5295/1021/27086/861/7494/387/6597/677/4221/55193/6794/673/639,19
GO:0006338,chromatin remodeling,20/90,402/18614,3.89E-15,6.16E-13,3.01E-13,7157/5290/4609/2625/5925/57492/8289/23451/2099/3169/10664/7403/29072/1788/546/8312/54880/6597/55193/4778,20
GO:0045786,negative regulation of cell cycle,20/90,404/18614,4.28E-15,6.44E-13,3.16E-13,7157/595/5728/2625/5925/1029/4193/1030/675/1021/672/545/472/546/1027/677/324/4221/4436/701,20
GO:0010212,response to ionizing radiation,14/90,143/18614,7.16E-15,1.03E-12,5.05E-13,7157/4609/595/2625/4193/675/672/1788/545/472/4221/4436/6794/3265,14
GO:0014065,phosphatidylinositol 3-kinase signaling,14/90,144/18614,7.91E-15,1.09E-12,5.33E-13,5290/5728/2064/2260/2625/207/3480/4763/5295/1956/5156/2065/677/80243,14
GO:0048015,phosphatidylinositol-mediated signaling,14/90,172/18614,9.53E-14,1.26E-11,6.15E-12,5290/5728/2064/2260/2625/207/3480/4763/5295/1956/5156/2065/677/80243,14
GO:0051402,neuron apoptotic process,16/90,259/18614,1.06E-13,1.35E-11,6.59E-12,7157/5290/595/2625/5925/6416/55294/4763/3845/208/2065/387/472/4436/673/3265,16
GO:0048017,inositol lipid-mediated signaling,14/90,176/18614,1.31E-13,1.60E-11,7.81E-12,5290/5728/2064/2260/2625/207/3480/4763/5295/1956/5156/2065/677/80243,14
GO:0090398,cellular senescence,Dec-90,108/18614,1.46E-13,1.71E-11,8.39E-12,7157/5728/6416/1029/1030/6926/3480/675/1021/472/1027/3265,12
GO:0071900,regulation of protein serine/threonine kinase activity,18/90,369/18614,1.53E-13,1.73E-11,8.46E-12,595/5728/2064/2260/5925/1029/207/896/898/1030/4763/1956/387/8312/1027/324/4221/3265,18
GO:0010948,negative regulation of cell cycle process,17/90,317/18614,1.69E-13,1.84E-11,9.03E-12,7157/595/5728/5925/4193/1030/675/672/545/472/546/1027/677/324/4221/4436/701,17
GO:0070997,neuron death,18/90,373/18614,1.84E-13,1.93E-11,9.45E-12,7157/5290/595/2625/5925/6416/207/55294/4763/3845/208/2065/387/472/841/4436/673/3265,18
GO:0010720,positive regulation of cell development,19/90,432/18614,1.89E-13,1.93E-11,9.45E-12,2625/5925/57492/8289/865/23013/3845/4853/861/7494/387/1523/4851/6597/677/841/55193/6794/673,19
GO:0009416,response to light stimulus,17/90,323/18614,2.29E-13,2.27E-11,1.11E-11,7157/4609/595/207/675/4763/5295/1956/3845/208/1387/545/4221/4436/6794/673/2072,17
GO:1901988,negative regulation of cell cycle phase transition,16/90,274/18614,2.54E-13,2.44E-11,1.19E-11,7157/595/5728/5925/4193/1030/675/672/545/472/1027/677/324/4221/4436/701,16
GO:0071478,cellular response to radiation,14/90,191/18614,4.06E-13,3.78E-11,1.85E-11,7157/4609/2625/4193/675/5295/208/672/1387/545/472/6794/2072/3265,14
GO:0009411,response to UV,13/90,154/18614,4.84E-13,4.38E-11,2.14E-11,7157/4609/595/207/675/5295/1956/1387/545/4221/4436/6794/2072,13
GO:0051054,positive regulation of DNA metabolic process,16/90,303/18614,1.19E-12,1.04E-10,5.12E-11,4609/6416/57492/207/8289/3480/1956/672/8239/545/472/546/4292/6597/4436/55193,16
GO:0007059,chromosome segregation,18/90,435/18614,2.47E-12,2.11E-10,1.03E-10,5925/57492/8289/898/9611/672/10664/8239/387/472/546/4292/6597/10735/324/55193/701/2072,18
GO:0043523,regulation of neuron apoptotic process,14/90,219/18614,2.64E-12,2.20E-10,1.08E-10,7157/5290/595/2625/6416/55294/4763/3845/2065/387/472/4436/673/3265,14
GO:1901214,regulation of neuron death,16/90,327/18614,3.79E-12,3.01E-10,1.47E-10,7157/5290/595/2625/6416/207/55294/4763/3845/2065/387/472/841/4436/673/3265,16
GO:0050679,positive regulation of epithelial cell proliferation,14/90,225/18614,3.81E-12,3.01E-10,1.47E-10,4609/595/2064/80139/2260/207/4763/1956/4853/7494/2263/4851/4893/3265,14
GO:1902107,positive regulation of leukocyte differentiation,13/90,184/18614,4.75E-12,3.58E-10,1.75E-10,2625/5925/57492/8289/865/4853/861/7494/387/6597/677/841/55193,13
GO:1903708,positive regulation of hemopoiesis,13/90,184/18614,4.75E-12,3.58E-10,1.75E-10,2625/5925/57492/8289/865/4853/861/7494/387/6597/677/841/55193,13
GO:2000628,regulation of miRNA metabolic process,Oct-90,81/18614,5.93E-12,4.36E-10,2.14E-10,7157/4609/2625/9611/1956/2099/3169/4089/6597/3265,10
GO:0000079,regulation of cyclin-dependent protein serine/threonine kinase activity,Nov-90,112/18614,6.34E-12,4.56E-10,2.23E-10,595/5728/1029/207/896/898/1030/1956/1027/324/4221,11
GO:0010332,response to gamma radiation,Sep-90,57/18614,7.13E-12,5.01E-10,2.46E-10,7157/4609/2625/4193/675/545/472/4221/3265,9
GO:1904029,regulation of cyclin-dependent protein kinase activity,Nov-90,116/18614,9.35E-12,6.43E-10,3.15E-10,595/5728/1029/207/896/898/1030/1956/1027/324/4221,11
GO:0048608,reproductive structure development,15/90,301/18614,1.47E-11,9.90E-10,4.85E-10,595/2625/6926/675/2099/3169/5156/2263/4089/472/546/1027/4851/4436/6794,15
GO:0061458,reproductive system development,15/90,305/18614,1.77E-11,1.15E-09,5.64E-10,595/2625/6926/675/2099/3169/5156/2263/4089/472/546/1027/4851/4436/6794,15
GO:0002761,regulation of myeloid leukocyte differentiation,Nov-90,123/18614,1.78E-11,1.15E-09,5.64E-10,4609/5925/55294/4763/5295/1021/4853/27086/861/677/841,11
GO:0007162,negative regulation of cell adhesion,15/90,312/18614,2.45E-11,1.55E-09,7.58E-10,5728/2064/80139/999/1029/207/865/4763/5295/861/2065/387/4851/868/4221,15
GO:0045619,regulation of lymphocyte differentiation,13/90,212/18614,2.85E-11,1.77E-09,8.67E-10,2064/2625/57492/8289/865/861/7494/387/6597/677/55193/673/639,13
GO:0010586,miRNA metabolic process,Oct-90,97/18614,3.73E-11,2.15E-09,1.05E-09,7157/4609/2625/9611/1956/2099/3169/4089/6597/3265,10
GO:1902807,negative regulation of cell cycle G1/S phase transition,Oct-90,97/18614,3.73E-11,2.15E-09,1.05E-09,7157/595/5728/5925/4193/1030/472/1027/324/4221,10
GO:0061180,mammary gland epithelium development,Sep-90,68/18614,3.74E-11,2.15E-09,1.05E-09,595/80139/2625/207/6926/675/2099/208/2263,9
GO:1902893,regulation of miRNA transcription,Sep-90,68/18614,3.74E-11,2.15E-09,1.05E-09,7157/4609/2625/9611/1956/2099/3169/4089/6597,9
GO:0061614,miRNA transcription,Sep-90,69/18614,4.29E-11,2.42E-09,1.19E-09,7157/4609/2625/9611/1956/2099/3169/4089/6597,9
GO:0050680,negative regulation of epithelial cell proliferation,Dec-90,177/18614,5.40E-11,3.00E-09,1.47E-09,2625/5925/55294/1030/675/4763/1021/2263/1027/4851/4221/6794,12
GO:0045580,regulation of T cell differentiation,Dec-90,180/18614,6.58E-11,3.59E-09,1.76E-09,2064/2625/57492/8289/865/861/7494/387/6597/55193/673/639,12
GO:0003170,heart valve development,Sep-90,73/18614,7.23E-11,3.88E-09,1.90E-09,2625/5925/4193/4853/387/4089/4851/324/639,9
GO:0010721,negative regulation of cell development,14/90,286/18614,9.46E-11,4.99E-09,2.44E-09,7157/4609/5728/2064/5925/999/55294/865/1030/4763/5295/1021/861/4851,14
GO:0045930,negative regulation of mitotic cell cycle,13/90,243/18614,1.57E-10,8.03E-09,3.93E-09,7157/595/5728/5925/4193/1030/672/472/1027/677/324/4436/701,13
GO:1901991,negative regulation of mitotic cell cycle phase transition,Dec-90,194/18614,1.57E-10,8.03E-09,3.93E-09,7157/595/5728/5925/4193/1030/672/472/1027/677/324/701,12
GO:0022407,regulation of cell-cell adhesion,17/90,491/18614,1.74E-10,8.76E-09,4.29E-09,5290/2064/80139/2625/999/57492/207/8289/865/3169/861/7494/387/4851/6597/868/55193,17
GO:0097193,intrinsic apoptotic signaling pathway,14/90,301/18614,1.86E-10,9.18E-09,4.49E-09,7157/4609/207/55294/4193/675/5295/672/7494/472/4292/4436/6794/3265,14
GO:0006302,double-strand break repair,14/90,303/18614,2.03E-10,9.86E-09,4.83E-09,7157/57492/8289/675/672/29072/545/79728/472/4292/6597/4436/55193/2072,14
GO:0033044,regulation of chromosome organization,13/90,250/18614,2.22E-10,1.06E-08,5.18E-09,4609/5925/57492/8289/10664/545/472/546/6597/324/55193/701/2072,13
GO:0033674,positive regulation of kinase activity,16/90,430/18614,2.24E-10,1.06E-08,5.18E-09,595/2064/2260/207/55294/896/3480/1956/5156/2065/2263/387/8312/1027/6794/3265,16
GO:2001020,regulation of response to DNA damage stimulus,14/90,311/18614,2.85E-10,1.33E-08,6.50E-09,7157/4609/57492/8289/4193/675/1956/672/29072/545/472/6597/55193/2072,14
GO:1901653,cellular response to peptide,15/90,375/18614,3.21E-10,1.47E-08,7.20E-09,7157/5290/5925/57492/207/896/4193/3480/5295/208/7494/677/324/4221/3265,15
GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,Sep-90,86/18614,3.25E-10,1.47E-08,7.20E-09,7157/595/5728/5925/4193/1030/472/1027/324,9
GO:0050863,regulation of T cell activation,15/90,377/18614,3.46E-10,1.54E-08,7.55E-09,5290/2064/2625/57492/207/8289/865/861/7494/387/6597/868/55193/673/639,15
GO:0060485,mesenchyme development,14/90,320/18614,4.14E-10,1.82E-08,8.91E-09,4609/5728/80139/2260/2625/4193/6926/3169/2065/2263/4089/4851/677/324,14
GO:2000630,positive regulation of miRNA metabolic process,Aug-90,60/18614,4.53E-10,1.96E-08,9.62E-09,7157/4609/2625/1956/3169/4089/6597/3265,8
GO:0072331,signal transduction by p53 class mediator,Nov-90,173/18614,7.16E-10,3.06E-08,1.50E-08,7157/4609/207/4193/675/545/472/546/1027/4436/6794,11
GO:0098813,nuclear chromosome segregation,14/90,339/18614,8.77E-10,3.70E-08,1.81E-08,5925/57492/8289/898/387/472/546/4292/6597/10735/324/55193/701/2072,14
GO:0002573,myeloid leukocyte differentiation,Dec-90,227/18614,9.59E-10,3.99E-08,1.96E-08,4609/2625/5925/55294/4763/5295/1021/4853/27086/861/677/841,12
GO:0030879,mammary gland development,Oct-90,136/18614,1.08E-09,4.44E-08,2.18E-08,595/80139/2625/207/6926/675/2099/208/7494/2263,10
GO:0045785,positive regulation of cell adhesion,16/90,482/18614,1.18E-09,4.77E-08,2.34E-08,5290/2064/2625/57492/207/8289/865/3169/1021/861/7494/387/472/6597/55193/673,16
GO:0045787,positive regulation of cell cycle,14/90,354/18614,1.54E-09,6.15E-08,3.01E-08,595/5925/207/896/4193/6926/3480/675/1956/3169/2263/387/546/1027,14
GO:0030099,myeloid cell differentiation,15/90,421/18614,1.58E-09,6.24E-08,3.05E-08,4609/2625/5925/55294/865/1030/4763/5295/1021/4853/27086/861/677/841/54790,15
GO:0016049,cell growth,16/90,495/18614,1.73E-09,6.68E-08,3.27E-08,7157/2064/5925/6416/999/1029/207/1956/672/27086/8239/387/4089/1027/6597/6794,16
GO:0000075,cell cycle checkpoint signaling,Nov-90,188/18614,1.73E-09,6.68E-08,3.27E-08,7157/595/4193/675/672/545/472/1027/324/4436/701,11
GO:0043434,response to peptide hormone,15/90,427/18614,1.91E-09,7.29E-08,3.57E-08,5290/5925/57492/207/896/3480/5295/208/7494/1027/677/324/4221/6794/3265,15
GO:0003279,cardiac septum development,Sep-90,107/18614,2.34E-09,8.80E-08,4.31E-08,7157/2625/4193/6926/4853/2263/4089/4851/639,9
GO:0036293,response to decreased oxygen levels,13/90,306/18614,2.63E-09,9.78E-08,4.79E-08,7157/4609/207/4193/4763/1387/1788/387/4089/472/1027/4851/677,13
GO:0071479,cellular response to ionizing radiation,Aug-90,75/18614,2.82E-09,1.03E-07,5.06E-08,7157/2625/4193/675/672/545/472/3265,8
GO:0071375,cellular response to peptide hormone stimulus,13/90,308/18614,2.84E-09,1.03E-07,5.06E-08,5290/5925/57492/207/896/3480/5295/208/7494/677/324/4221/3265,13
GO:0045445,myoblast differentiation,Sep-90,110/18614,2.99E-09,1.07E-07,5.26E-08,5925/57492/8289/6926/4851/6597/677/4893/55193,9
GO:0001890,placenta development,Oct-90,152/18614,3.20E-09,1.14E-07,5.57E-08,207/1956/4853/29072/2263/1027/677/841/4221/639,10
GO:0042063,gliogenesis,13/90,320/18614,4.50E-09,1.58E-07,7.75E-08,7157/5728/2064/5925/207/1030/4763/3845/1021/208/2065/387/4851,13
GO:1902895,positive regulation of miRNA transcription,Jul-90,51/18614,4.75E-09,1.63E-07,7.99E-08,7157/4609/2625/1956/3169/4089/6597,7
GO:0034502,protein localization to chromosome,Sep-90,116/18614,4.79E-09,1.63E-07,7.99E-08,5925/675/2099/10664/29072/545/546/4436/701,9
GO:0045582,positive regulation of T cell differentiation,Sep-90,116/18614,4.79E-09,1.63E-07,7.99E-08,2625/57492/8289/865/861/7494/387/6597/55193,9
GO:0032869,cellular response to insulin stimulus,Nov-90,211/18614,5.82E-09,1.94E-07,9.52E-08,5290/5925/207/896/3480/5295/208/7494/677/324/3265,11
GO:0051251,positive regulation of lymphocyte activation,13/90,327/18614,5.84E-09,1.94E-07,9.52E-08,5290/2625/57492/207/8289/865/861/7494/387/4292/6597/4436/55193,13
GO:0032355,response to estradiol,Sep-90,120/18614,6.47E-09,2.13E-07,1.04E-07,595/80139/3480/1956/2099/3169/1788/1027/841,9
GO:0030900,forebrain development,14/90,397/18614,6.66E-09,2.17E-07,1.06E-07,5728/999/6926/3480/4763/1956/3845/1021/29072/27086/2263/387/546/4851,14
GO:0045637,regulation of myeloid cell differentiation,Nov-90,214/18614,6.74E-09,2.18E-07,1.07E-07,4609/5925/55294/4763/5295/1021/4853/27086/861/677/841,11
GO:0070482,response to oxygen levels,13/90,333/18614,7.26E-09,2.32E-07,1.14E-07,7157/4609/207/4193/4763/1387/1788/387/4089/472/1027/4851/677,13
GO:0003205,cardiac chamber development,Oct-90,166/18614,7.51E-09,2.36E-07,1.15E-07,7157/2625/4193/6926/3480/4853/2263/4089/4851/639,10
GO:0060562,epithelial tube morphogenesis,13/90,334/18614,7.52E-09,2.36E-07,1.15E-07,4609/2625/6926/3845/2099/3169/4853/29072/27086/2263/387/4089/4851,13
GO:0071560,cellular response to transforming growth factor beta stimulus,Dec-90,274/18614,8.04E-09,2.43E-07,1.19E-07,7157/80139/1030/3480/1387/8239/2263/4089/8312/677/4221/6794,12
GO:0000077,DNA damage checkpoint signaling,Sep-90,123/18614,8.05E-09,2.43E-07,1.19E-07,7157/595/4193/675/672/545/472/1027/4436,9
GO:0022612,gland morphogenesis,Sep-90,123/18614,8.05E-09,2.43E-07,1.19E-07,55294/6926/1956/2099/3169/4853/7494/2263/4851,9
GO:0071901,negative regulation of protein serine/threonine kinase activity,Sep-90,123/18614,8.05E-09,2.43E-07,1.19E-07,5728/5925/1029/207/1030/4763/1027/324/4221,9
GO:0010165,response to X-ray,Jun-90,32/18614,8.84E-09,2.61E-07,1.28E-07,7157/595/2625/675/472/4436,6
GO:0045736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,Jun-90,32/18614,8.84E-09,2.61E-07,1.28E-07,5728/1029/1030/1027/324/4221,6
GO:0048545,response to steroid hormone,13/90,339/18614,8.98E-09,2.63E-07,1.29E-07,5290/595/8289/9611/3480/2099/3169/672/27086/387/4851/6597/677,13
GO:0048145,regulation of fibroblast proliferation,Aug-90,87/18614,9.31E-09,2.70E-07,1.32E-07,7157/4609/4763/1956/2099/1021/5156/3265,8
GO:0070371,ERK1 and ERK2 cascade,13/90,341/18614,9.63E-09,2.77E-07,1.36E-07,4609/5728/2064/55294/1956/4853/5156/2263/4089/4851/677/673/3265,13
GO:0051348,negative regulation of transferase activity,Dec-90,279/18614,9.84E-09,2.80E-07,1.37E-07,7157/5728/5925/1029/207/1030/4763/1027/324/868/4221/701,12
GO:0071559,response to transforming growth factor beta,Dec-90,280/18614,1.02E-08,2.89E-07,1.42E-07,7157/80139/1030/3480/1387/8239/2263/4089/8312/677/4221/6794,12
GO:0045165,cell fate commitment,Dec-90,281/18614,1.07E-08,2.98E-07,1.46E-07,7157/2625/6926/3169/4853/2263/387/4089/4851/324/673/639,12
GO:1904030,negative regulation of cyclin-dependent protein kinase activity,Jun-90,33/18614,1.08E-08,2.99E-07,1.46E-07,5728/1029/1030/1027/324/4221,6
GO:0030511,positive regulation of transforming growth factor beta receptor signaling pathway,Jun-90,34/18614,1.30E-08,3.54E-07,1.74E-07,1030/1387/4089/8312/4221/6794,6
GO:1903846,positive regulation of cellular response to transforming growth factor beta stimulus,Jun-90,34/18614,1.30E-08,3.54E-07,1.74E-07,1030/1387/4089/8312/4221/6794,6
GO:0045621,positive regulation of lymphocyte differentiation,Sep-90,130/18614,1.31E-08,3.54E-07,1.74E-07,2625/57492/8289/865/861/7494/387/6597/55193,9
GO:0030071,regulation of mitotic metaphase/anaphase transition,Aug-90,91/18614,1.33E-08,3.57E-07,1.75E-07,5925/57492/8289/472/6597/324/55193/701,8
GO:0001558,regulation of cell growth,14/90,420/18614,1.36E-08,3.61E-07,1.77E-07,7157/2064/5925/999/1029/207/1956/672/27086/387/4089/1027/6597/6794,14
GO:0060253,negative regulation of glial cell proliferation,May-90,17/18614,1.40E-08,3.68E-07,1.80E-07,7157/5925/1030/4763/4851,5
GO:0031570,DNA integrity checkpoint signaling,Sep-90,132/18614,1.50E-08,3.92E-07,1.92E-07,7157/595/4193/675/672/545/472/1027/4436,9
GO:0003179,heart valve morphogenesis,Jul-90,60/18614,1.53E-08,3.96E-07,1.94E-07,2625/5925/4193/4853/387/4089/4851,7
GO:0060537,muscle tissue development,14/90,426/18614,1.62E-08,4.17E-07,2.04E-07,5925/6416/6926/4763/3845/4853/27086/861/5156/2065/2263/387/4089/4851,14
GO:0001666,response to hypoxia,Dec-90,293/18614,1.70E-08,4.33E-07,2.12E-07,7157/4609/4193/4763/1387/1788/387/4089/472/1027/4851/677,12
GO:1902099,regulation of metaphase/anaphase transition of cell cycle,Aug-90,94/18614,1.73E-08,4.37E-07,2.14E-07,5925/57492/8289/472/6597/324/55193/701,8
GO:0007091,metaphase/anaphase transition of mitotic cell cycle,Aug-90,95/18614,1.88E-08,4.71E-07,2.31E-07,5925/57492/8289/472/6597/324/55193/701,8
GO:0042770,signal transduction in response to DNA damage,Oct-90,184/18614,2.01E-08,5.01E-07,2.46E-07,7157/595/4193/675/672/545/472/546/1027/4436,10
GO:0035270,endocrine system development,Sep-90,137/18614,2.07E-08,5.13E-07,2.51E-07,2625/999/207/4763/1021/5156/4089/4221/673,9
GO:0045860,positive regulation of protein kinase activity,13/90,366/18614,2.23E-08,5.46E-07,2.68E-07,595/2064/2260/207/55294/896/1956/2065/387/8312/1027/6794/3265,13
GO:0044784,metaphase/anaphase transition of cell cycle,Aug-90,98/18614,2.40E-08,5.84E-07,2.86E-07,5925/57492/8289/472/6597/324/55193/701,8
GO:0040029,epigenetic regulation of gene expression,Oct-90,188/18614,2.47E-08,5.97E-07,2.92E-07,7157/5290/5925/57492/8289/672/10664/1788/546/8312,10
GO:0007093,mitotic cell cycle checkpoint signaling,Sep-90,140/18614,2.51E-08,6.01E-07,2.94E-07,7157/595/4193/672/472/1027/324/4436/701,9
GO:0001889,liver development,Sep-90,142/18614,2.84E-08,6.74E-07,3.30E-07,5290/595/55294/1030/6926/4763/4853/7494/4851,9
GO:0030308,negative regulation of cell growth,Oct-90,191/18614,2.87E-08,6.78E-07,3.32E-07,7157/5925/999/1029/672/27086/4089/1027/6597/6794,10
GO:0010812,negative regulation of cell-substrate adhesion,Jul-90,66/18614,3.01E-08,7.06E-07,3.46E-07,5728/1029/4763/5295/387/4851/4221,7
GO:0060251,regulation of glial cell proliferation,Jun-90,39/18614,3.10E-08,7.20E-07,3.53E-07,7157/5925/1030/4763/3845/4851,6
GO:0002696,positive regulation of leukocyte activation,13/90,377/18614,3.16E-08,7.29E-07,3.57E-07,5290/2625/57492/207/8289/865/861/7494/387/4292/6597/4436/55193,13
GO:0033002,muscle cell proliferation,Nov-90,249/18614,3.23E-08,7.35E-07,3.60E-07,5290/5728/207/3480/4763/27086/861/2263/387/1027/4851,11
GO:0050870,positive regulation of T cell activation,Nov-90,249/18614,3.23E-08,7.35E-07,3.60E-07,5290/2625/57492/207/8289/865/861/7494/387/6597/55193,11
GO:1903037,regulation of leukocyte cell-cell adhesion,13/90,378/18614,3.26E-08,7.36E-07,3.60E-07,5290/2064/2625/57492/207/8289/865/861/7494/387/6597/868/55193,13
GO:0060193,positive regulation of lipase activity,Jul-90,67/18614,3.35E-08,7.49E-07,3.67E-07,2260/1956/2099/5156/2263/387/3265,7
GO:0000819,sister chromatid segregation,Nov-90,250/18614,3.36E-08,7.49E-07,3.67E-07,5925/57492/8289/387/472/546/6597/10735/324/55193/701,11
GO:0061008,hepaticobiliary system development,Sep-90,145/18614,3.40E-08,7.52E-07,3.68E-07,5290/595/55294/1030/6926/4763/4853/7494/4851,9
GO:0071902,positive regulation of protein serine/threonine kinase activity,Oct-90,195/18614,3.49E-08,7.64E-07,3.74E-07,595/2064/2260/207/896/1956/387/8312/1027/3265,10
GO:0048568,embryonic organ development,14/90,453/18614,3.50E-08,7.64E-07,3.74E-07,7157/2625/207/6926/1956/4853/29072/5156/2263/79728/4851/677/841/639,14
GO:0048144,fibroblast proliferation,Aug-90,103/18614,3.56E-08,7.71E-07,3.77E-07,7157/4609/4763/1956/2099/1021/5156/3265,8
GO:0045926,negative regulation of growth,Nov-90,252/18614,3.65E-08,7.85E-07,3.85E-07,7157/5728/5925/999/1029/672/27086/4089/1027/6597/6794,11
GO:0033045,regulation of sister chromatid segregation,Aug-90,104/18614,3.84E-08,8.17E-07,4.00E-07,5925/57492/8289/472/6597/324/55193/701,8
GO:0002520,immune system development,Oct-90,197/18614,3.85E-08,8.17E-07,4.00E-07,7157/2625/1030/472/4292/868/4436/5395/171023/673,10
GO:0051053,negative regulation of DNA metabolic process,Sep-90,148/18614,4.06E-08,8.57E-07,4.20E-07,7157/2625/675/545/472/4292/4221/4436/2072,9
GO:0043414,macromolecule methylation,Dec-90,320/18614,4.48E-08,9.39E-07,4.60E-07,4609/2625/672/10664/7403/29072/1788/4089/546/54880/4221/639,12
GO:0022409,positive regulation of cell-cell adhesion,Dec-90,321/18614,4.64E-08,9.65E-07,4.73E-07,5290/2625/57492/207/8289/865/3169/861/7494/387/6597/55193,12
GO:0001763,morphogenesis of a branching structure,Oct-90,203/18614,5.11E-08,1.06E-06,5.18E-07,4609/6926/3845/2099/3169/29072/2263/4089/4851/639,10
GO:0050867,positive regulation of cell activation,13/90,394/18614,5.29E-08,1.09E-06,5.32E-07,5290/2625/57492/207/8289/865/861/7494/387/4292/6597/4436/55193,13
GO:1902106,negative regulation of leukocyte differentiation,Aug-90,109/18614,5.55E-08,1.12E-06,5.49E-07,4609/2064/55294/865/4763/5295/1021/861,8
GO:0030330,"DNA damage response, signal transduction by p53 class mediator",Jul-90,72/18614,5.56E-08,1.12E-06,5.49E-07,7157/4193/675/545/472/546/1027,7
GO:0060411,cardiac septum morphogenesis,Jul-90,72/18614,5.56E-08,1.12E-06,5.49E-07,7157/4193/6926/4853/2263/4089/4851,7
GO:0043524,negative regulation of neuron apoptotic process,Sep-90,155/18614,6.06E-08,1.21E-06,5.94E-07,5290/595/6416/3845/2065/387/4436/673/3265,9
GO:0071383,cellular response to steroid hormone stimulus,Oct-90,209/18614,6.72E-08,1.33E-06,6.49E-07,8289/9611/3480/2099/3169/672/27086/387/6597/677,10
GO:0003281,ventricular septum development,Jul-90,74/18614,6.74E-08,1.33E-06,6.49E-07,2625/4193/6926/2263/4089/4851/639,7
GO:0045661,regulation of myoblast differentiation,Jul-90,74/18614,6.74E-08,1.33E-06,6.49E-07,57492/8289/6926/4851/6597/677/55193,7
GO:0032868,response to insulin,Nov-90,272/18614,7.95E-08,1.55E-06,7.60E-07,5290/5925/207/896/3480/5295/208/7494/677/324/3265,11
GO:1903039,positive regulation of leukocyte cell-cell adhesion,Nov-90,273/18614,8.25E-08,1.60E-06,7.84E-07,5290/2625/57492/207/8289/865/861/7494/387/6597/55193,11
GO:0030518,intracellular steroid hormone receptor signaling pathway,Aug-90,115/18614,8.44E-08,1.62E-06,7.93E-07,8289/9611/2099/3169/672/27086/387/6597,8
GO:1903707,negative regulation of hemopoiesis,Aug-90,115/18614,8.44E-08,1.62E-06,7.93E-07,4609/2064/55294/865/4763/5295/1021/861,8
GO:0006469,negative regulation of protein kinase activity,Oct-90,217/18614,9.56E-08,1.82E-06,8.93E-07,5728/5925/1029/207/1030/4763/1027/324/868/4221,10
GO:0007159,leukocyte cell-cell adhesion,13/90,415/18614,9.67E-08,1.83E-06,8.97E-07,5290/2064/2625/57492/207/8289/865/861/7494/387/6597/868/55193,13
GO:0090287,regulation of cellular response to growth factor stimulus,Dec-90,345/18614,1.02E-07,1.92E-06,9.39E-07,7157/80139/2260/2625/1030/4853/1387/4089/8312/4851/4221/6794,12
GO:1901215,negative regulation of neuron death,Oct-90,219/18614,1.04E-07,1.95E-06,9.55E-07,5290/595/6416/207/3845/2065/387/4436/673/3265,10
GO:0060525,prostate glandular acinus development,Apr-90,10/18614,1.05E-07,1.95E-06,9.57E-07,2099/3169/2263/4851,4
GO:0046632,alpha-beta T cell differentiation,Aug-90,119/18614,1.10E-07,2.04E-06,9.98E-07,2625/865/27086/861/387/4221/673/639,8
GO:0030850,prostate gland development,Jun-90,48/18614,1.12E-07,2.07E-06,1.01E-06,2099/3169/2263/1027/4851/6794,6
GO:2001022,positive regulation of response to DNA damage stimulus,Sep-90,167/18614,1.15E-07,2.10E-06,1.03E-06,4609/57492/8289/1956/672/545/472/6597/55193,9
GO:0006304,DNA modification,Aug-90,120/18614,1.18E-07,2.13E-06,1.04E-06,4609/2625/672/10664/1788/8239/546/54790,8
GO:0043200,response to amino acid,Aug-90,120/18614,1.18E-07,2.13E-06,1.04E-06,5290/3480/1956/1788/7494/5156/387/1027,8
GO:0072089,stem cell proliferation,Aug-90,121/18614,1.25E-07,2.25E-06,1.10E-06,7157/898/6926/675/4763/861/4851/677,8
GO:0044773,mitotic DNA damage checkpoint signaling,Jul-90,81/18614,1.27E-07,2.27E-06,1.11E-06,7157/595/4193/672/472/1027/4436,7
GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,Aug-90,122/18614,1.34E-07,2.38E-06,1.16E-06,1030/4853/1387/4089/8312/4851/4221/6794,8
GO:0033598,mammary gland epithelial cell proliferation,May-90,26/18614,1.43E-07,2.53E-06,1.24E-06,595/80139/2625/675/2099,5
GO:0046777,protein autophosphorylation,Oct-90,227/18614,1.46E-07,2.56E-06,1.25E-06,2064/2260/207/3480/1956/5156/545/2263/472/6794,10
GO:0001837,epithelial to mesenchymal transition,Sep-90,172/18614,1.48E-07,2.59E-06,1.27E-06,5728/80139/2260/2625/6926/3169/2263/4089/4851,9
GO:0046631,alpha-beta T cell activation,Sep-90,175/18614,1.72E-07,2.97E-06,1.45E-06,2625/865/27086/861/387/868/4221/673/639,9
GO:0003206,cardiac chamber morphogenesis,Aug-90,126/18614,1.72E-07,2.97E-06,1.45E-06,7157/2625/4193/6926/4853/2263/4089/4851,8
GO:0006289,nucleotide-excision repair,Jul-90,85/18614,1.77E-07,3.03E-06,1.48E-06,7157/57492/8289/675/6597/55193/2072,7
GO:0044774,mitotic DNA integrity checkpoint signaling,Jul-90,85/18614,1.77E-07,3.03E-06,1.48E-06,7157/595/4193/672/472/1027/4436,7
GO:0048660,regulation of smooth muscle cell proliferation,Sep-90,176/18614,1.80E-07,3.06E-06,1.50E-06,5290/5728/207/3480/4763/27086/2263/387/1027,9
GO:0071482,cellular response to light stimulus,Aug-90,127/18614,1.82E-07,3.09E-06,1.51E-06,7157/4609/5295/208/1387/545/6794/2072,8
GO:0003197,endocardial cushion development,Jun-90,52/18614,1.84E-07,3.09E-06,1.51E-06,4193/6926/2065/4089/4851/324,6
GO:0042060,wound healing,13/90,439/18614,1.85E-07,3.09E-06,1.52E-06,5290/5728/2064/4763/4853/7494/5156/2065/2263/387/4089/2778/3265,13
GO:0032259,methylation,Dec-90,365/18614,1.87E-07,3.12E-06,1.53E-06,4609/2625/672/10664/7403/29072/1788/4089/546/54880/4221/639,12
GO:0033077,T cell differentiation in thymus,Jul-90,86/18614,1.92E-07,3.18E-06,1.56E-06,7157/2064/2625/1021/677/6794/673,7
GO:0009743,response to carbohydrate,Oct-90,234/18614,1.93E-07,3.18E-06,1.56E-06,5290/6416/3480/7494/387/4089/1027/6597/677/4221,10
GO:0008286,insulin receptor signaling pathway,Aug-90,128/18614,1.94E-07,3.18E-06,1.56E-06,5290/207/896/3480/5295/208/324/3265,8
GO:0010001,glial cell differentiation,Oct-90,235/18614,2.01E-07,3.28E-06,1.60E-06,5728/2064/207/4763/3845/1021/208/2065/387/4851,10
GO:0045931,positive regulation of mitotic cell cycle,Aug-90,129/18614,2.06E-07,3.33E-06,1.63E-06,595/5925/207/896/4193/675/1956/3169,8
GO:0048146,positive regulation of fibroblast proliferation,Jun-90,53/18614,2.06E-07,3.33E-06,1.63E-06,4609/1956/2099/1021/5156/3265,6
GO:0048659,smooth muscle cell proliferation,Sep-90,180/18614,2.18E-07,3.50E-06,1.72E-06,5290/5728/207/3480/4763/27086/2263/387/1027,9
GO:0014009,glial cell proliferation,Jun-90,54/18614,2.31E-07,3.67E-06,1.80E-06,7157/5925/1030/4763/3845/4851,6
GO:0038127,ERBB signaling pathway,Aug-90,131/18614,2.32E-07,3.67E-06,1.80E-06,5290/2064/207/55294/1956/2065/868/673,8
GO:0051983,regulation of chromosome segregation,Aug-90,131/18614,2.32E-07,3.67E-06,1.80E-06,5925/57492/8289/472/6597/324/55193/701,8
GO:0033673,negative regulation of kinase activity,Oct-90,239/18614,2.35E-07,3.70E-06,1.81E-06,5728/5925/1029/207/1030/4763/1027/324/868/4221,10
GO:0006479,protein methylation,Sep-90,182/18614,2.40E-07,3.73E-06,1.83E-06,2625/672/7403/29072/1788/4089/54880/4221/639,9
GO:0008213,protein alkylation,Sep-90,182/18614,2.40E-07,3.73E-06,1.83E-06,2625/672/7403/29072/1788/4089/54880/4221/639,9
GO:0001892,embryonic placenta development,Jul-90,89/18614,2.44E-07,3.76E-06,1.84E-06,207/1956/29072/2263/677/841/639,7
GO:0060191,regulation of lipase activity,Jul-90,89/18614,2.44E-07,3.76E-06,1.84E-06,2260/1956/2099/5156/2263/387/3265,7
GO:0031571,mitotic G1 DNA damage checkpoint signaling,May-90,29/18614,2.56E-07,3.91E-06,1.92E-06,7157/595/4193/472/1027,5
GO:0044819,mitotic G1/S transition checkpoint signaling,May-90,29/18614,2.56E-07,3.91E-06,1.92E-06,7157/595/4193/472/1027,5
GO:0010518,positive regulation of phospholipase activity,Jun-90,55/18614,2.59E-07,3.92E-06,1.92E-06,2260/1956/2099/5156/2263/3265,6
GO:0043525,positive regulation of neuron apoptotic process,Jun-90,55/18614,2.59E-07,3.92E-06,1.92E-06,7157/6416/55294/4763/387/472,6
GO:0048738,cardiac muscle tissue development,Oct-90,243/18614,2.74E-07,4.13E-06,2.02E-06,6416/6926/4853/27086/861/5156/2065/2263/4089/4851,10
GO:0043401,steroid hormone mediated signaling pathway,Aug-90,135/18614,2.92E-07,4.38E-06,2.15E-06,8289/9611/2099/3169/672/27086/387/6597,8
GO:0031098,stress-activated protein kinase signaling cascade,Oct-90,245/18614,2.95E-07,4.38E-06,2.15E-06,4609/6416/9611/3480/1956/387/8312/677/4221/3265,10
GO:0001822,kidney development,Nov-90,310/18614,2.96E-07,4.38E-06,2.15E-06,4609/2625/4763/4853/5156/2263/387/4089/4851/171023/639,11
GO:0050767,regulation of neurogenesis,Dec-90,381/18614,2.96E-07,4.38E-06,2.15E-06,7157/5728/5925/999/1030/23013/4763/3845/1523/4851/6794/673,12
GO:0071480,cellular response to gamma radiation,May-90,30/18614,3.06E-07,4.48E-06,2.20E-06,7157/4193/545/472/3265,5
GO:1901216,positive regulation of neuron death,Jul-90,92/18614,3.06E-07,4.48E-06,2.20E-06,7157/6416/55294/4763/387/472/841,7
GO:0001101,response to acid chemical,Aug-90,136/18614,3.09E-07,4.51E-06,2.21E-06,5290/3480/1956/1788/7494/5156/387/1027,8
GO:0048863,stem cell differentiation,Oct-90,247/18614,3.18E-07,4.62E-06,2.26E-06,7157/6926/2099/3169/1021/29072/5156/2263/4089/4851,10
GO:0072132,mesenchyme morphogenesis,Jun-90,57/18614,3.21E-07,4.63E-06,2.27E-06,4609/4193/6926/4089/4851/324,6
GO:0016055,Wnt signaling pathway,13/90,461/18614,3.23E-07,4.63E-06,2.27E-06,595/5728/80139/2625/898/1956/2263/387/8312/4851/6597/324/6794,13
GO:0051960,regulation of nervous system development,13/90,461/18614,3.23E-07,4.63E-06,2.27E-06,7157/5728/5925/999/207/1030/23013/4763/3845/1523/4851/6794/673,13
GO:0034644,cellular response to UV,Jul-90,93/18614,3.30E-07,4.69E-06,2.30E-06,7157/4609/5295/1387/545/6794/2072,7
GO:0042593,glucose homeostasis,Oct-90,248/18614,3.31E-07,4.69E-06,2.30E-06,5290/207/3480/5295/3169/7494/4089/6597/4221/6794,10
GO:0198738,cell-cell signaling by wnt,13/90,463/18614,3.39E-07,4.80E-06,2.35E-06,595/5728/80139/2625/898/1956/2263/387/8312/4851/6597/324/6794,13
GO:0033500,carbohydrate homeostasis,Oct-90,249/18614,3.43E-07,4.82E-06,2.36E-06,5290/207/3480/5295/3169/7494/4089/6597/4221/6794,10
GO:0070372,regulation of ERK1 and ERK2 cascade,Nov-90,315/18614,3.47E-07,4.86E-06,2.38E-06,5728/2064/55294/1956/4853/5156/2263/4089/4851/673/3265,11
GO:0097305,response to alcohol,Oct-90,252/18614,3.83E-07,5.34E-06,2.61E-06,595/2625/999/207/3480/672/1788/2263/387/841,10
GO:1904019,epithelial cell apoptotic process,Aug-90,140/18614,3.86E-07,5.36E-06,2.63E-06,2625/5925/3480/2099/1788/1027/677/673,8
GO:0007062,sister chromatid cohesion,Jun-90,59/18614,3.96E-07,5.47E-06,2.68E-06,5925/55294/10664/546/10735/701,6
GO:0072001,renal system development,Nov-90,320/18614,4.06E-07,5.58E-06,2.73E-06,4609/2625/4763/4853/5156/2263/387/4089/4851/171023/639,11
GO:0014706,striated muscle tissue development,Oct-90,259/18614,4.92E-07,6.75E-06,3.30E-06,6416/6926/4853/27086/861/5156/2065/2263/4089/4851,10
GO:0003007,heart morphogenesis,Oct-90,262/18614,5.47E-07,7.46E-06,3.65E-06,7157/2625/4193/6926/4853/2263/4089/4851/324/171023,10
GO:0071824,protein-DNA complex subunit organization,Oct-90,263/18614,5.67E-07,7.69E-06,3.77E-06,7157/4609/5925/8289/2099/9439/29072/546/6597/4778,10
GO:0017015,regulation of transforming growth factor beta receptor signaling pathway,Aug-90,148/18614,5.90E-07,7.98E-06,3.91E-06,7157/80139/1030/1387/4089/8312/4221/6794,8
GO:0051568,histone H3-K4 methylation,Jun-90,64/18614,6.46E-07,8.66E-06,4.24E-06,2625/672/7403/4089/54880/4221,6
GO:0042692,muscle cell differentiation,Dec-90,410/18614,6.46E-07,8.66E-06,4.24E-06,5925/6416/207/4193/6926/3845/27086/7494/5156/2263/4089/4851,12
GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,Jul-90,103/18614,6.63E-07,8.85E-06,4.33E-06,7157/675/5295/672/472/4292/4436,7
GO:0033599,regulation of mammary gland epithelial cell proliferation,Apr-90,15/18614,6.70E-07,8.90E-06,4.36E-06,595/80139/2625/675,4
GO:1903844,regulation of cellular response to transforming growth factor beta stimulus,Aug-90,151/18614,6.88E-07,9.11E-06,4.46E-06,7157/80139/1030/1387/4089/8312/4221/6794,8
GO:0034968,histone lysine methylation,Jul-90,104/18614,7.08E-07,9.33E-06,4.57E-06,2625/672/7403/29072/4089/54880/4221,7
GO:0043410,positive regulation of MAPK cascade,13/90,495/18614,7.22E-07,9.46E-06,4.63E-06,2064/2260/6416/55294/3480/1956/4853/5156/2263/8312/4851/673/3265,13
GO:0071322,cellular response to carbohydrate stimulus,Aug-90,152/18614,7.23E-07,9.46E-06,4.63E-06,5290/6416/3480/7494/4089/6597/677/4221,8
GO:0001655,urogenital system development,Jun-90,66/18614,7.77E-07,1.01E-05,4.93E-06,2099/3169/2263/1027/4851/6794,6
GO:0010517,regulation of phospholipase activity,Jun-90,66/18614,7.77E-07,1.01E-05,4.93E-06,2260/1956/2099/5156/2263/3265,6
GO:0002064,epithelial cell development,Sep-90,210/18614,7.99E-07,1.03E-05,5.06E-06,207/2099/3169/1021/4853/546/4851/171023/639,9
GO:1901796,regulation of signal transduction by p53 class mediator,Jul-90,106/18614,8.06E-07,1.04E-05,5.08E-06,7157/4609/207/4193/545/472/6794,7
GO:0033144,negative regulation of intracellular steroid hormone receptor signaling pathway,May-90,37/18614,9.11E-07,1.17E-05,5.72E-06,9611/672/27086/387/6597,5
GO:0036294,cellular response to decreased oxygen levels,Aug-90,157/18614,9.24E-07,1.17E-05,5.75E-06,7157/4609/207/4193/1788/1027/4851/677,8
GO:0048754,branching morphogenesis of an epithelial tube,Aug-90,157/18614,9.24E-07,1.17E-05,5.75E-06,4609/6926/3845/2099/3169/2263/4089/4851,8
GO:0043491,protein kinase B signaling,Sep-90,215/18614,9.73E-07,1.23E-05,6.01E-06,5290/5728/2260/2625/207/3480/1956/677/6794,9
GO:1904035,regulation of epithelial cell apoptotic process,Jul-90,109/18614,9.74E-07,1.23E-05,6.01E-06,2625/5925/3480/2099/1027/677/673,7
GO:0007409,axonogenesis,Dec-90,427/18614,9.91E-07,1.24E-05,6.09E-06,5728/2064/2625/999/3480/4853/8239/2263/4089/4851/6794/673,12
GO:0007179,transforming growth factor beta receptor signaling pathway,Sep-90,218/18614,1.09E-06,1.37E-05,6.69E-06,7157/80139/1030/1387/8239/4089/8312/4221/6794,9
GO:0007548,sex differentiation,Oct-90,283/18614,1.10E-06,1.37E-05,6.73E-06,595/2625/6926/675/2099/5156/4089/472/546/4436,10
GO:0090399,replicative senescence,Apr-90,17/18614,1.16E-06,1.44E-05,7.04E-06,7157/1029/545/472,4
GO:0045737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,May-90,39/18614,1.19E-06,1.47E-05,7.20E-06,595/207/896/1956/1027,5
GO:0070316,regulation of G0 to G1 transition,May-90,39/18614,1.19E-06,1.47E-05,7.20E-06,57492/8289/1030/6597/55193,5
GO:0010810,regulation of cell-substrate adhesion,Sep-90,222/18614,1.27E-06,1.56E-05,7.62E-06,5728/1029/4763/5295/1021/387/4851/4221/673,9
GO:0033143,regulation of intracellular steroid hormone receptor signaling pathway,Jun-90,72/18614,1.31E-06,1.59E-05,7.81E-06,9611/3169/672/27086/387/6597,6
GO:0007173,epidermal growth factor receptor signaling pathway,Jul-90,114/18614,1.32E-06,1.60E-05,7.85E-06,5290/2064/207/55294/1956/868/673,7
GO:0045936,negative regulation of phosphate metabolic process,Dec-90,439/18614,1.32E-06,1.60E-05,7.85E-06,7157/5728/5925/1029/207/1030/9611/4763/1027/324/868/4221,12
GO:0042176,regulation of protein catabolic process,Nov-90,361/18614,1.33E-06,1.60E-05,7.85E-06,999/207/55294/4193/1956/8239/4089/8312/1027/324/868,11
GO:0009410,response to xenobiotic stimulus,Dec-90,440/18614,1.36E-06,1.62E-05,7.94E-06,7157/4609/595/2625/5925/999/1788/545/387/1027/5395/673,12
GO:0010563,negative regulation of phosphorus metabolic process,Dec-90,440/18614,1.36E-06,1.62E-05,7.94E-06,7157/5728/5925/1029/207/1030/9611/4763/1027/324/868/4221,12
GO:0010863,positive regulation of phospholipase C activity,May-90,40/18614,1.36E-06,1.62E-05,7.94E-06,2260/1956/2099/5156/3265,5
GO:0010639,negative regulation of organelle organization,Nov-90,362/18614,1.36E-06,1.62E-05,7.94E-06,7157/5290/207/5295/672/4089/472/546/324/701/2072,11
GO:0035710,"CD4-positive, alpha-beta T cell activation",Jul-90,115/18614,1.40E-06,1.66E-05,8.12E-06,2625/865/27086/861/868/4221/673,7
GO:0030856,regulation of epithelial cell differentiation,Aug-90,166/18614,1.41E-06,1.66E-05,8.14E-06,595/2625/1030/6926/3845/1027/4851/677,8
GO:0006977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",Apr-90,18/18614,1.48E-06,1.75E-05,8.55E-06,7157/4193/472/1027,4
GO:0002067,glandular epithelial cell differentiation,Jun-90,74/18614,1.54E-06,1.79E-05,8.76E-06,207/3169/1021/2263/4851/4221,6
GO:0046661,male sex differentiation,Aug-90,168/18614,1.54E-06,1.79E-05,8.76E-06,595/2625/6926/2099/5156/4089/546/4436,8
GO:0003203,endocardial cushion morphogenesis,May-90,41/18614,1.54E-06,1.79E-05,8.76E-06,4193/6926/4089/4851/324,5
GO:0045023,G0 to G1 transition,May-90,41/18614,1.54E-06,1.79E-05,8.76E-06,57492/8289/1030/6597/55193,5
GO:0008406,gonad development,Sep-90,228/18614,1.58E-06,1.83E-05,8.95E-06,595/2625/675/2099/5156/4089/472/546/4436,9
GO:0002065,columnar/cuboidal epithelial cell differentiation,Jul-90,118/18614,1.66E-06,1.91E-05,9.37E-06,207/3169/1021/2263/4851/4221/639,7
GO:0018108,peptidyl-tyrosine phosphorylation,Nov-90,370/18614,1.69E-06,1.93E-05,9.47E-06,7157/2064/2260/6416/55294/3480/1956/5156/2065/2263/868,11
GO:0051146,striated muscle cell differentiation,Oct-90,297/18614,1.71E-06,1.95E-05,9.54E-06,5925/6416/207/6926/3845/27086/7494/5156/4089/4851,10
GO:0000280,nuclear division,Dec-90,450/18614,1.71E-06,1.95E-05,9.55E-06,5925/898/675/387/472/546/1027/4292/10735/324/701/2072,12
GO:0010631,epithelial cell migration,Nov-90,371/18614,1.73E-06,1.96E-05,9.61E-06,5290/5728/2260/2625/207/55294/4763/27086/387/4089/4851,11
GO:1900274,regulation of phospholipase C activity,May-90,42/18614,1.74E-06,1.96E-05,9.62E-06,2260/1956/2099/5156/3265,5
GO:1904031,positive regulation of cyclin-dependent protein kinase activity,May-90,42/18614,1.74E-06,1.96E-05,9.62E-06,595/207/896/1956/1027,5
GO:0018212,peptidyl-tyrosine modification,Nov-90,372/18614,1.78E-06,1.99E-05,9.76E-06,7157/2064/2260/6416/55294/3480/1956/5156/2065/2263/868,11
GO:0007422,peripheral nervous system development,Jun-90,76/18614,1.80E-06,2.01E-05,9.85E-06,2064/207/4763/208/861/2065,6
GO:0071453,cellular response to oxygen levels,Aug-90,172/18614,1.84E-06,2.05E-05,1.00E-05,7157/4609/207/4193/1788/1027/4851/677,8
GO:0018205,peptidyl-lysine modification,Nov-90,374/18614,1.87E-06,2.07E-05,1.01E-05,2625/4193/23451/675/672/7403/29072/1387/4089/54880/4221,11
GO:0090132,epithelium migration,Nov-90,374/18614,1.87E-06,2.07E-05,1.01E-05,5290/5728/2260/2625/207/55294/4763/27086/387/4089/4851,11
GO:0045137,development of primary sexual characteristics,Sep-90,233/18614,1.89E-06,2.09E-05,1.02E-05,595/2625/675/2099/5156/4089/472/546/4436,9
GO:0090092,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,Oct-90,301/18614,1.92E-06,2.11E-05,1.03E-05,7157/80139/1030/4853/1387/4089/8312/4851/4221/6794,10
GO:0090130,tissue migration,Nov-90,379/18614,2.13E-06,2.33E-05,1.14E-05,5290/5728/2260/2625/207/55294/4763/27086/387/4089/4851,11
GO:0051403,stress-activated MAPK cascade,Sep-90,237/18614,2.18E-06,2.38E-05,1.16E-05,4609/6416/9611/3480/1956/8312/677/4221/3265,9
GO:0018022,peptidyl-lysine methylation,Jul-90,123/18614,2.20E-06,2.39E-05,1.17E-05,2625/672/7403/29072/4089/54880/4221,7
GO:2001233,regulation of apoptotic signaling pathway,Nov-90,381/18614,2.24E-06,2.43E-05,1.19E-05,7157/4609/5728/2260/5925/207/55294/4193/4763/672/7494,11
GO:0045655,regulation of monocyte differentiation,Apr-90,20/18614,2.33E-06,2.52E-05,1.23E-05,4609/1021/27086/677,4
GO:0042326,negative regulation of phosphorylation,Nov-90,383/18614,2.35E-06,2.53E-05,1.24E-05,5728/5925/1029/207/1030/9611/4763/1027/324/868/4221,11
GO:0007219,Notch signaling pathway,Aug-90,179/18614,2.48E-06,2.65E-05,1.30E-05,207/55294/23013/3169/1021/4853/1027/4851,8
GO:0014014,negative regulation of gliogenesis,May-90,45/18614,2.48E-06,2.65E-05,1.30E-05,7157/5925/1030/4763/4851,5
GO:0007389,pattern specification process,Dec-90,467/18614,2.51E-06,2.68E-05,1.31E-05,7157/6926/3169/4853/2263/79728/4089/472/8312/54880/4851/324,12
GO:0035265,organ growth,Aug-90,180/18614,2.58E-06,2.72E-05,1.33E-05,5728/6416/207/2099/27086/861/2263/4851,8
GO:0003231,cardiac ventricle development,Jul-90,126/18614,2.58E-06,2.72E-05,1.33E-05,2625/4193/6926/2263/4089/4851/639,7
GO:0045471,response to ethanol,Jul-90,126/18614,2.58E-06,2.72E-05,1.33E-05,595/2625/3480/1788/2263/387/841,7
GO:0032986,protein-DNA complex disassembly,Apr-90,21/18614,2.87E-06,3.02E-05,1.48E-05,4609/8289/6597/4778,4
GO:0045444,fat cell differentiation,Sep-90,246/18614,2.96E-06,3.10E-05,1.52E-05,595/2625/207/208/7494/5156/8312/677/171023,9
GO:0016570,histone modification,Dec-90,475/18614,2.99E-06,3.13E-05,1.53E-05,7157/2625/23451/675/672/7403/29072/1387/4089/54880/4221/171023,12
GO:0072332,intrinsic apoptotic signaling pathway by p53 class mediator,Jun-90,83/18614,3.02E-06,3.14E-05,1.54E-05,7157/4609/4193/675/4436/6794,6
GO:0030521,androgen receptor signaling pathway,May-90,47/18614,3.09E-06,3.19E-05,1.56E-05,8289/9611/27086/387/6597,5
GO:1905314,semi-lunar valve development,May-90,47/18614,3.09E-06,3.19E-05,1.56E-05,2625/5925/4853/387/4851,5
GO:0061564,axon development,Dec-90,479/18614,3.26E-06,3.36E-05,1.65E-05,5728/2064/2625/999/3480/4853/8239/2263/4089/4851/6794/673,12
GO:0007178,transmembrane receptor protein serine/threonine kinase signaling pathway,Nov-90,398/18614,3.41E-06,3.50E-05,1.71E-05,7157/80139/1030/4853/1387/8239/4089/8312/4851/4221/6794,11
GO:0061138,morphogenesis of a branching epithelium,Aug-90,188/18614,3.57E-06,3.65E-05,1.79E-05,4609/6926/3845/2099/3169/2263/4089/4851,8
GO:0016571,histone methylation,Jul-90,133/18614,3.70E-06,3.78E-05,1.85E-05,2625/672/7403/29072/4089/54880/4221,7
GO:0048762,mesenchymal cell differentiation,Sep-90,255/18614,3.97E-06,4.03E-05,1.98E-05,5728/80139/2260/2625/6926/3169/2263/4089/4851,9
GO:0006913,nucleocytoplasmic transport,Oct-90,328/18614,4.14E-06,4.18E-05,2.05E-05,7157/999/207/4763/5295/29072/8312/1027/4851/868,10
GO:0051169,nuclear transport,Oct-90,328/18614,4.14E-06,4.18E-05,2.05E-05,7157/999/207/4763/5295/29072/8312/1027/4851/868,10
GO:0009755,hormone-mediated signaling pathway,Aug-90,192/18614,4.17E-06,4.20E-05,2.06E-05,8289/9611/2099/3169/672/27086/387/6597,8
GO:0002768,immune response-regulating cell surface receptor signaling pathway,Oct-90,329/18614,4.25E-06,4.27E-05,2.09E-05,5290/2625/4214/6416/1387/27086/868/6794/673/3265,10
GO:0032872,regulation of stress-activated MAPK cascade,Aug-90,193/18614,4.33E-06,4.34E-05,2.12E-05,4609/6416/9611/3480/1956/8312/4221/3265,8
GO:0009749,response to glucose,Aug-90,194/18614,4.50E-06,4.48E-05,2.20E-05,5290/3480/7494/387/4089/1027/6597/4221,8
GO:0007498,mesoderm development,Jul-90,137/18614,4.51E-06,4.48E-05,2.20E-05,6926/29072/2263/79728/4089/8312/677,7
GO:0043367,"CD4-positive, alpha-beta T cell differentiation",Jun-90,89/18614,4.55E-06,4.51E-05,2.21E-05,2625/865/27086/861/4221/673,6
GO:0001667,ameboidal-type cell migration,Dec-90,496/18614,4.66E-06,4.61E-05,2.26E-05,5290/5728/2260/2625/207/55294/4763/27086/387/4089/4851/673,12
GO:0007265,Ras protein signal transduction,Oct-90,333/18614,4.73E-06,4.66E-05,2.28E-05,7157/5925/1029/4763/3845/4853/387/4851/4893/3265,10
GO:0048285,organelle fission,Dec-90,497/18614,4.76E-06,4.68E-05,2.29E-05,5925/898/675/387/472/546/1027/4292/10735/324/701/2072,12
GO:0070302,regulation of stress-activated protein kinase signaling cascade,Aug-90,196/18614,4.85E-06,4.76E-05,2.33E-05,4609/6416/9611/3480/1956/8312/4221/3265,8
GO:0090068,positive regulation of cell cycle process,Sep-90,262/18614,4.94E-06,4.83E-05,2.36E-05,595/5925/207/896/4193/3480/1956/387/546,9
GO:0046328,regulation of JNK cascade,Jul-90,139/18614,4.96E-06,4.83E-05,2.36E-05,6416/9611/3480/1956/8312/4221/3265,7
GO:0002762,negative regulation of myeloid leukocyte differentiation,May-90,52/18614,5.13E-06,4.98E-05,2.44E-05,4609/55294/4763/5295/1021,5
GO:0072091,regulation of stem cell proliferation,Jun-90,91/18614,5.17E-06,5.01E-05,2.45E-05,7157/898/6926/4763/4851/677,6
GO:0009746,response to hexose,Aug-90,199/18614,5.43E-06,5.24E-05,2.56E-05,5290/3480/7494/387/4089/1027/6597/4221,8
GO:0009798,axis specification,Jun-90,92/18614,5.51E-06,5.29E-05,2.59E-05,6926/4853/4089/8312/54880/4851,6
GO:0055006,cardiac cell development,Jun-90,92/18614,5.51E-06,5.29E-05,2.59E-05,6416/6926/27086/5156/4089/4851,6
GO:0001933,negative regulation of protein phosphorylation,Oct-90,341/18614,5.83E-06,5.57E-05,2.73E-05,5728/5925/1029/207/1030/4763/1027/324/868/4221,10
GO:0006312,mitotic recombination,Apr-90,25/18614,5.98E-06,5.70E-05,2.79E-05,675/4292/4436/2072,4
GO:0008584,male gonad development,Jul-90,144/18614,6.26E-06,5.95E-05,2.91E-05,595/2625/2099/5156/4089/546/4436,7
GO:0035264,multicellular organism growth,Jul-90,145/18614,6.56E-06,6.19E-05,3.03E-05,7157/5290/4853/79728/472/546/677,7
GO:0046546,development of primary male sexual characteristics,Jul-90,145/18614,6.56E-06,6.19E-05,3.03E-05,595/2625/2099/5156/4089/546/4436,7
GO:0045638,negative regulation of myeloid cell differentiation,Jun-90,95/18614,6.64E-06,6.25E-05,3.06E-05,4609/55294/4763/5295/1021/677,6
GO:0022408,negative regulation of cell-cell adhesion,Aug-90,205/18614,6.75E-06,6.34E-05,3.11E-05,2064/80139/999/207/865/861/4851/868,8
GO:1900087,positive regulation of G1/S transition of mitotic cell cycle,May-90,55/18614,6.79E-06,6.36E-05,3.11E-05,595/207/896/4193/1956,5
GO:0035107,appendage morphogenesis,Jul-90,146/18614,6.86E-06,6.36E-05,3.12E-05,6926/4853/1387/2263/4089/546/4851,7
GO:0035108,limb morphogenesis,Jul-90,146/18614,6.86E-06,6.36E-05,3.12E-05,6926/4853/1387/2263/4089/546/4851,7
GO:0072073,kidney epithelium development,Jul-90,146/18614,6.86E-06,6.36E-05,3.12E-05,4609/2625/4853/2263/4089/4851/171023,7
GO:0001503,ossification,Nov-90,429/18614,6.95E-06,6.43E-05,3.15E-05,207/865/4763/1956/1021/2263/387/4089/54880/4851/4221,11
GO:0060740,prostate gland epithelium morphogenesis,Apr-90,26/18614,7.04E-06,6.47E-05,3.17E-05,2099/3169/2263/4851,4
GO:0031507,heterochromatin formation,Jun-90,96/18614,7.06E-06,6.47E-05,3.17E-05,5290/5925/10664/1788/546/8312,6
GO:0048534,hematopoietic or lymphoid organ development,Jun-90,96/18614,7.06E-06,6.47E-05,3.17E-05,7157/2625/1030/472/171023/673,6
GO:0120161,regulation of cold-induced thermogenesis,Jul-90,147/18614,7.17E-06,6.56E-05,3.21E-05,5925/3480/2778/4851/324/4849/6794,7
GO:0034284,response to monosaccharide,Aug-90,207/18614,7.25E-06,6.61E-05,3.24E-05,5290/3480/7494/387/4089/1027/6597/4221,8
GO:0106106,cold-induced thermogenesis,Jul-90,148/18614,7.50E-06,6.80E-05,3.33E-05,5925/3480/2778/4851/324/4849/6794,7
GO:0002285,lymphocyte activation involved in immune response,Aug-90,208/18614,7.51E-06,6.80E-05,3.33E-05,7157/2625/4853/27086/7494/4292/4221/4436,8
GO:0042113,B cell activation,Sep-90,276/18614,7.53E-06,6.80E-05,3.33E-05,7157/5295/4853/7494/472/4292/677/841/4436,9
GO:0071456,cellular response to hypoxia,Jul-90,149/18614,7.84E-06,7.07E-05,3.46E-05,7157/4609/4193/1788/1027/4851/677,7
GO:0050768,negative regulation of neurogenesis,Jul-90,150/18614,8.19E-06,7.36E-05,3.61E-05,7157/5728/5925/999/1030/4763/4851,7
GO:0045815,transcription initiation-coupled chromatin remodeling,Apr-90,27/18614,8.24E-06,7.38E-05,3.62E-05,7157/5290/57492/8289,4
GO:0048661,positive regulation of smooth muscle cell proliferation,Jun-90,99/18614,8.43E-06,7.52E-05,3.68E-05,5290/207/3480/4763/27086/2263,6
GO:1901992,positive regulation of mitotic cell cycle phase transition,Jun-90,99/18614,8.43E-06,7.52E-05,3.68E-05,595/5925/207/896/4193/1956,6
GO:0072006,nephron development,Jul-90,152/18614,8.93E-06,7.90E-05,3.87E-05,4609/2625/4853/5156/4089/4851/171023,7
GO:0035282,segmentation,Jun-90,100/18614,8.94E-06,7.90E-05,3.87E-05,7157/6926/79728/4089/472/4851,6
GO:0031396,regulation of protein ubiquitination,Aug-90,213/18614,8.94E-06,7.90E-05,3.87E-05,5728/207/55294/672/8312/1027/868/701,8
GO:0043542,endothelial cell migration,Sep-90,283/18614,9.20E-06,8.11E-05,3.97E-05,5290/2260/2625/207/55294/4763/27086/387/4851,9
GO:0006282,regulation of DNA repair,Aug-90,214/18614,9.25E-06,8.13E-05,3.98E-05,57492/8289/1956/672/29072/545/6597/55193,8
GO:0030183,B cell differentiation,Jul-90,153/18614,9.33E-06,8.17E-05,4.00E-05,7157/5295/4853/7494/472/677/4436,7
GO:0051569,regulation of histone H3-K4 methylation,Apr-90,28/18614,9.57E-06,8.32E-05,4.07E-05,2625/672/4089/54880,4
GO:0060512,prostate gland morphogenesis,Apr-90,28/18614,9.57E-06,8.32E-05,4.07E-05,2099/3169/2263/4851,4
GO:2000819,regulation of nucleotide-excision repair,Apr-90,28/18614,9.57E-06,8.32E-05,4.07E-05,57492/8289/6597/55193,4
GO:0002763,positive regulation of myeloid leukocyte differentiation,May-90,59/18614,9.63E-06,8.32E-05,4.07E-05,5925/4853/861/677/841,5
GO:0051438,regulation of ubiquitin-protein transferase activity,May-90,59/18614,9.63E-06,8.32E-05,4.07E-05,5728/55294/8312/1027/701,5
GO:0046620,regulation of organ growth,Jun-90,102/18614,1.00E-05,8.61E-05,4.22E-05,5728/207/27086/861/2263/4851,6
GO:1905477,positive regulation of protein localization to membrane,Jun-90,102/18614,1.00E-05,8.61E-05,4.22E-05,2064/207/5295/1956/208/3265,6
GO:0000723,telomere maintenance,Jul-90,156/18614,1.06E-05,9.05E-05,4.43E-05,4609/898/675/545/472/546/2072,7
GO:0051961,negative regulation of nervous system development,Jul-90,156/18614,1.06E-05,9.05E-05,4.43E-05,7157/5728/5925/999/1030/4763/4851,7
GO:0002764,immune response-regulating signaling pathway,Nov-90,450/18614,1.09E-05,9.27E-05,4.54E-05,5290/2625/4214/6416/2099/1387/27086/868/6794/673/3265,11
GO:0031331,positive regulation of cellular catabolic process,Nov-90,450/18614,1.09E-05,9.27E-05,4.54E-05,5728/207/55294/4193/208/472/8312/4292/677/4849/6794,11
GO:0001678,intracellular glucose homeostasis,Jul-90,157/18614,1.10E-05,9.36E-05,4.59E-05,5290/3480/5295/7494/4089/6597/4221,7
GO:0070828,heterochromatin organization,Jun-90,105/18614,1.18E-05,0.000100113,4.90E-05,5290/5925/10664/1788/546/8312,6
GO:0070374,positive regulation of ERK1 and ERK2 cascade,Aug-90,222/18614,1.21E-05,0.000101928,4.99E-05,55294/1956/4853/5156/2263/4851/673/3265,8
GO:1904036,negative regulation of epithelial cell apoptotic process,May-90,62/18614,1.23E-05,0.000103503,5.07E-05,2625/5925/3480/1027/673,5
GO:0035066,positive regulation of histone acetylation,Apr-90,30/18614,1.27E-05,0.000106752,5.23E-05,2625/23451/672/4089,4
GO:0043970,histone H3-K9 acetylation,Mar-90,10/18614,1.28E-05,0.000106785,5.23E-05,2625/672/4089,3
GO:0060768,regulation of epithelial cell proliferation involved in prostate gland development,Mar-90,10/18614,1.28E-05,0.000106785,5.23E-05,1027/4851/6794,3
GO:0010632,regulation of epithelial cell migration,Sep-90,295/18614,1.28E-05,0.000106785,5.23E-05,5728/2260/2625/207/55294/4763/27086/387/4851,9
GO:0035051,cardiocyte differentiation,Jul-90,161/18614,1.30E-05,0.000107729,5.28E-05,6416/6926/1956/27086/5156/4089/4851,7
GO:1990845,adaptive thermogenesis,Jul-90,161/18614,1.30E-05,0.000107729,5.28E-05,5925/3480/2778/4851/324/4849/6794,7
GO:0014013,regulation of gliogenesis,Jun-90,108/18614,1.39E-05,0.000114901,5.63E-05,7157/5925/1030/4763/3845/4851,6
GO:0006606,protein import into nucleus,Jul-90,163/18614,1.41E-05,0.000116124,5.69E-05,7157/999/207/4763/5295/4851/868,7
GO:0097191,extrinsic apoptotic signaling pathway,Aug-90,227/18614,1.42E-05,0.000116672,5.71E-05,5728/2260/207/4763/5295/672/2065/841,8
GO:0030522,intracellular receptor signaling pathway,Sep-90,299/18614,1.43E-05,0.000117015,5.73E-05,8289/9611/2099/3169/672/27086/387/6597/171023,9
GO:0045814,"negative regulation of gene expression, epigenetic",Jun-90,109/18614,1.47E-05,0.000119874,5.87E-05,5290/5925/10664/1788/546/8312,6
GO:0010717,regulation of epithelial to mesenchymal transition,Jun-90,110/18614,1.54E-05,0.000125975,6.17E-05,5728/80139/2625/3169/4089/4851,6
GO:0048511,rhythmic process,Sep-90,303/18614,1.59E-05,0.000129032,6.32E-05,7157/5728/55294/9611/3480/2099/1387/8239/5156,9
GO:0034504,protein localization to nucleus,Sep-90,304/18614,1.63E-05,0.000131769,6.45E-05,7157/999/207/4193/4763/5295/4851/868/6794,9
GO:0048872,homeostasis of number of cells,Sep-90,304/18614,1.63E-05,0.000131769,6.45E-05,2625/5925/207/4763/3845/1021/4851/677/171023,9
GO:0006298,mismatch repair,Apr-90,32/18614,1.66E-05,0.000133726,6.55E-05,29072/4292/4436/5395,4
GO:0010594,regulation of endothelial cell migration,Aug-90,232/18614,1.66E-05,0.000133782,6.55E-05,2260/2625/207/55294/4763/27086/387/4851,8
GO:0001756,somitogenesis,May-90,66/18614,1.67E-05,0.000134358,6.58E-05,7157/79728/4089/472/4851,5
GO:0014066,regulation of phosphatidylinositol 3-kinase signaling,Jun-90,112/18614,1.71E-05,0.000136979,6.71E-05,5728/2260/3480/1956/5156/2065,6
GO:0051170,import into nucleus,Jul-90,168/18614,1.71E-05,0.000136979,6.71E-05,7157/999/207/4763/5295/4851/868,7
GO:0060742,epithelial cell differentiation involved in prostate gland development,Mar-90,11/18614,1.75E-05,0.000139065,6.81E-05,3169/2263/4851,3
GO:0060767,epithelial cell proliferation involved in prostate gland development,Mar-90,11/18614,1.75E-05,0.000139065,6.81E-05,1027/4851/6794,3
GO:2000672,negative regulation of motor neuron apoptotic process,Mar-90,11/18614,1.75E-05,0.000139065,6.81E-05,6416/2065/387,3
GO:0060348,bone development,Aug-90,235/18614,1.82E-05,0.000144194,7.06E-05,7157/55294/4853/27086/2263/387/2778/171023,8
GO:0007254,JNK cascade,Jul-90,170/18614,1.85E-05,0.000145828,7.14E-05,6416/9611/3480/1956/8312/4221/3265,7
GO:0018105,peptidyl-serine phosphorylation,Sep-90,309/18614,1.85E-05,0.000145828,7.14E-05,5290/5728/207/1956/208/545/472/8312/673,9
GO:0046634,regulation of alpha-beta T cell activation,Jun-90,114/18614,1.89E-05,0.000148705,7.28E-05,2625/865/861/387/868/639,6
GO:1902808,positive regulation of cell cycle G1/S phase transition,May-90,68/18614,1.94E-05,0.000151681,7.43E-05,595/207/896/4193/1956,5
GO:0021761,limbic system development,Jun-90,115/18614,1.99E-05,0.000155514,7.62E-05,5728/6926/3480/4763/1021/2263,6
GO:0060070,canonical Wnt signaling pathway,Sep-90,313/18614,2.05E-05,0.000159824,7.83E-05,5728/80139/2625/1956/2263/8312/4851/324/6794,9
GO:0072009,nephron epithelium development,Jun-90,116/18614,2.09E-05,0.000162562,7.96E-05,4609/2625/4853/4089/4851/171023,6
GO:0007264,small GTPase mediated signal transduction,Nov-90,483/18614,2.10E-05,0.000163004,7.98E-05,7157/5925/1029/4763/3845/4853/387/4851/4893/3265/80243,11
GO:0010661,positive regulation of muscle cell apoptotic process,Apr-90,34/18614,2.12E-05,0.000164076,8.04E-05,7157/6416/1029/4089,4
GO:0006305,DNA alkylation,May-90,70/18614,2.23E-05,0.000171801,8.41E-05,4609/672/10664/1788/546,5
GO:0006306,DNA methylation,May-90,70/18614,2.23E-05,0.000171801,8.41E-05,4609/672/10664/1788/546,5
GO:0002683,negative regulation of immune system process,Nov-90,487/18614,2.27E-05,0.000174157,8.53E-05,4609/2064/207/55294/865/4763/5295/1021/861/472/868,11
GO:0016446,somatic hypermutation of immunoglobulin genes,Mar-90,12/18614,2.33E-05,0.000178077,8.72E-05,4292/4436/5395,3
GO:0071514,genomic imprinting,Mar-90,12/18614,2.33E-05,0.000178077,8.72E-05,5290/10664/8312,3
GO:0043276,anoikis,Apr-90,35/18614,2.39E-05,0.000181458,8.89E-05,5290/207/4851/6794,4
GO:0051443,positive regulation of ubiquitin-protein transferase activity,Apr-90,35/18614,2.39E-05,0.000181458,8.89E-05,5728/55294/8312/1027,4
GO:0019827,stem cell population maintenance,Jul-90,177/18614,2.40E-05,0.000182161,8.92E-05,4609/8289/6926/4851/6597/4849/673,7
GO:0021782,glial cell development,Jun-90,119/18614,2.42E-05,0.00018298,8.96E-05,5728/207/4763/3845/1021/208,6
GO:0001659,temperature homeostasis,Jul-90,179/18614,2.58E-05,0.000194868,9.54E-05,5925/3480/2778/4851/324/4849/6794,7
GO:0031398,positive regulation of protein ubiquitination,Jun-90,121/18614,2.66E-05,0.000199551,9.77E-05,5728/55294/672/8312/1027/868,6
GO:1901989,positive regulation of cell cycle phase transition,Jun-90,121/18614,2.66E-05,0.000199551,9.77E-05,595/5925/207/896/4193/1956,6
GO:0003161,cardiac conduction system development,Apr-90,36/18614,2.67E-05,0.000199551,9.77E-05,6926/4853/4089/4851,4
GO:0030224,monocyte differentiation,Apr-90,36/18614,2.67E-05,0.000199551,9.77E-05,4609/1021/27086/677,4
GO:2000758,positive regulation of peptidyl-lysine acetylation,Apr-90,36/18614,2.67E-05,0.000199551,9.77E-05,2625/23451/672/4089,4
GO:0046637,regulation of alpha-beta T cell differentiation,May-90,73/18614,2.74E-05,0.000203853,9.98E-05,2625/865/861/387/639,5
GO:0098727,maintenance of cell number,Jul-90,181/18614,2.77E-05,0.000205833,0.000100801,4609/8289/6926/4851/6597/4849/673,7
GO:0046660,female sex differentiation,Jun-90,122/18614,2.78E-05,0.000206248,0.000101004,6926/675/2099/5156/4089/472,6
GO:0001649,osteoblast differentiation,Aug-90,250/18614,2.84E-05,0.000209978,0.00010283,207/865/4763/1021/2263/4089/4851/4221,8
GO:0048736,appendage development,Jul-90,182/18614,2.87E-05,0.00021125,0.000103453,6926/4853/1387/2263/4089/546/4851,7
GO:0060173,limb development,Jul-90,182/18614,2.87E-05,0.00021125,0.000103453,6926/4853/1387/2263/4089/546/4851,7
GO:0018209,peptidyl-serine modification,Sep-90,327/18614,2.89E-05,0.000212324,0.000103979,5290/5728/207/1956/208/545/472/8312/673,9
GO:0048638,regulation of developmental growth,Sep-90,328/18614,2.96E-05,0.00021678,0.000106161,5290/5728/999/207/27086/861/2263/1027/4851,9
GO:0043409,negative regulation of MAPK cascade,Jul-90,183/18614,2.97E-05,0.00021678,0.000106161,4609/5728/9611/3480/4763/4089/4221,7
GO:0003230,cardiac atrium development,Apr-90,37/18614,2.99E-05,0.00021678,0.000106161,4193/3480/4853/4851,4
GO:0014037,Schwann cell differentiation,Apr-90,37/18614,2.99E-05,0.00021678,0.000106161,207/4763/208/2065,4
GO:0043516,"regulation of DNA damage response, signal transduction by p53 class mediator",Apr-90,37/18614,2.99E-05,0.00021678,0.000106161,7157/4193/545/472,4
GO:0002566,somatic diversification of immune receptors via somatic mutation,Mar-90,13/18614,3.02E-05,0.000218049,0.000106783,4292/4436/5395,3
GO:0071236,cellular response to antibiotic,Mar-90,13/18614,3.02E-05,0.000218049,0.000106783,7157/4193/1027,3
GO:0070192,chromosome organization involved in meiotic cell cycle,May-90,75/18614,3.12E-05,0.000225056,0.000110214,898/472/546/4292/701,5
GO:0001952,regulation of cell-matrix adhesion,Jun-90,125/18614,3.19E-05,0.000229592,0.000112436,5728/1029/4763/5295/1021/387,6
GO:0032386,regulation of intracellular transport,Sep-90,332/18614,3.26E-05,0.00023364,0.000114418,2064/999/55294/4763/5295/208/29072/6794/3265,9
GO:1903320,regulation of protein modification by small protein conjugation or removal,Aug-90,255/18614,3.27E-05,0.000234131,0.000114659,5728/207/55294/672/8312/1027/868/701,8
GO:0030324,lung development,Jul-90,186/18614,3.30E-05,0.000235129,0.000115148,55294/3845/3169/5156/2263/4851/171023,7
GO:0051896,regulation of protein kinase B signaling,Jul-90,186/18614,3.30E-05,0.000235129,0.000115148,5290/5728/2260/2625/3480/1956/6794,7
GO:0003180,aortic valve morphogenesis,Apr-90,38/18614,3.33E-05,0.000236509,0.000115823,2625/5925/387/4851,4
GO:0032200,telomere organization,Jul-90,187/18614,3.41E-05,0.000242232,0.000118626,4609/898/675/545/472/546/2072,7
GO:0003002,regionalization,Oct-90,422/18614,3.66E-05,0.000259259,0.000126964,7157/6926/3169/4853/2263/79728/4089/472/8312/4851,10
GO:0043010,camera-type eye development,Sep-90,338/18614,3.74E-05,0.000264437,0.0001295,2625/4763/1956/4853/5156/1027/4851/6597/639,9
GO:0030323,respiratory tube development,Jul-90,190/18614,3.78E-05,0.000266327,0.000130426,55294/3845/3169/5156/2263/4851/171023,7
GO:0070141,response to UV-A,Mar-90,14/18614,3.83E-05,0.000269172,0.000131819,595/207/1956,3
GO:0045739,positive regulation of DNA repair,Jun-90,130/18614,3.98E-05,0.000279331,0.000136794,57492/8289/1956/672/6597/55193,6
GO:0001953,negative regulation of cell-matrix adhesion,Apr-90,40/18614,4.09E-05,0.000285535,0.000139832,5728/1029/4763/5295,4
GO:0071392,cellular response to estradiol stimulus,Apr-90,40/18614,4.09E-05,0.000285535,0.000139832,80139/3480/1956/2099,4
GO:0002244,hematopoietic progenitor cell differentiation,Jun-90,132/18614,4.34E-05,0.00030231,0.000148047,7157/2625/1021/5156/4851/673,6
GO:0051154,negative regulation of striated muscle cell differentiation,Apr-90,41/18614,4.51E-05,0.000313852,0.0001537,27086/7494/4089/4851,4
GO:2000779,regulation of double-strand break repair,Jun-90,133/18614,4.53E-05,0.00031399,0.000153767,57492/8289/29072/545/6597/55193,6
GO:0048565,digestive tract development,Jun-90,134/18614,4.72E-05,0.000326727,0.000160005,5925/1956/5156/2263/4851/639,6
GO:0032388,positive regulation of intracellular transport,Jul-90,197/18614,4.76E-05,0.000327998,0.000160627,2064/999/55294/5295/208/6794/3265,7
GO:0060766,negative regulation of androgen receptor signaling pathway,Mar-90,15/18614,4.77E-05,0.000327998,0.000160627,9611/27086/6597,3
GO:2000671,regulation of motor neuron apoptotic process,Mar-90,15/18614,4.77E-05,0.000327998,0.000160627,6416/2065/387,3
GO:0062197,cellular response to chemical stress,Sep-90,349/18614,4.80E-05,0.000329444,0.000161335,7157/5290/207/55294/1956/27086/5156/472/677,9
GO:0043467,regulation of generation of precursor metabolites and energy,Jun-90,135/18614,4.92E-05,0.000336921,0.000164997,7157/5290/207/9611/208/387,6
GO:0007517,muscle organ development,Sep-90,351/18614,5.02E-05,0.000342833,0.000167892,5925/4763/3845/7494/2065/2263/387/4089/4851,9
GO:0000070,mitotic sister chromatid segregation,Jul-90,199/18614,5.07E-05,0.000345805,0.000169348,5925/387/472/546/10735/324/701,7
GO:0006275,regulation of DNA replication,Jun-90,136/18614,5.13E-05,0.0003481,0.000170471,7157/6416/675/1956/545/546,6
GO:0071333,cellular response to glucose stimulus,Jun-90,136/18614,5.13E-05,0.0003481,0.000170471,5290/3480/7494/4089/6597/4221,6
GO:0031929,TOR signaling,Jun-90,137/18614,5.34E-05,0.000361865,0.000177213,5290/2625/207/8239/472/6794,6
GO:0050851,antigen receptor-mediated signaling pathway,Jul-90,201/18614,5.40E-05,0.000365247,0.000178869,5290/2625/27086/868/6794/673/3265,7
GO:0003176,aortic valve development,Apr-90,43/18614,5.46E-05,0.000365983,0.000179229,2625/5925/387/4851,4
GO:0045663,positive regulation of myoblast differentiation,Apr-90,43/18614,5.46E-05,0.000365983,0.000179229,57492/8289/6597/55193,4
GO:0060412,ventricular septum morphogenesis,Apr-90,43/18614,5.46E-05,0.000365983,0.000179229,6926/2263/4089/4851,4
GO:0071364,cellular response to epidermal growth factor stimulus,Apr-90,43/18614,5.46E-05,0.000365983,0.000179229,2064/207/1956/677,4
GO:0071331,cellular response to hexose stimulus,Jun-90,138/18614,5.56E-05,0.000372077,0.000182214,5290/3480/7494/4089/6597/4221,6
GO:0010660,regulation of muscle cell apoptotic process,May-90,85/18614,5.71E-05,0.000380583,0.000186379,7157/6416/1029/3480/4089,5
GO:0055013,cardiac muscle cell development,May-90,85/18614,5.71E-05,0.000380583,0.000186379,6416/6926/27086/5156/4089,5
GO:1903322,positive regulation of protein modification by small protein conjugation or removal,Jun-90,139/18614,5.79E-05,0.000384924,0.000188505,5728/55294/672/8312/1027/868,6
GO:0003188,heart valve formation,Mar-90,16/18614,5.85E-05,0.000387941,0.000189983,387/4089/4851,3
GO:0031589,cell-substrate adhesion,Sep-90,359/18614,5.97E-05,0.000395061,0.000193469,5728/1029/4763/5295/1021/387/4851/4221/673,9
GO:0010828,positive regulation of glucose transmembrane transport,Apr-90,44/18614,5.98E-05,0.000395061,0.000193469,207/5295/208/673,4
GO:0006260,DNA replication,Aug-90,278/18614,6.02E-05,0.000395061,0.000193469,7157/6416/898/675/1956/672/545/546,8
GO:0050852,T cell receptor signaling pathway,Jun-90,140/18614,6.03E-05,0.000395061,0.000193469,5290/2625/868/6794/673/3265,6
GO:0071326,cellular response to monosaccharide stimulus,Jun-90,140/18614,6.03E-05,0.000395061,0.000193469,5290/3480/7494/4089/6597/4221,6
GO:0008625,extrinsic apoptotic signaling pathway via death domain receptors,May-90,86/18614,6.04E-05,0.000395061,0.000193469,5728/4763/5295/672/841,5
GO:0061053,somite development,May-90,86/18614,6.04E-05,0.000395061,0.000193469,7157/79728/4089/472/4851,5
GO:0031056,regulation of histone modification,Jun-90,141/18614,6.27E-05,0.000409072,0.000200331,7157/2625/23451/672/4089/54880,6
GO:0072594,establishment of protein localization to organelle,Oct-90,453/18614,6.64E-05,0.000432009,0.000211563,7157/999/207/55294/675/4763/5295/8239/4851/868,10
GO:0031058,positive regulation of histone modification,May-90,88/18614,6.75E-05,0.000438325,0.000214657,7157/2625/23451/672/4089,5
GO:0033135,regulation of peptidyl-serine phosphorylation,Jun-90,143/18614,6.78E-05,0.00043968,0.00021532,5290/5728/207/1956/8312/673,6
GO:0045732,positive regulation of protein catabolic process,Jul-90,209/18614,6.91E-05,0.000447112,0.00021896,207/55294/4193/8312/1027/324/868,7
GO:0051321,meiotic cell cycle,Aug-90,284/18614,6.99E-05,0.000451355,0.000221038,898/675/472/546/4292/10735/701/2072,8
GO:0006349,regulation of gene expression by genomic imprinting,Mar-90,17/18614,7.08E-05,0.000455113,0.000222878,672/10664/1788,3
GO:1900034,regulation of cellular response to heat,Mar-90,17/18614,7.08E-05,0.000455113,0.000222878,1387/545/472,3
GO:0071229,cellular response to acid chemical,May-90,89/18614,7.12E-05,0.000456377,0.000223497,5290/1956/1788/7494/5156,5
GO:0006356,regulation of transcription by RNA polymerase I,Apr-90,46/18614,7.14E-05,0.000456377,0.000223497,2064/23451/1387/6597,4
GO:0031297,replication fork processing,Apr-90,46/18614,7.14E-05,0.000456377,0.000223497,675/672/545/546,4
GO:0060541,respiratory system development,Jul-90,211/18614,7.34E-05,0.000467349,0.00022887,55294/3845/3169/5156/2263/4851/171023,7
GO:0140014,mitotic nuclear division,Aug-90,286/18614,7.34E-05,0.000467349,0.00022887,5925/387/472/546/1027/10735/324/701,8
GO:0010657,muscle cell apoptotic process,May-90,90/18614,7.51E-05,0.00047724,0.000233714,7157/6416/1029/3480/4089,5
GO:0045598,regulation of fat cell differentiation,Jun-90,146/18614,7.61E-05,0.000481531,0.000235815,2625/207/7494/8312/677/171023,6
GO:0055123,digestive system development,Jun-90,146/18614,7.61E-05,0.000481531,0.000235815,5925/1956/5156/2263/4851/639,6
GO:0046677,response to antibiotic,Apr-90,47/18614,7.78E-05,0.000488121,0.000239042,7157/4193/1027/841,4
GO:0060711,labyrinthine layer development,Apr-90,47/18614,7.78E-05,0.000488121,0.000239042,207/2263/677/841,4
GO:0070849,response to epidermal growth factor,Apr-90,47/18614,7.78E-05,0.000488121,0.000239042,2064/207/1956/677,4
GO:1901985,positive regulation of protein acetylation,Apr-90,47/18614,7.78E-05,0.000488121,0.000239042,2625/23451/672/4089,4
GO:0001942,hair follicle development,May-90,91/18614,7.92E-05,0.000496102,0.000242951,4763/1956/2263/4089/4851,5
GO:1903046,meiotic cell cycle process,Jul-90,215/18614,8.25E-05,0.000516077,0.000252733,898/675/472/546/4292/701/2072,7
GO:0001656,metanephros development,May-90,92/18614,8.34E-05,0.000518521,0.00025393,4609/2625/4763/5156/4089,5
GO:0009791,post-embryonic development,May-90,92/18614,8.34E-05,0.000518521,0.00025393,2625/2263/472/546/639,5
GO:0055017,cardiac muscle tissue growth,May-90,92/18614,8.34E-05,0.000518521,0.00025393,6416/27086/861/2263/4851,5
GO:0035850,epithelial cell differentiation involved in kidney development,Apr-90,48/18614,8.45E-05,0.000518913,0.000254122,2625/4853/4851/171023,4
GO:0048538,thymus development,Apr-90,48/18614,8.45E-05,0.000518913,0.000254122,2625/472/171023/673,4
GO:0036035,osteoclast development,Mar-90,18/18614,8.46E-05,0.000518913,0.000254122,55294/4853/27086,3
GO:0038128,ERBB2 signaling pathway,Mar-90,18/18614,8.46E-05,0.000518913,0.000254122,2064/1956/2065,3
GO:0043217,myelin maintenance,Mar-90,18/18614,8.46E-05,0.000518913,0.000254122,5728/207/208,3
GO:0060644,mammary gland epithelial cell differentiation,Mar-90,18/18614,8.46E-05,0.000518913,0.000254122,80139/207/208,3
GO:2000136,regulation of cell proliferation involved in heart morphogenesis,Mar-90,18/18614,8.46E-05,0.000518913,0.000254122,6926/4089/4851,3
GO:1903829,positive regulation of protein localization,Oct-90,468/18614,8.69E-05,0.000531957,0.00026051,2064/999/207/55294/5295/1956/208/324/6794/3265,10
GO:0050886,endocrine process,May-90,93/18614,8.78E-05,0.00053539,0.000262191,2625/6926/3845/387/4089,5
GO:2001251,negative regulation of chromosome organization,May-90,93/18614,8.78E-05,0.00053539,0.000262191,472/546/324/701/2072,5
GO:0022404,molting cycle process,May-90,94/18614,9.24E-05,0.000561166,0.000274814,4763/1956/2263/4089/4851,5
GO:0022405,hair cycle process,May-90,94/18614,9.24E-05,0.000561166,0.000274814,4763/1956/2263/4089/4851,5
GO:0002366,leukocyte activation involved in immune response,Aug-90,296/18614,9.32E-05,0.000565172,0.000276776,7157/2625/4853/27086/7494/4292/4221/4436,8
GO:0043535,regulation of blood vessel endothelial cell migration,Jun-90,152/18614,9.51E-05,0.000575172,0.000281673,2260/207/55294/4763/387/4851,6
GO:0016573,histone acetylation,Jun-90,153/18614,9.86E-05,0.000595207,0.000291485,2625/23451/675/672/1387/4089,6
GO:0048009,insulin-like growth factor receptor signaling pathway,Apr-90,50/18614,9.93E-05,0.000597248,0.000292484,5290/207/3480/5295,4
GO:0048546,digestive tract morphogenesis,Apr-90,50/18614,9.93E-05,0.000597248,0.000292484,1956/5156/2263/4851,4
GO:0006337,nucleosome disassembly,Mar-90,19/18614,0.000100143,0.000598964,0.000293325,8289/6597/4778,3
GO:0061323,cell proliferation involved in heart morphogenesis,Mar-90,19/18614,0.000100143,0.000598964,0.000293325,6926/4089/4851,3
GO:1901522,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,Mar-90,19/18614,0.000100143,0.000598964,0.000293325,7157/7494/4089,3
GO:0001654,eye development,Sep-90,385/18614,0.000101804,0.000607752,0.000297628,2625/4763/1956/4853/5156/1027/4851/6597/639,9
GO:0072080,nephron tubule development,May-90,96/18614,0.00010212,0.00060849,0.00029799,4609/2625/4853/4089/4851,5
GO:0002263,cell activation involved in immune response,Aug-90,300/18614,0.00010233,0.000608594,0.000298041,7157/2625/4853/27086/7494/4292/4221/4436,8
GO:0090316,positive regulation of intracellular protein transport,Jun-90,155/18614,0.000105881,0.000628534,0.000307806,2064/999/55294/5295/208/3265,6
GO:0033157,regulation of intracellular protein transport,Jul-90,224/18614,0.000106614,0.0006317,0.000309356,2064/999/55294/4763/5295/208/3265,7
GO:0002429,immune response-activating cell surface receptor signaling pathway,Aug-90,302/18614,0.000107142,0.000633639,0.000310306,5290/2625/1387/27086/868/6794/673/3265,8
GO:0045058,T cell selection,Apr-90,51/18614,0.000107344,0.000633648,0.00031031,2625/387/6794/673,4
GO:0150063,visual system development,Sep-90,389/18614,0.000110094,0.00064867,0.000317667,2625/4763/1956/4853/5156/1027/4851/6597/639,9
GO:0097306,cellular response to alcohol,May-90,98/18614,0.000112602,0.000662218,0.000324301,999/207/3480/672/1788,5
GO:0008340,determination of adult lifespan,Mar-90,20/18614,0.000117403,0.000687897,0.000336877,7157/472/4436,3
GO:0097284,hepatocyte apoptotic process,Mar-90,20/18614,0.000117403,0.000687897,0.000336877,5925/3480/1788,3
GO:0022411,cellular component disassembly,Oct-90,488/18614,0.000122579,0.000716892,0.000351076,7157/5290/4609/55294/8289/3480/5295/6597/324/4778,10
GO:0048880,sensory system development,Sep-90,395/18614,0.000123586,0.000720571,0.000352878,2625/4763/1956/4853/5156/1027/4851/6597/639,9
GO:0060419,heart growth,May-90,100/18614,0.000123891,0.000720571,0.000352878,6416/27086/861/2263/4851,5
GO:0061326,renal tubule development,May-90,100/18614,0.000123891,0.000720571,0.000352878,4609/2625/4853/4089/4851,5
GO:0035065,regulation of histone acetylation,Apr-90,53/18614,0.000124859,0.000724867,0.000354982,2625/23451/672/4089,4
GO:0018393,internal peptidyl-lysine acetylation,Jun-90,161/18614,0.000130421,0.000754391,0.00036944,2625/23451/675/672/1387/4089,6
GO:0051147,regulation of muscle cell differentiation,Jun-90,161/18614,0.000130421,0.000754391,0.00036944,4193/27086/7494/2263/4089/4851,6
GO:0030520,intracellular estrogen receptor signaling pathway,Apr-90,54/18614,0.000134352,0.000774295,0.000379188,8289/2099/3169/672,4
GO:0030857,negative regulation of epithelial cell differentiation,Apr-90,54/18614,0.000134352,0.000774295,0.000379188,595/6926/3845/4851,4
GO:0008585,female gonad development,May-90,102/18614,0.000136028,0.000781109,0.000382525,675/2099/5156/4089/472,5
GO:0030316,osteoclast differentiation,May-90,102/18614,0.000136028,0.000781109,0.000382525,55294/4763/5295/4853/27086,5
GO:0097049,motor neuron apoptotic process,Mar-90,21/18614,0.000136492,0.000782356,0.000383135,6416/2065/387,3
GO:0006475,internal protein amino acid acetylation,Jun-90,163/18614,0.000139534,0.000798345,0.000390966,2625/23451/675/672/1387/4089,6
GO:0045639,positive regulation of myeloid cell differentiation,May-90,103/18614,0.000142427,0.000813429,0.000398352,5925/4853/861/677/841,5
GO:0071356,cellular response to tumor necrosis factor,Jul-90,235/18614,0.000143516,0.000818171,0.000400675,7157/2625/207/672/27086/677/841,7
GO:0003229,ventricular cardiac muscle tissue development,Apr-90,55/18614,0.000144356,0.000821481,0.000402295,6926/2263/4089/4851,4
GO:0032204,regulation of telomere maintenance,May-90,104/18614,0.000149055,0.000846695,0.000414643,4609/545/472/546/2072,5
GO:0031960,response to corticosteroid,Jun-90,166/18614,0.000154142,0.000874026,0.000428028,5290/595/3480/387/4851/677,6
GO:0045005,DNA-templated DNA replication maintenance of fidelity,Apr-90,56/18614,0.000154889,0.00087669,0.000429332,675/672/545/546,4
GO:0021700,developmental maturation,Aug-90,319/18614,0.000156133,0.000882151,0.000432007,5728/2625/5925/865/675/4763/3169/387,8
GO:0046545,development of primary female sexual characteristics,May-90,106/18614,0.000163016,0.000919397,0.000450247,675/2099/5156/4089/472,5
GO:0032984,protein-containing complex disassembly,Jul-90,240/18614,0.000163409,0.000919977,0.000450531,5290/4609/8289/3480/6597/324/4778,7
GO:0031060,regulation of histone methylation,Apr-90,57/18614,0.000165967,0.000932716,0.000456769,2625/672/4089/54880,4
GO:0031647,regulation of protein stability,Aug-90,322/18614,0.000166447,0.000933754,0.000457278,7157/5728/55294/4193/6926/5295/1387/8239,8
GO:1903034,regulation of response to wounding,Jun-90,170/18614,0.000175477,0.000982671,0.000481234,5728/3480/7494/5156/673/3265,6
GO:0010965,regulation of mitotic sister chromatid separation,Apr-90,58/18614,0.000177606,0.000989338,0.000484499,5925/472/324/701,4
GO:0042733,embryonic digit morphogenesis,Apr-90,58/18614,0.000177606,0.000989338,0.000484499,6926/1387/4089/4851,4
GO:0061005,cell differentiation involved in kidney development,Apr-90,58/18614,0.000177606,0.000989338,0.000484499,2625/4853/4851/171023,4
GO:0033138,positive regulation of peptidyl-serine phosphorylation,May-90,108/18614,0.000177955,0.000989543,0.000484599,5290/207/1956/8312/673,5
GO:0048169,regulation of long-term neuronal synaptic plasticity,Mar-90,23/18614,0.000180482,0.00099659,0.00048805,4763/3845/3265,3
GO:0060065,uterus development,Mar-90,23/18614,0.000180482,0.00099659,0.00048805,2625/2099/4089,3
GO:0072574,hepatocyte proliferation,Mar-90,23/18614,0.000180482,0.00099659,0.00048805,55294/4853/7494,3
GO:0072575,epithelial cell proliferation involved in liver morphogenesis,Mar-90,23/18614,0.000180482,0.00099659,0.00048805,55294/4853/7494,3
GO:0000724,double-strand break repair via homologous recombination,Jun-90,171/18614,0.000181159,0.000998584,0.000489026,675/672/29072/79728/472/2072,6
GO:0045132,meiotic chromosome segregation,May-90,109/18614,0.000185806,0.001022416,0.000500697,898/472/4292/701/2072,5
GO:0018394,peptidyl-lysine acetylation,Jun-90,172/18614,0.000186985,0.001027121,0.000503002,2625/23451/675/672/1387/4089,6
GO:2000058,regulation of ubiquitin-dependent protein catabolic process,Jun-90,173/18614,0.000192959,0.001056267,0.000517275,5728/207/55294/4193/8239/8312,6
GO:2001242,regulation of intrinsic apoptotic signaling pathway,Jun-90,173/18614,0.000192959,0.001056267,0.000517275,7157/4609/207/55294/4193/7494,6
GO:0009408,response to heat,May-90,110/18614,0.000193918,0.001059683,0.000518948,207/4763/1387/545/472,5
GO:0071695,anatomical structure maturation,Jul-90,247/18614,0.000194959,0.001063537,0.000520835,2625/5925/865/675/4763/3169/387,7
GO:2000060,positive regulation of ubiquitin-dependent protein catabolic process,May-90,111/18614,0.000202298,0.001101604,0.000539478,5728/207/55294/4193/8312,5
GO:0002011,morphogenesis of an epithelial sheet,Apr-90,60/18614,0.000202634,0.001101604,0.000539478,5728/4853/387/4851,4
GO:0006310,DNA recombination,Aug-90,332/18614,0.000204966,0.001109803,0.000543493,675/672/29072/79728/472/4292/4436/2072,8
GO:0000725,recombinational repair,Jun-90,175/18614,0.000205358,0.001109803,0.000543493,675/672/29072/79728/472/2072,6
GO:1905475,regulation of protein localization to membrane,Jun-90,175/18614,0.000205358,0.001109803,0.000543493,2064/207/5295/1956/208/3265,6
GO:0072576,liver morphogenesis,Mar-90,24/18614,0.000205545,0.001109803,0.000543493,55294/4853/7494,3
GO:0002757,immune response-activating signaling pathway,Sep-90,423/18614,0.000206313,0.001112049,0.000544593,5290/2625/2099/1387/27086/868/6794/673/3265,9
GO:1902749,regulation of cell cycle G2/M phase transition,May-90,112/18614,0.000210951,0.001135116,0.000555889,7157/595/1021/672/472,5
GO:0051306,mitotic sister chromatid separation,Apr-90,61/18614,0.000216057,0.001158653,0.000567415,5925/472/324/701,4
GO:0060135,maternal process involved in female pregnancy,Apr-90,61/18614,0.000216057,0.001158653,0.000567415,207/2099/4221/639,4
GO:2000756,regulation of peptidyl-lysine acetylation,Apr-90,62/18614,0.00023011,0.001231923,0.000603297,2625/23451/672/4089,4
GO:0030111,regulation of Wnt signaling pathway,Aug-90,338/18614,0.000231404,0.001236759,0.000605665,80139/1956/2263/8312/4851/6597/324/6794,8
GO:0043534,blood vessel endothelial cell migration,Jun-90,179/18614,0.00023204,0.001238069,0.000606307,2260/207/55294/4763/387/4851,6
GO:0003181,atrioventricular valve morphogenesis,Mar-90,25/18614,0.000232758,0.001239811,0.00060716,4193/4089/4851,3
GO:0042303,molting cycle,May-90,115/18614,0.000238609,0.001266712,0.000620334,4763/1956/2263/4089/4851,5
GO:0042633,hair cycle,May-90,115/18614,0.000238609,0.001266712,0.000620334,4763/1956/2263/4089/4851,5
GO:0034612,response to tumor necrosis factor,Jul-90,257/18614,0.000248407,0.001314359,0.000643668,7157/2625/207/672/27086/677/841,7
GO:0001824,blastocyst development,May-90,116/18614,0.000248416,0.001314359,0.000643668,675/79728/54880/84295/4849,5
GO:0043406,positive regulation of MAP kinase activity,May-90,117/18614,0.000258525,0.001363291,0.00066763,2064/2260/1956/8312/3265,5
GO:0071887,leukocyte apoptotic process,May-90,117/18614,0.000258525,0.001363291,0.00066763,7157/1029/207/4763/27086,5
GO:0006360,transcription by RNA polymerase I,Apr-90,64/18614,0.000260169,0.001367402,0.000669644,2064/23451/1387/6597,4
GO:0035825,homologous recombination,Apr-90,64/18614,0.000260169,0.001367402,0.000669644,672/472/4292/2072,4
GO:0009266,response to temperature stimulus,Jun-90,183/18614,0.000261383,0.0013715,0.000671651,207/4763/1387/545/472/841,6
GO:0044346,fibroblast apoptotic process,Mar-90,26/18614,0.0002622,0.001373509,0.000672635,7157/5290/4609,3
GO:0060828,regulation of canonical Wnt signaling pathway,Jul-90,260/18614,0.00026656,0.001394043,0.000682691,80139/1956/2263/8312/4851/324/6794,7
GO:0051897,positive regulation of protein kinase B signaling,May-90,118/18614,0.000268945,0.001402978,0.000687066,5290/2260/2625/3480/1956,5
GO:0021543,pallium development,Jun-90,184/18614,0.000269155,0.001402978,0.000687066,5728/3480/4763/1956/1021/387,6
GO:0032956,regulation of actin cytoskeleton organization,Aug-90,346/18614,0.00027095,0.001410008,0.000690509,5290/5295/4853/5156/387/4089/673/3265,8
GO:0043405,regulation of MAP kinase activity,Jun-90,186/18614,0.000285246,0.001481967,0.000725749,2064/2260/4763/1956/8312/3265,6
GO:0030326,embryonic limb morphogenesis,May-90,120/18614,0.000290738,0.001505559,0.000737302,6926/4853/1387/4089/4851,5
GO:0035113,embryonic appendage morphogenesis,May-90,120/18614,0.000290738,0.001505559,0.000737302,6926/4853/1387/4089/4851,5
GO:0051302,regulation of cell division,Jun-90,187/18614,0.00029357,0.001514726,0.000741792,4609/3480/675/29072/2263/387,6
GO:0060669,embryonic placenta morphogenesis,Mar-90,27/18614,0.000293945,0.001514726,0.000741792,29072/2263/677,3
GO:2000108,positive regulation of leukocyte apoptotic process,Mar-90,27/18614,0.000293945,0.001514726,0.000741792,7157/1029/4763,3
GO:0098773,skin epidermis development,May-90,121/18614,0.000302125,0.001551824,0.000759959,4763/1956/2263/4089/4851,5
GO:2000278,regulation of DNA biosynthetic process,May-90,121/18614,0.000302125,0.001551824,0.000759959,7157/4609/545/472/4221,5
GO:0031346,positive regulation of cell projection organization,Aug-90,353/18614,0.000309946,0.001581537,0.00077451,5290/3480/5295/1523/324/6794/673/3265,8
GO:0034605,cellular response to heat,Apr-90,67/18614,0.000310409,0.001581537,0.00077451,4763/1387/545/472,4
GO:0038034,signal transduction in absence of ligand,Apr-90,67/18614,0.000310409,0.001581537,0.00077451,2260/207/4763/2065,4
GO:0043966,histone H3 acetylation,Apr-90,67/18614,0.000310409,0.001581537,0.00077451,2625/675/672/4089,4
GO:0097192,extrinsic apoptotic signaling pathway in absence of ligand,Apr-90,67/18614,0.000310409,0.001581537,0.00077451,2260/207/4763/2065,4
GO:0031099,regeneration,Jun-90,190/18614,0.000319691,0.001626211,0.000796388,595/3480/861/1027/4851/673,6
GO:0090596,sensory organ morphogenesis,Jul-90,269/18614,0.000327523,0.001645076,0.000805626,2625/6926/4763/4853/2263/4851/639,7
GO:0003171,atrioventricular valve development,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,4193/4089/4851,3
GO:0003272,endocardial cushion formation,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,6926/4089/4851,3
GO:0022011,myelination in peripheral nervous system,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,207/4763/208,3
GO:0030325,adrenal gland development,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,4763/5156/4089,3
GO:0032292,peripheral nervous system axon ensheathment,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,207/4763/208,3
GO:0060765,regulation of androgen receptor signaling pathway,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,9611/27086/6597,3
GO:0090314,positive regulation of protein targeting to membrane,Mar-90,28/18614,0.00032807,0.001645076,0.000805626,2064/208/3265,3
GO:0045670,regulation of osteoclast differentiation,Apr-90,68/18614,0.000328599,0.001645076,0.000805626,55294/4763/5295/4853,4
GO:0055021,regulation of cardiac muscle tissue growth,Apr-90,68/18614,0.000328599,0.001645076,0.000805626,27086/861/2263/4851,4
GO:0021537,telencephalon development,Jul-90,270/18614,0.000334935,0.001674146,0.000819863,5728/3480/4763/1956/1021/27086/387,7
GO:0010975,regulation of neuron projection development,Sep-90,452/18614,0.00033622,0.001677919,0.00082171,5728/2625/999/207/3480/387/1523/6794/673,9
GO:0055001,muscle cell development,Jun-90,192/18614,0.000338095,0.00168462,0.000824992,6416/6926/27086/5156/4089/4851,6
GO:0032835,glomerulus development,Apr-90,69/18614,0.000347541,0.00172896,0.000846706,4853/5156/4851/171023,4
GO:0060441,epithelial tube branching involved in lung morphogenesis,Mar-90,29/18614,0.000364647,0.001805545,0.000884211,3845/3169/2263,3
GO:0061647,histone H3-K9 modification,Mar-90,29/18614,0.000364647,0.001805545,0.000884211,2625/672/4089,3
GO:0072012,glomerulus vasculature development,Mar-90,29/18614,0.000364647,0.001805545,0.000884211,4853/5156/4851,3
GO:0031334,positive regulation of protein-containing complex assembly,Jun-90,195/18614,0.000367248,0.001809942,0.000886365,7157/2099/545/387/472/1027,6
GO:0043627,response to estrogen,Apr-90,70/18614,0.000367251,0.001809942,0.000886365,595/2625/2099/672,4
GO:0051148,negative regulation of muscle cell differentiation,Apr-90,70/18614,0.000367251,0.001809942,0.000886365,27086/7494/4089/4851,4
GO:0140013,meiotic nuclear division,Jun-90,196/18614,0.000377391,0.001855716,0.000908781,898/675/472/4292/701/2072,6
GO:0055007,cardiac muscle cell differentiation,May-90,127/18614,0.000377712,0.001855716,0.000908781,6416/6926/27086/5156/4089,5
GO:0045862,positive regulation of proteolysis,Aug-90,365/18614,0.000387422,0.001899129,0.000930041,4609/5728/207/55294/4193/387/8312/841,8
GO:0003208,cardiac ventricle morphogenesis,Apr-90,71/18614,0.000387749,0.001899129,0.000930041,2625/2263/4089/4851,4
GO:0010038,response to metal ion,Aug-90,367/18614,0.000401749,0.001959302,0.000959509,595/999/207/1956/1788/1027/841/673,8
GO:0002360,T cell lineage commitment,Mar-90,30/18614,0.00040375,0.001959302,0.000959509,7157/387/673,3
GO:0007064,mitotic sister chromatid cohesion,Mar-90,30/18614,0.00040375,0.001959302,0.000959509,5925/546/10735,3
GO:0060603,mammary gland duct morphogenesis,Mar-90,30/18614,0.00040375,0.001959302,0.000959509,6926/2099/2263,3
GO:0070198,"protein localization to chromosome, telomeric region",Mar-90,30/18614,0.00040375,0.001959302,0.000959509,675/545/546,3
GO:1901798,positive regulation of signal transduction by p53 class mediator,Mar-90,30/18614,0.00040375,0.001959302,0.000959509,4609/545/472,3
GO:0007127,meiosis I,May-90,129/18614,0.000405835,0.001966405,0.000962988,898/675/472/4292/2072,5
GO:2000036,regulation of stem cell population maintenance,Apr-90,72/18614,0.000409051,0.001978958,0.000969135,4609/8289/6597/4849,4
GO:0051098,regulation of binding,Aug-90,369/18614,0.000416506,0.002011944,0.000985289,2625/5925/207/55294/8239/4089/868/2072,8
GO:0050864,regulation of B cell activation,May-90,130/18614,0.000420476,0.002028028,0.000993165,7494/472/4292/677/4436,5
GO:0007405,neuroblast proliferation,Apr-90,73/18614,0.000431177,0.002067037,0.001012269,7157/4763/2263/4851,4
GO:0070988,demethylation,Apr-90,73/18614,0.000431177,0.002067037,0.001012269,2625/7403/8239/54790,4
GO:0071260,cellular response to mechanical stimulus,Apr-90,73/18614,0.000431177,0.002067037,0.001012269,4214/6416/3480/841,4
GO:1905818,regulation of chromosome separation,Apr-90,73/18614,0.000431177,0.002067037,0.001012269,5925/472/324/701,4
GO:0003309,type B pancreatic cell differentiation,Mar-90,31/18614,0.00044545,0.002119404,0.001037914,207/1021/4221,3
GO:0014044,Schwann cell development,Mar-90,31/18614,0.00044545,0.002119404,0.001037914,207/4763/208,3
GO:0033688,regulation of osteoblast proliferation,Mar-90,31/18614,0.00044545,0.002119404,0.001037914,3480/2263/387,3
GO:0061437,renal system vasculature development,Mar-90,31/18614,0.00044545,0.002119404,0.001037914,4853/5156/4851,3
GO:0061440,kidney vasculature development,Mar-90,31/18614,0.00044545,0.002119404,0.001037914,4853/5156/4851,3
GO:0035924,cellular response to vascular endothelial growth factor stimulus,Apr-90,74/18614,0.000454144,0.002154291,0.001054999,5290/207/5156/4851,4
GO:0060420,regulation of heart growth,Apr-90,74/18614,0.000454144,0.002154291,0.001054999,27086/861/2263/4851,4
GO:1902903,regulation of supramolecular fiber organization,Aug-90,376/18614,0.000471672,0.002234087,0.001094077,5290/5925/5295/387/4089/1027/324/673,8
GO:0061982,meiosis I cell cycle process,May-90,134/18614,0.000483062,0.002281205,0.001117152,898/675/472/4292/2072,5
GO:1900180,regulation of protein localization to nucleus,May-90,134/18614,0.000483062,0.002281205,0.001117152,999/207/4763/5295/6794,5
GO:0008156,negative regulation of DNA replication,Mar-90,32/18614,0.000489817,0.002306222,0.001129403,7157/675/545,3
GO:0045671,negative regulation of osteoclast differentiation,Mar-90,32/18614,0.000489817,0.002306222,0.001129403,55294/4763/5295,3
GO:1903036,positive regulation of response to wounding,Apr-90,76/18614,0.000502675,0.002363243,0.001157327,3480/7494/673/3265,4
GO:0044262,cellular carbohydrate metabolic process,Jul-90,290/18614,0.000513814,0.002412027,0.001181218,7157/5728/207/9611/208/6794/673,7
GO:0006473,protein acetylation,Jun-90,208/18614,0.000517069,0.002423713,0.001186941,2625/23451/675/672/1387/4089,6
GO:0010827,regulation of glucose transmembrane transport,Apr-90,77/18614,0.000528274,0.00246165,0.001205519,207/5295/208/673,4
GO:0048332,mesoderm morphogenesis,Apr-90,77/18614,0.000528274,0.00246165,0.001205519,6926/29072/2263/8312,4
GO:1901983,regulation of protein acetylation,Apr-90,77/18614,0.000528274,0.00246165,0.001205519,2625/23451/672/4089,4
GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",Apr-90,77/18614,0.000528274,0.00246165,0.001205519,2625/865/861/868,4
GO:0009952,anterior/posterior pattern specification,Jun-90,209/18614,0.000530309,0.002467499,0.001208383,7157/6926/79728/4089/472/4851,6
GO:1903052,positive regulation of proteolysis involved in protein catabolic process,May-90,137/18614,0.000534422,0.002482981,0.001215965,5728/207/55294/4193/8312,5
GO:0048147,negative regulation of fibroblast proliferation,Mar-90,33/18614,0.00053692,0.002487286,0.001218073,7157/4609/4763,3
GO:0080111,DNA demethylation,Mar-90,33/18614,0.00053692,0.002487286,0.001218073,2625/8239/54790,3
GO:0034728,nucleosome organization,May-90,138/18614,0.000552422,0.002555354,0.001251407,8289/29072/546/6597/4778,5
GO:0002200,somatic diversification of immune receptors,Apr-90,78/18614,0.000554789,0.002558821,0.001253106,472/4292/4436/5395,4
GO:1903533,regulation of protein targeting,Apr-90,78/18614,0.000554789,0.002558821,0.001253106,2064/55294/208/3265,4
GO:0048562,embryonic organ morphogenesis,Jul-90,294/18614,0.00055736,0.002566938,0.001257081,2625/6926/4853/29072/5156/2263/4851,7
GO:0032970,regulation of actin filament-based process,Aug-90,387/18614,0.000570254,0.002622505,0.001284293,5290/5295/4853/5156/387/4089/673/3265,8
GO:0051304,chromosome separation,Apr-90,79/18614,0.000582235,0.002669845,0.001307476,5925/472/324/701,4
GO:2000736,regulation of stem cell differentiation,Apr-90,79/18614,0.000582235,0.002669845,0.001307476,6926/1021/5156/4851,4
GO:0016242,negative regulation of macroautophagy,Mar-90,34/18614,0.000586828,0.002675394,0.001310194,7157/5290/207,3
GO:0060317,cardiac epithelial to mesenchymal transition,Mar-90,34/18614,0.000586828,0.002675394,0.001310194,6926/4089/4851,3
GO:0090313,regulation of protein targeting to membrane,Mar-90,34/18614,0.000586828,0.002675394,0.001310194,2064/208/3265,3
GO:2000515,"negative regulation of CD4-positive, alpha-beta T cell activation",Mar-90,34/18614,0.000586828,0.002675394,0.001310194,865/861/868,3
GO:2001235,positive regulation of apoptotic signaling pathway,May-90,140/18614,0.000589785,0.002685006,0.001314901,7157/4609/5728/55294/4763,5
GO:0001819,positive regulation of cytokine production,Sep-90,489/18614,0.000593859,0.002699668,0.001322081,2625/5295/672/29072/27086/861/7494/841/3265,9
GO:2000146,negative regulation of cell motility,Aug-90,390/18614,0.000599855,0.002723014,0.001333514,5728/2625/999/207/4763/387/4851/673,8
GO:0071230,cellular response to amino acid stimulus,Apr-90,80/18614,0.000610633,0.002767971,0.00135553,1956/1788/7494/5156,4
GO:0009612,response to mechanical stimulus,Jun-90,215/18614,0.000615394,0.002785558,0.001364143,5290/4214/6416/3480/387/841,6
GO:0051384,response to glucocorticoid,May-90,142/18614,0.000629015,0.002843146,0.001392345,5290/595/3480/387/677,5
GO:0001893,maternal placenta development,Mar-90,35/18614,0.000639606,0.002878684,0.001409749,207/4221/639,3
GO:0045943,positive regulation of transcription by RNA polymerase I,Mar-90,35/18614,0.000639606,0.002878684,0.001409749,2064/23451/6597,3
GO:1902253,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,Mar-90,35/18614,0.000639606,0.002878684,0.001409749,7157/4609/4193,3
GO:0002253,activation of immune response,Sep-90,495/18614,0.0006479,0.002911867,0.001425999,5290/2625/2099/1387/27086/868/6794/673/3265,9
GO:0042552,myelination,May-90,144/18614,0.00067017,0.003004258,0.001471245,5728/2064/207/4763/208,5
GO:0003151,outflow tract morphogenesis,Apr-90,82/18614,0.000670356,0.003004258,0.001471245,6926/2263/4089/4851,4
GO:0010614,negative regulation of cardiac muscle hypertrophy,Mar-90,36/18614,0.000695321,0.00310734,0.001521726,27086/4089/4851,3
GO:0033687,osteoblast proliferation,Mar-90,36/18614,0.000695321,0.00310734,0.001521726,3480/2263/387,3
GO:0001570,vasculogenesis,Apr-90,83/18614,0.000701718,0.003118308,0.001527097,55294/29072/4851/677,4
GO:0007492,endoderm development,Apr-90,83/18614,0.000701718,0.003118308,0.001527097,29072/4089/4851/677,4
GO:0014068,positive regulation of phosphatidylinositol 3-kinase signaling,Apr-90,83/18614,0.000701718,0.003118308,0.001527097,2260/3480/5156/2065,4
GO:0070897,transcription preinitiation complex assembly,Apr-90,83/18614,0.000701718,0.003118308,0.001527097,7157/2099/9439/6597,4
GO:0007272,ensheathment of neurons,May-90,146/18614,0.000713311,0.003160948,0.001547979,5728/2064/207/4763/208,5
GO:0008366,axon ensheathment,May-90,146/18614,0.000713311,0.003160948,0.001547979,5728/2064/207/4763/208,5
GO:0035883,enteroendocrine cell differentiation,Mar-90,37/18614,0.000754038,0.003332088,0.00163179,207/1021/4221,3
GO:0046326,positive regulation of glucose import,Mar-90,37/18614,0.000754038,0.003332088,0.00163179,207/5295/208,3
GO:0050866,negative regulation of cell activation,Jun-90,225/18614,0.000780374,0.003443657,0.001686427,2064/865/861/5156/472/868,6
GO:1900182,positive regulation of protein localization to nucleus,Apr-90,86/18614,0.000802028,0.00352937,0.001728403,999/207/5295/6794,4
GO:2000781,positive regulation of double-strand break repair,Apr-90,86/18614,0.000802028,0.00352937,0.001728403,57492/8289/6597/55193,4
GO:0061351,neural precursor cell proliferation,May-90,150/18614,0.000805792,0.003536096,0.001731697,7157/4763/2263/387/4851,5
GO:1903038,negative regulation of leukocyte cell-cell adhesion,May-90,150/18614,0.000805792,0.003536096,0.001731697,2064/207/865/861/868,5
GO:0014741,negative regulation of muscle hypertrophy,Mar-90,38/18614,0.000815818,0.003570192,0.001748394,27086/4089/4851,3
GO:0035510,DNA dealkylation,Mar-90,38/18614,0.000815818,0.003570192,0.001748394,2625/8239/54790,3
GO:0044839,cell cycle G2/M phase transition,May-90,151/18614,0.000830248,0.003628321,0.001776861,7157/595/1021/672/472,5
GO:0008589,regulation of smoothened signaling pathway,Apr-90,87/18614,0.000837602,0.003650375,0.001787661,5925/3169/1387/2263,4
GO:0048708,astrocyte differentiation,Apr-90,87/18614,0.000837602,0.003650375,0.001787661,4763/3845/1021/4851,4
GO:0010675,regulation of cellular carbohydrate metabolic process,May-90,152/18614,0.000855254,0.003722178,0.001822824,7157/207/9611/208/6794,5
GO:1903050,regulation of proteolysis involved in protein catabolic process,Jun-90,230/18614,0.000874733,0.003801723,0.001861779,5728/207/55294/4193/8239/8312,6
GO:0045740,positive regulation of DNA replication,Mar-90,39/18614,0.000880726,0.003822518,0.001871963,6416/1956/546,3
GO:0071241,cellular response to inorganic substance,Jun-90,231/18614,0.000894617,0.003877492,0.001898885,999/207/1956/546/1027/673,6
GO:0002312,B cell activation involved in immune response,Apr-90,89/18614,0.000912066,0.003942319,0.001930632,4853/7494/4292/4436,4
GO:2000177,regulation of neural precursor cell proliferation,Apr-90,89/18614,0.000912066,0.003942319,0.001930632,7157/4763/387/4851,4
GO:0050769,positive regulation of neurogenesis,Jun-90,232/18614,0.000914849,0.003948953,0.001933881,23013/3845/1523/4851/6794/673,6
GO:0045922,negative regulation of fatty acid metabolic process,Mar-90,40/18614,0.000948821,0.004090014,0.002002961,207/9611/672,3
GO:2000106,regulation of leukocyte apoptotic process,Apr-90,90/18614,0.000950994,0.004093803,0.002004817,7157/1029/4763/27086,4
GO:0060560,developmental growth involved in morphogenesis,Jun-90,234/18614,0.00095637,0.004111351,0.002013411,999/2099/8239/2263/4851/6794,6
GO:0007584,response to nutrient,May-90,156/18614,0.000960932,0.004119767,0.002017532,595/1030/3480/1788/7494,5
GO:2001236,regulation of extrinsic apoptotic signaling pathway,May-90,156/18614,0.000960932,0.004119767,0.002017532,5728/2260/207/4763/672,5
GO:0060021,roof of mouth development,Apr-90,91/18614,0.000991077,0.00424326,0.002078009,6926/5156/4089/54880,4
GO:0010918,positive regulation of mitochondrial membrane potential,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,207/208,2
GO:0015911,long-chain fatty acid import across plasma membrane,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,207/208,2
GO:0032275,luteinizing hormone secretion,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,6926/4089,2
GO:0033034,positive regulation of myeloid cell apoptotic process,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,1029/4763,2
GO:0033197,response to vitamin E,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,595/3480,2
GO:0048304,positive regulation of isotype switching to IgG isotypes,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,4292/4436,2
GO:0051974,negative regulation of telomerase activity,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,7157/4221,2
GO:0090220,chromosome localization to nuclear envelope involved in homologous chromosome segregation,Feb-90,10/18614,0.001014457,0.004296845,0.002104251,472/4292,2
GO:0030513,positive regulation of BMP signaling pathway,Mar-90,41/18614,0.001020165,0.004309481,0.002110439,4853/4089/4851,3
GO:0098751,bone cell development,Mar-90,41/18614,0.001020165,0.004309481,0.002110439,55294/4853/27086,3
GO:0071496,cellular response to external stimulus,Jul-90,327/18614,0.001040072,0.004387715,0.002148751,7157/4214/6416/1030/3480/7494/841,7
GO:0007160,cell-matrix adhesion,Jun-90,239/18614,0.001066535,0.004493363,0.002200489,5728/1029/4763/5295/1021/387,6
GO:0032465,regulation of cytokinesis,Apr-90,93/18614,0.001074785,0.004521346,0.002214193,3480/675/29072/387,4
GO:0006261,DNA-templated DNA replication,May-90,160/18614,0.001076035,0.004521346,0.002214193,898/675/672/545/546,5
GO:0040013,negative regulation of locomotion,Aug-90,427/18614,0.0010786,0.004526114,0.002216528,5728/2625/999/207/4763/387/4851/673,8
GO:0065004,protein-DNA complex assembly,Jun-90,242/18614,0.001137164,0.004765544,0.002333782,7157/5925/2099/9439/546/6597,6
GO:0019217,regulation of fatty acid metabolic process,Apr-90,95/18614,0.001163337,0.004862351,0.00238119,207/9611/208/672,4
GO:1904705,regulation of vascular associated smooth muscle cell proliferation,Apr-90,95/18614,0.001163337,0.004862351,0.00238119,5728/4763/387/1027,4
GO:0021915,neural tube development,May-90,163/18614,0.001168854,0.004863488,0.002381747,4763/3169/29072/4851/677,5
GO:0010719,negative regulation of epithelial to mesenchymal transition,Mar-90,43/18614,0.001172832,0.004863488,0.002381747,5728/2625/3169,3
GO:0010907,positive regulation of glucose metabolic process,Mar-90,43/18614,0.001172832,0.004863488,0.002381747,207/208/6794,3
GO:0014002,astrocyte development,Mar-90,43/18614,0.001172832,0.004863488,0.002381747,4763/3845/1021,3
GO:0060428,lung epithelium development,Mar-90,43/18614,0.001172832,0.004863488,0.002381747,3845/3169/2263,3
GO:0071459,"protein localization to chromosome, centromeric region",Mar-90,43/18614,0.001172832,0.004863488,0.002381747,5925/10664/701,3
GO:0051494,negative regulation of cytoskeleton organization,May-90,164/18614,0.001201074,0.00497408,0.002435906,5290/5295/672/4089/324,5
GO:0002042,cell migration involved in sprouting angiogenesis,Apr-90,96/18614,0.001209477,0.004995804,0.002446545,207/55294/387/4851,4
GO:0070664,negative regulation of leukocyte proliferation,Apr-90,96/18614,0.001209477,0.004995804,0.002446545,2064/4763/472/868,4
GO:0007519,skeletal muscle tissue development,May-90,165/18614,0.001233947,0.005046615,0.002471428,5925/4763/3845/387/4851,5
GO:0007406,negative regulation of neuroblast proliferation,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,7157/4763,2
GO:0034397,telomere localization,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,472/4292,2
GO:0042118,endothelial cell activation,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,27086/4089,2
GO:0060736,prostate gland growth,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,2099/2263,2
GO:0061314,Notch signaling involved in heart development,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,4853/4851,2
GO:0070601,centromeric sister chromatid cohesion,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,10664/701,2
GO:2001204,regulation of osteoclast development,Feb-90,11/18614,0.001235995,0.005046615,0.002471428,55294/4853,2
GO:0009895,negative regulation of catabolic process,Jul-90,337/18614,0.001237729,0.005046615,0.002471428,7157/5290/207/9611/1956/8239/4089,7
GO:0015980,energy derivation by oxidation of organic compounds,Jul-90,337/18614,0.001237729,0.005046615,0.002471428,7157/5290/4609/207/208/387/4436,7
GO:0042771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,Mar-90,44/18614,0.001254271,0.005078904,0.00248724,7157/675/4436,3
GO:0048512,circadian behavior,Mar-90,44/18614,0.001254271,0.005078904,0.00248724,7157/5728/9611,3
GO:2000249,regulation of actin cytoskeleton reorganization,Mar-90,44/18614,0.001254271,0.005078904,0.00248724,4853/5156/3265,3
GO:0001657,ureteric bud development,Apr-90,97/18614,0.001256884,0.005078904,0.00248724,4609/2625/2263/4089,4
GO:0051153,regulation of striated muscle cell differentiation,Apr-90,97/18614,0.001256884,0.005078904,0.00248724,27086/7494/4089/4851,4
GO:0060993,kidney morphogenesis,Apr-90,97/18614,0.001256884,0.005078904,0.00248724,4609/2625/4089/171023,4
GO:1990874,vascular associated smooth muscle cell proliferation,Apr-90,97/18614,0.001256884,0.005078904,0.00248724,5728/4763/387/1027,4
GO:0072163,mesonephric epithelium development,Apr-90,98/18614,0.001305577,0.00525553,0.002573737,4609/2625/2263/4089,4
GO:0072164,mesonephric tubule development,Apr-90,98/18614,0.001305577,0.00525553,0.002573737,4609/2625/2263/4089,4
GO:0120162,positive regulation of cold-induced thermogenesis,Apr-90,98/18614,0.001305577,0.00525553,0.002573737,3480/2778/324/4849,4
GO:0051250,negative regulation of lymphocyte activation,May-90,168/18614,0.001336567,0.00534999,0.002619996,2064/865/861/472/868,5
GO:0046636,negative regulation of alpha-beta T cell activation,Mar-90,45/18614,0.001339188,0.00534999,0.002619996,865/861/868,3
GO:0048701,embryonic cranial skeleton morphogenesis,Mar-90,45/18614,0.001339188,0.00534999,0.002619996,29072/5156/2263,3
GO:0060443,mammary gland morphogenesis,Mar-90,45/18614,0.001339188,0.00534999,0.002619996,6926/2099/2263,3
GO:1902692,regulation of neuroblast proliferation,Mar-90,45/18614,0.001339188,0.00534999,0.002619996,7157/4763/4851,3
GO:1904706,negative regulation of vascular associated smooth muscle cell proliferation,Mar-90,45/18614,0.001339188,0.00534999,0.002619996,5728/387/1027,3
GO:0043543,protein acylation,Jun-90,250/18614,0.001343125,0.005358949,0.002624384,2625/23451/675/672/1387/4089,6
GO:0003300,cardiac muscle hypertrophy,Apr-90,99/18614,0.001355574,0.005401811,0.002645374,6416/27086/4089/4851,4
GO:0019216,regulation of lipid metabolic process,Jul-90,344/18614,0.001392806,0.005543192,0.002714611,207/55294/9611/3480/208/672/5156,7
GO:0032886,regulation of microtubule-based process,Jun-90,252/18614,0.001398808,0.005560086,0.002722885,2064/672/387/1027/324/6794,6
GO:0032496,response to lipopolysaccharide,Jul-90,345/18614,0.001416148,0.005614902,0.002749729,207/27086/7494/2263/387/4851/841,7
GO:1990778,protein localization to cell periphery,Jul-90,345/18614,0.001416148,0.005614902,0.002749729,2064/999/207/5295/1956/208/3265,7
GO:0007094,mitotic spindle assembly checkpoint signaling,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,472/324/701,3
GO:0007622,rhythmic behavior,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,7157/5728/9611,3
GO:0055010,ventricular cardiac muscle tissue morphogenesis,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,2263/4089/4851,3
GO:0071173,spindle assembly checkpoint signaling,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,472/324/701,3
GO:0071174,mitotic spindle checkpoint signaling,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,472/324/701,3
GO:2001239,regulation of extrinsic apoptotic signaling pathway in absence of ligand,Mar-90,46/18614,0.001427639,0.00561822,0.002751354,2260/207/4763,3
GO:0002262,myeloid cell homeostasis,May-90,171/18614,0.001445362,0.005680901,0.00278205,2625/5925/4763/1021/677,5
GO:0010389,regulation of G2/M transition of mitotic cell cycle,Apr-90,101/18614,0.001459556,0.005722473,0.002802409,595/1021/672/472,4
GO:0048709,oligodendrocyte differentiation,Apr-90,101/18614,0.001459556,0.005722473,0.002802409,5728/2064/4763/4851,4
GO:0003157,endocardium development,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,4089/4851,2
GO:0031061,negative regulation of histone methylation,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,672/54880,2
GO:0033327,Leydig cell differentiation,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,595/5156,2
GO:0034086,maintenance of sister chromatid cohesion,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,5925/546,2
GO:0034088,maintenance of mitotic sister chromatid cohesion,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,5925/546,2
GO:0048680,positive regulation of axon regeneration,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,3480/673,2
GO:0051095,regulation of helicase activity,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,7157/4436,2
GO:0060442,branching involved in prostate gland morphogenesis,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,2099/2263,2
GO:0072015,podocyte development,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,4853/171023,2
GO:1901535,regulation of DNA demethylation,Feb-90,12/18614,0.001478534,0.005725927,0.0028041,2625/8239,2
GO:0010506,regulation of autophagy,Jul-90,348/18614,0.001488016,0.005755602,0.002818633,7157/5290/207/55294/472/6794/2072,7
GO:0001823,mesonephros development,Apr-90,102/18614,0.001513578,0.005807072,0.002843839,4609/2625/2263/4089,4
GO:0014897,striated muscle hypertrophy,Apr-90,102/18614,0.001513578,0.005807072,0.002843839,6416/27086/4089/4851,4
GO:0006984,ER-nucleus signaling pathway,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,7157/55294/7494,3
GO:0010837,regulation of keratinocyte proliferation,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,4853/2263/677,3
GO:0031018,endocrine pancreas development,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,207/1021/4221,3
GO:0031577,spindle checkpoint signaling,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,472/324/701,3
GO:0048286,lung alveolus development,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,3169/2263/171023,3
GO:0048806,genitalia development,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,6926/2099/5156,3
GO:0051972,regulation of telomerase activity,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,7157/4609/4221,3
GO:0120163,negative regulation of cold-induced thermogenesis,Mar-90,47/18614,0.001519676,0.005807072,0.002843839,5925/4851/6794,3
GO:0010906,regulation of glucose metabolic process,Apr-90,103/18614,0.001568978,0.005988234,0.002932557,7157/207/208/6794,4
GO:0045927,positive regulation of growth,Jun-90,258/18614,0.00157649,0.006009656,0.002943048,2064/207/1956/2263/387/4851,6
GO:0008542,visual learning,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,4763/3845/673,3
GO:0031648,protein destabilization,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,55294/4193/1387,3
GO:0033046,negative regulation of sister chromatid segregation,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,472/324/701,3
GO:0033048,negative regulation of mitotic sister chromatid segregation,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,472/324/701,3
GO:0044331,cell-cell adhesion mediated by cadherin,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,999/3169/4851,3
GO:0045841,negative regulation of mitotic metaphase/anaphase transition,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,472/324/701,3
GO:0060976,coronary vasculature development,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,29072/4851/639,3
GO:2000816,negative regulation of mitotic sister chromatid separation,Mar-90,48/18614,0.001615354,0.006099022,0.002986812,472/324/701,3
GO:0014896,muscle hypertrophy,Apr-90,104/18614,0.001625775,0.006123752,0.002998923,6416/27086/4089/4851,4
GO:0110020,regulation of actomyosin structure organization,Apr-90,104/18614,0.001625775,0.006123752,0.002998923,5295/387/4089/673,4
GO:0060043,regulation of cardiac muscle cell proliferation,Mar-90,49/18614,0.001714724,0.006451113,0.003159238,861/2263/4851,3
GO:0060538,skeletal muscle organ development,May-90,178/18614,0.001724491,0.006480152,0.003173459,5925/4763/3845/387/4851,5
GO:0036302,atrioventricular canal development,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,6926/4089,2
GO:0036462,TRAIL-activated apoptotic signaling pathway,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,5728/841,2
GO:0048853,forebrain morphogenesis,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,5728/4763,2
GO:0070572,positive regulation of neuron projection regeneration,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,3480/673,2
GO:0071481,cellular response to X-ray,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,2625/472,2
GO:0072310,glomerular epithelial cell development,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,4853/171023,2
GO:1900103,positive regulation of endoplasmic reticulum unfolded protein response,Feb-90,13/18614,0.00174187,0.006491494,0.003179013,5295/7494,2
GO:0071216,cellular response to biotic stimulus,Jun-90,264/18614,0.001770884,0.006591856,0.003228163,7157/207/4853/7494/387/4851,6
GO:0046822,regulation of nucleocytoplasmic transport,Apr-90,107/18614,0.001804731,0.006702076,0.00328214,999/4763/5295/29072,4
GO:0062014,negative regulation of small molecule metabolic process,Apr-90,107/18614,0.001804731,0.006702076,0.00328214,7157/207/9611/672,4
GO:0002066,columnar/cuboidal epithelial cell development,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,207/1021/639,3
GO:0045581,negative regulation of T cell differentiation,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,2064/865/861,3
GO:0051985,negative regulation of chromosome segregation,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,472/324/701,3
GO:1902100,negative regulation of metaphase/anaphase transition of cell cycle,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,472/324/701,3
GO:1905819,negative regulation of chromosome separation,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,472/324/701,3
GO:2000378,negative regulation of reactive oxygen species metabolic process,Mar-90,50/18614,0.001817837,0.006703538,0.003282856,7157/672/387,3
GO:0051090,regulation of DNA-binding transcription factor activity,Aug-90,465/18614,0.001849014,0.006810571,0.003335272,5728/5925/1029/207/2099/3169/6597/4221,8
GO:0048771,tissue remodeling,May-90,181/18614,0.001855492,0.006826486,0.003343066,7157/4193/4763/4853/861,5
GO:0032873,negative regulation of stress-activated MAPK cascade,Mar-90,51/18614,0.001924743,0.007048225,0.003451656,4609/9611/4221,3
GO:0043124,negative regulation of I-kappaB kinase/NF-kappaB signaling,Mar-90,51/18614,0.001924743,0.007048225,0.003451656,2099/387/841,3
GO:0060612,adipose tissue development,Mar-90,51/18614,0.001924743,0.007048225,0.003451656,5290/7494/3265,3
GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,Mar-90,51/18614,0.001924743,0.007048225,0.003451656,4609/9611/4221,3
GO:0001708,cell fate specification,Apr-90,109/18614,0.001931356,0.007048225,0.003451656,6926/3169/4851/324,4
GO:0045833,negative regulation of lipid metabolic process,Apr-90,109/18614,0.001931356,0.007048225,0.003451656,207/55294/9611/672,4
GO:0120034,positive regulation of plasma membrane bounded cell projection assembly,Apr-90,109/18614,0.001931356,0.007048225,0.003451656,5290/5295/324/3265,4
GO:0006109,regulation of carbohydrate metabolic process,May-90,183/18614,0.001946788,0.007096355,0.003475226,7157/207/9611/208/6794,5
GO:0002237,response to molecule of bacterial origin,Jul-90,366/18614,0.001981162,0.007213344,0.003532518,207/27086/7494/2263/387/4851/841,7
GO:0048469,cell maturation,May-90,184/18614,0.001993649,0.007250466,0.003550697,2625/5925/865/675/3169,5
GO:0000722,telomere maintenance via recombination,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,675/2072,2
GO:0001833,inner cell mass cell proliferation,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,675/79728,2
GO:0048302,regulation of isotype switching to IgG isotypes,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,4292/4436,2
GO:0048715,negative regulation of oligodendrocyte differentiation,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,4763/4851,2
GO:0071285,cellular response to lithium ion,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,999/1027,2
GO:1904668,positive regulation of ubiquitin protein ligase activity,Feb-90,14/18614,0.002025802,0.007316937,0.003583249,5728/1027,2
GO:0046622,positive regulation of organ growth,Mar-90,52/18614,0.00203549,0.007318513,0.003584021,207/2263/4851,3
GO:0046638,positive regulation of alpha-beta T cell differentiation,Mar-90,52/18614,0.00203549,0.007318513,0.003584021,865/861/387,3
GO:0060425,lung morphogenesis,Mar-90,52/18614,0.00203549,0.007318513,0.003584021,3845/3169/2263,3
GO:2000677,regulation of transcription regulatory region DNA binding,Mar-90,52/18614,0.00203549,0.007318513,0.003584021,2625/5925/55294,3
GO:0000910,cytokinesis,May-90,185/18614,0.002041331,0.007331181,0.003590225,3480/675/29072/387/324,5
GO:0006006,glucose metabolic process,May-90,187/18614,0.002139189,0.007656556,0.003749567,7157/5290/207/208/6794,5
GO:0071772,response to BMP,May-90,187/18614,0.002139189,0.007656556,0.003749567,2625/4853/8239/4089/4851,5
GO:0071773,cellular response to BMP stimulus,May-90,187/18614,0.002139189,0.007656556,0.003749567,2625/4853/8239/4089/4851,5
GO:0002639,positive regulation of immunoglobulin production,Mar-90,53/18614,0.002150128,0.00766968,0.003755995,7494/4292/4436,3
GO:0007140,male meiotic nuclear division,Mar-90,53/18614,0.002150128,0.00766968,0.003755995,675/472/4292,3
GO:0033047,regulation of mitotic sister chromatid segregation,Mar-90,53/18614,0.002150128,0.00766968,0.003755995,472/324/701,3
GO:0061448,connective tissue development,Jun-90,275/18614,0.002174002,0.007746108,0.003793423,5290/5925/3169/7494/4851/3265,6
GO:0044344,cellular response to fibroblast growth factor stimulus,Apr-90,113/18614,0.002202833,0.007840005,0.003839406,2260/2625/2263/677,4
GO:0007611,learning or memory,Jun-90,276/18614,0.002213818,0.007870248,0.003854217,5728/4763/1956/3845/673/23152,6
GO:0007632,visual behavior,Mar-90,54/18614,0.002268703,0.008023245,0.003929143,4763/3845/673,3
GO:0043550,regulation of lipid kinase activity,Mar-90,54/18614,0.002268703,0.008023245,0.003929143,5925/5295/5156,3
GO:0046686,response to cadmium ion,Mar-90,54/18614,0.002268703,0.008023245,0.003929143,207/1956/1027,3
GO:0071168,protein localization to chromatin,Mar-90,54/18614,0.002268703,0.008023245,0.003929143,2099/29072/4436,3
GO:0030336,negative regulation of cell migration,Jul-90,375/18614,0.002271074,0.008023245,0.003929143,5728/999/207/4763/387/4851/673,7
GO:0031532,actin cytoskeleton reorganization,Apr-90,114/18614,0.002274605,0.008023245,0.003929143,4853/5156/387/3265,4
GO:1904659,glucose transmembrane transport,Apr-90,114/18614,0.002274605,0.008023245,0.003929143,207/5295/208/673,4
GO:0003214,cardiac left ventricle morphogenesis,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4089/4851,2
GO:0010225,response to UV-C,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,7157/675,2
GO:0010832,negative regulation of myotube differentiation,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,7494/4851,2
GO:0032352,positive regulation of hormone metabolic process,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,2625/3480,2
GO:0043374,"CD8-positive, alpha-beta T cell differentiation",Feb-90,15/18614,0.002330127,0.008083906,0.00395885,865/861,2
GO:0045475,locomotor rhythm,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,5728/9611,2
GO:0045725,positive regulation of glycogen biosynthetic process,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,207/208,2
GO:0045838,positive regulation of membrane potential,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,207/208,2
GO:0048291,isotype switching to IgG isotypes,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4292/4436,2
GO:0070986,left/right axis specification,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4853/4851,2
GO:0071599,otic vesicle development,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,2625/2263,2
GO:0072075,metanephric mesenchyme development,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4609/4089,2
GO:0072520,seminiferous tubule development,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4089/546,2
GO:1901722,regulation of cell proliferation involved in kidney development,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,4609/2625,2
GO:1905208,negative regulation of cardiocyte differentiation,Feb-90,15/18614,0.002330127,0.008083906,0.00395885,1956/4089,2
GO:0001938,positive regulation of endothelial cell proliferation,Apr-90,115/18614,0.002347974,0.008136902,0.003984802,2260/207/4763/4893,4
GO:0051962,positive regulation of nervous system development,Jun-90,280/18614,0.002378618,0.00823408,0.004032392,23013/3845/1523/4851/6794/673,6
GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",Mar-90,55/18614,0.002391262,0.008259773,0.004044975,2625/865/861,3
GO:2000772,regulation of cellular senescence,Mar-90,55/18614,0.002391262,0.008259773,0.004044975,7157/5728/1021,3
GO:0032006,regulation of TOR signaling,Apr-90,116/18614,0.002422959,0.008351025,0.004089663,5290/8239/472/6794,4
GO:0048640,negative regulation of developmental growth,Apr-90,116/18614,0.002422959,0.008351025,0.004089663,5728/999/27086/1027,4
GO:0048839,inner ear development,May-90,193/18614,0.002453345,0.008446553,0.004136445,2625/6926/2263/1027/4851,5
GO:0007088,regulation of mitotic nuclear division,Apr-90,117/18614,0.002499576,0.00857772,0.00420068,5925/472/324/701,4
GO:0008645,hexose transmembrane transport,Apr-90,117/18614,0.002499576,0.00857772,0.00420068,207/5295/208/673,4
GO:1901800,positive regulation of proteasomal protein catabolic process,Apr-90,117/18614,0.002499576,0.00857772,0.00420068,207/55294/4193/8312,4
GO:0061136,regulation of proteasomal protein catabolic process,May-90,194/18614,0.002508795,0.00860003,0.004211606,207/55294/4193/8239/8312,5
GO:0045839,negative regulation of mitotic nuclear division,Mar-90,56/18614,0.002517849,0.008612405,0.004217666,472/324/701,3
GO:0060986,endocrine hormone secretion,Mar-90,56/18614,0.002517849,0.008612405,0.004217666,2625/6926/4089,3
GO:1902074,response to salt,Jul-90,383/18614,0.002555406,0.008731431,0.004275955,5290/595/999/3480/1788/1027/673,7
GO:0007369,gastrulation,May-90,196/18614,0.002622423,0.008950751,0.00438336,7157/29072/2263/4089/8312,5
GO:0001541,ovarian follicle development,Mar-90,57/18614,0.002648509,0.008954482,0.004385188,2099/4089/472,3
GO:0007131,reciprocal meiotic recombination,Mar-90,57/18614,0.002648509,0.008954482,0.004385188,472/4292/2072,3
GO:0010676,positive regulation of cellular carbohydrate metabolic process,Mar-90,57/18614,0.002648509,0.008954482,0.004385188,207/208/6794,3
GO:0048168,regulation of neuronal synaptic plasticity,Mar-90,57/18614,0.002648509,0.008954482,0.004385188,4763/3845/3265,3
GO:0140527,reciprocal homologous recombination,Mar-90,57/18614,0.002648509,0.008954482,0.004385188,472/4292/2072,3
GO:0034349,glial cell apoptotic process,Feb-90,16/18614,0.002654647,0.008954482,0.004385188,7157/5925,2
GO:0034393,positive regulation of smooth muscle cell apoptotic process,Feb-90,16/18614,0.002654647,0.008954482,0.004385188,6416/1029,2
GO:0043517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",Feb-90,16/18614,0.002654647,0.008954482,0.004385188,545/472,2
GO:0045651,positive regulation of macrophage differentiation,Feb-90,16/18614,0.002654647,0.008954482,0.004385188,5925/841,2
GO:0070875,positive regulation of glycogen metabolic process,Feb-90,16/18614,0.002654647,0.008954482,0.004385188,207/208,2
GO:2000345,regulation of hepatocyte proliferation,Feb-90,16/18614,0.002654647,0.008954482,0.004385188,55294/7494,2
GO:0002286,T cell activation involved in immune response,Apr-90,119/18614,0.00265778,0.0089555,0.004385687,7157/2625/27086/4221,4
GO:0015749,monosaccharide transmembrane transport,Apr-90,120/18614,0.002739402,0.009182786,0.004496993,207/5295/208/673,4
GO:0051101,regulation of DNA binding,Apr-90,120/18614,0.002739402,0.009182786,0.004496993,2625/5925/55294/2072,4
GO:0071774,response to fibroblast growth factor,Apr-90,120/18614,0.002739402,0.009182786,0.004496993,2260/2625/2263/677,4
GO:0007051,spindle organization,May-90,198/18614,0.002739744,0.009182786,0.004496993,9611/387/546/4292/10735,5
GO:0071897,DNA biosynthetic process,May-90,198/18614,0.002739744,0.009182786,0.004496993,7157/4609/545/472/4221,5
GO:0010718,positive regulation of epithelial to mesenchymal transition,Mar-90,58/18614,0.002783286,0.009289363,0.004549186,80139/4089/4851,3
GO:0030225,macrophage differentiation,Mar-90,58/18614,0.002783286,0.009289363,0.004549186,2625/5925/841,3
GO:0042306,regulation of protein import into nucleus,Mar-90,58/18614,0.002783286,0.009289363,0.004549186,999/4763/5295,3
GO:0043616,keratinocyte proliferation,Mar-90,58/18614,0.002783286,0.009289363,0.004549186,4853/2263/677,3
GO:0140694,non-membrane-bounded organelle assembly,Jul-90,390/18614,0.002826057,0.009422174,0.004614226,9611/672/5156/387/4089/4292/10735,7
GO:0034599,cellular response to oxidative stress,Jun-90,290/18614,0.002831083,0.009428998,0.004617568,7157/207/55294/1956/27086/5156,6
GO:0071248,cellular response to metal ion,May-90,200/18614,0.002860827,0.009518041,0.004661174,999/207/1956/1027/673,5
GO:0046324,regulation of glucose import,Mar-90,59/18614,0.002922221,0.009701897,0.004751212,207/5295/208,3
GO:1903053,regulation of extracellular matrix organization,Mar-90,59/18614,0.002922221,0.009701897,0.004751212,5925/861/4851,3
GO:0002695,negative regulation of leukocyte activation,May-90,202/18614,0.002985742,0.00987446,0.004835719,2064/865/861/472/868,5
GO:0031032,actomyosin structure organization,May-90,202/18614,0.002985742,0.00987446,0.004835719,5295/5156/387/4089/673,5
GO:0000712,resolution of meiotic recombination intermediates,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,4292/2072,2
GO:0003198,epithelial to mesenchymal transition involved in endocardial cushion formation,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,4089/4851,2
GO:0021542,dentate gyrus development,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,5728/1021,2
GO:0032274,gonadotropin secretion,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,6926/4089,2
GO:0044539,long-chain fatty acid import into cell,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,207/208,2
GO:0048557,embryonic digestive tract morphogenesis,Feb-90,17/18614,0.002999164,0.00987446,0.004835719,5156/2263,2
GO:0045620,negative regulation of lymphocyte differentiation,Mar-90,60/18614,0.003065357,0.01005056,0.004921959,2064/865/861,3
GO:0046579,positive regulation of Ras protein signal transduction,Mar-90,60/18614,0.003065357,0.01005056,0.004921959,3845/4853/4851,3
GO:0055008,cardiac muscle tissue morphogenesis,Mar-90,60/18614,0.003065357,0.01005056,0.004921959,2263/4089/4851,3
GO:1903078,positive regulation of protein localization to plasma membrane,Mar-90,60/18614,0.003065357,0.01005056,0.004921959,207/5295/1956,3
GO:0045599,negative regulation of fat cell differentiation,Mar-90,61/18614,0.003212735,0.010479478,0.005132009,2625/8312/171023,3
GO:0045668,negative regulation of osteoblast differentiation,Mar-90,61/18614,0.003212735,0.010479478,0.005132009,1021/4851/4221,3
GO:0046854,phosphatidylinositol phosphate biosynthetic process,Mar-90,61/18614,0.003212735,0.010479478,0.005132009,5290/5295/472,3
GO:0060038,cardiac muscle cell proliferation,Mar-90,61/18614,0.003212735,0.010479478,0.005132009,861/2263/4851,3
GO:1904356,regulation of telomere maintenance via telomere lengthening,Mar-90,61/18614,0.003212735,0.010479478,0.005132009,545/472/2072,3
GO:0000956,nuclear-transcribed mRNA catabolic process,Apr-90,126/18614,0.00326552,0.010640686,0.005210955,472/4292/677/4849,4
GO:0007623,circadian rhythm,May-90,207/18614,0.003315244,0.010791596,0.005284859,7157/5728/55294/9611/8239,5
GO:0048593,camera-type eye morphogenesis,Apr-90,127/18614,0.003359433,0.010829036,0.005303194,4763/4853/4851/639,4
GO:0003159,morphogenesis of an endothelium,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,27086/387,2
GO:0006978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",Feb-90,18/18614,0.003363482,0.010829036,0.005303194,7157/675,2
GO:0007063,regulation of sister chromatid cohesion,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,10664/546,2
GO:0010663,positive regulation of striated muscle cell apoptotic process,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,7157/4089,2
GO:0010666,positive regulation of cardiac muscle cell apoptotic process,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,7157/4089,2
GO:0045064,T-helper 2 cell differentiation,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,2625/4221,2
GO:0060602,branch elongation of an epithelium,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,2099/2263,2
GO:0061154,endothelial tube morphogenesis,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,27086/387,2
GO:2000811,negative regulation of anoikis,Feb-90,18/18614,0.003363482,0.010829036,0.005303194,5290/4851,2
GO:0060261,positive regulation of transcription initiation by RNA polymerase II,Mar-90,62/18614,0.003364394,0.010829036,0.005303194,7157/2099/9439,3
GO:1901654,response to ketone,May-90,208/18614,0.003384164,0.010881601,0.005328936,5290/595/207/3480/27086,5
GO:1904375,regulation of protein localization to cell periphery,Apr-90,128/18614,0.00345517,0.011098637,0.005435223,207/5295/1956/3265,4
GO:0051784,negative regulation of nuclear division,Mar-90,63/18614,0.003520373,0.011285168,0.005526571,472/324/701,3
GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,Mar-90,63/18614,0.003520373,0.011285168,0.005526571,7157/4609/55294,3
GO:0030218,erythrocyte differentiation,Apr-90,130/18614,0.003652186,0.011695866,0.005727698,2625/5925/1021/677,4
GO:0043254,regulation of protein-containing complex assembly,Jul-90,409/18614,0.00367243,0.011748804,0.005753623,7157/5925/2099/545/387/472/1027,7
GO:0006303,double-strand break repair via nonhomologous end joining,Mar-90,64/18614,0.003680711,0.011751534,0.00575496,472/4292/2072,3
GO:0045143,homologous chromosome segregation,Mar-90,64/18614,0.003680711,0.011751534,0.00575496,898/472/4292,3
GO:0050821,protein stabilization,May-90,213/18614,0.003744342,0.011805237,0.005781259,7157/5728/55294/5295/8239,5
GO:0003184,pulmonary valve morphogenesis,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,4853/4851,2
GO:0030540,female genitalia development,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,6926/2099,2
GO:0035518,histone H2A monoubiquitination,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,675/672,2
GO:0036342,post-anal tail morphogenesis,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,79728/8312,2
GO:0042772,"DNA damage response, signal transduction resulting in transcription",Feb-90,19/18614,0.003747404,0.011805237,0.005781259,7157/675,2
GO:0055003,cardiac myofibril assembly,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,5156/4089,2
GO:0060039,pericardium development,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,29072/4851,2
GO:0060977,coronary vasculature morphogenesis,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,29072/4851,2
GO:0072074,kidney mesenchyme development,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,4609/4089,2
GO:0140354,lipid import into cell,Feb-90,19/18614,0.003747404,0.011805237,0.005781259,207/208,2
GO:0006661,phosphatidylinositol biosynthetic process,Apr-90,131/18614,0.003753498,0.011805237,0.005781259,5290/5728/5295/472,4
GO:0010595,positive regulation of endothelial cell migration,Apr-90,131/18614,0.003753498,0.011805237,0.005781259,2260/2625/207/27086,4
GO:0050868,negative regulation of T cell activation,Apr-90,131/18614,0.003753498,0.011805237,0.005781259,2064/865/861/868,4
GO:0051225,spindle assembly,Apr-90,131/18614,0.003753498,0.011805237,0.005781259,9611/387/4292/10735,4
GO:0043588,skin development,Jun-90,308/18614,0.003804507,0.011953784,0.005854006,4763/1956/2263/4089/4851/677,6
GO:0098781,ncRNA transcription,Mar-90,65/18614,0.003845445,0.012058461,0.005905268,7157/546/6597,3
GO:1905330,regulation of morphogenesis of an epithelium,Mar-90,65/18614,0.003845445,0.012058461,0.005905268,2625/2099/27086,3
GO:0051222,positive regulation of protein transport,Jun-90,309/18614,0.003865041,0.012107911,0.005929485,2064/999/55294/5295/208/3265,6
GO:0034219,carbohydrate transmembrane transport,Apr-90,133/18614,0.003961816,0.0123988,0.006071939,207/5295/208/673,4
GO:0060675,ureteric bud morphogenesis,Mar-90,66/18614,0.004014611,0.01255161,0.006146773,4609/2625/4089,3
GO:0002702,positive regulation of production of molecular mediator of immune response,Apr-90,134/18614,0.004068855,0.012708644,0.006223676,2625/7494/4292/4436,4
GO:0003215,cardiac right ventricle morphogenesis,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,2625/4851,2
GO:0031998,regulation of fatty acid beta-oxidation,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,207/208,2
GO:0060749,mammary gland alveolus development,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,595/2099,2
GO:0061377,mammary gland lobule development,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,595/2099,2
GO:0070314,G1 to G0 transition,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,7157/6794,2
GO:1902001,fatty acid transmembrane transport,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,207/208,2
GO:2000269,regulation of fibroblast apoptotic process,Feb-90,20/18614,0.004150737,0.012862814,0.006299175,7157/5290,2
GO:2001185,"regulation of CD8-positive, alpha-beta T cell activation",Feb-90,20/18614,0.004150737,0.012862814,0.006299175,865/861,2
GO:0010565,regulation of cellular ketone metabolic process,Apr-90,135/18614,0.004177835,0.012921476,0.006327904,207/9611/208/672,4
GO:0042476,odontogenesis,Apr-90,135/18614,0.004177835,0.012921476,0.006327904,5156/2263/387/54880,4
GO:0072171,mesonephric tubule morphogenesis,Mar-90,67/18614,0.004188246,0.012941025,0.006337477,4609/2625/4089,3
GO:0000086,G2/M transition of mitotic cell cycle,Apr-90,136/18614,0.004288774,0.013238712,0.00648326,595/1021/672/472,4
GO:0000288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",Mar-90,68/18614,0.004366383,0.013373898,0.006549464,4292/677/4849,3
GO:0016445,somatic diversification of immunoglobulins,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,4292/4436/5395,3
GO:0035914,skeletal muscle cell differentiation,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,5925/3845/4851,3
GO:0048663,neuron fate commitment,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,3169/4089/4851,3
GO:0051057,positive regulation of small GTPase mediated signal transduction,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,3845/4853/4851,3
GO:0051123,RNA polymerase II preinitiation complex assembly,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,7157/2099/9439,3
GO:1904377,positive regulation of protein localization to cell periphery,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,207/5295/1956,3
GO:2000144,positive regulation of DNA-templated transcription initiation,Mar-90,68/18614,0.004366383,0.013373898,0.006549464,7157/2099/9439,3
GO:0050890,cognition,Jun-90,317/18614,0.004375419,0.013379623,0.006552267,5728/4763/1956/3845/673/23152,6
GO:0043583,ear development,May-90,221/18614,0.00437671,0.013379623,0.006552267,2625/6926/2263/1027/4851,5
GO:0003158,endothelium development,Apr-90,137/18614,0.004401686,0.013430025,0.00657695,27086/387/4089/4851,4
GO:0061041,regulation of wound healing,Apr-90,137/18614,0.004401686,0.013430025,0.00657695,5728/7494/5156/3265,4
GO:0007281,germ cell development,Jun-90,319/18614,0.004510453,0.013748625,0.006732975,207/675/472/4292/4436/639,6
GO:0010611,regulation of cardiac muscle hypertrophy,Mar-90,69/18614,0.004549058,0.013807145,0.006761633,27086/4089/4851,3
GO:0042093,T-helper cell differentiation,Mar-90,69/18614,0.004549058,0.013807145,0.006761633,2625/27086/4221,3
GO:0150116,regulation of cell-substrate junction organization,Mar-90,69/18614,0.004549058,0.013807145,0.006761633,5728/5295/387,3
GO:0010224,response to UV-B,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,4436/6794,2
GO:0035020,regulation of Rac protein signal transduction,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,4763/3845,2
GO:0036092,phosphatidylinositol-3-phosphate biosynthetic process,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,5290/472,2
GO:0038083,peptidyl-tyrosine autophosphorylation,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,3480/1956,2
GO:0051571,positive regulation of histone H3-K4 methylation,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,672/4089,2
GO:1903209,positive regulation of oxidative stress-induced cell death,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,55294/27086,2
GO:2000047,regulation of cell-cell adhesion mediated by cadherin,Feb-90,21/18614,0.004573289,0.013807145,0.006761633,3169/4851,2
GO:0034101,erythrocyte homeostasis,Apr-90,139/18614,0.0046335,0.01396228,0.006837606,2625/5925/1021/677,4
GO:0090090,negative regulation of canonical Wnt signaling pathway,Apr-90,139/18614,0.0046335,0.01396228,0.006837606,8312/4851/324/6794,4
GO:0007411,axon guidance,May-90,225/18614,0.004719943,0.014195723,0.006951928,2064/2625/4853/4089/4851,5
GO:0097485,neuron projection guidance,May-90,225/18614,0.004719943,0.014195723,0.006951928,2064/2625/4853/4089/4851,5
GO:0009880,embryonic pattern specification,Mar-90,70/18614,0.004736303,0.014217896,0.006962786,6926/2263/4089,3
GO:0032206,positive regulation of telomere maintenance,Mar-90,70/18614,0.004736303,0.014217896,0.006962786,545/472/546,3
GO:0048813,dendrite morphogenesis,Apr-90,140/18614,0.004752433,0.014252794,0.006979876,5728/1523/6794/80243,4
GO:0032434,regulation of proteasomal ubiquitin-dependent protein catabolic process,Apr-90,141/18614,0.004873404,0.014601753,0.007150768,207/4193/8239/8312,4
GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",Mar-90,71/18614,0.004928151,0.014710066,0.007203811,2625/27086/4221,3
GO:0002562,somatic diversification of immune receptors via germline recombination within a single locus,Mar-90,71/18614,0.004928151,0.014710066,0.007203811,472/4292/4436,3
GO:0016444,somatic cell DNA recombination,Mar-90,71/18614,0.004928151,0.014710066,0.007203811,472/4292/4436,3
GO:0045600,positive regulation of fat cell differentiation,Mar-90,71/18614,0.004928151,0.014710066,0.007203811,207/7494/677,3
GO:1904951,positive regulation of establishment of protein localization,Jun-90,325/18614,0.004934066,0.014713839,0.007205659,2064/999/55294/5295/208/3265,6
GO:0019318,hexose metabolic process,May-90,228/18614,0.004989651,0.014801349,0.007248515,7157/5290/207/208/6794,5
GO:0001832,blastocyst growth,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,675/79728,2
GO:0043371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",Feb-90,22/18614,0.005014869,0.014801349,0.007248515,865/861,2
GO:0045061,thymic T cell selection,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,2625/6794,2
GO:0048485,sympathetic nervous system development,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,2625/4763,2
GO:0060444,branching involved in mammary gland duct morphogenesis,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,6926/2099,2
GO:0060713,labyrinthine layer morphogenesis,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,2263/677,2
GO:0061318,renal filtration cell differentiation,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,4853/171023,2
GO:0072111,cell proliferation involved in kidney development,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,4609/2625,2
GO:0072112,podocyte differentiation,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,4853/171023,2
GO:1902894,negative regulation of miRNA transcription,Feb-90,22/18614,0.005014869,0.014801349,0.007248515,9611/2099,2
GO:0002287,alpha-beta T cell activation involved in immune response,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,2625/27086/4221,3
GO:0002293,alpha-beta T cell differentiation involved in immune response,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,2625/27086/4221,3
GO:0014743,regulation of muscle hypertrophy,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,27086/4089/4851,3
GO:0046635,positive regulation of alpha-beta T cell activation,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,865/861/387,3
GO:0060260,regulation of transcription initiation by RNA polymerase II,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,7157/2099/9439,3
GO:1904888,cranial skeletal system development,Mar-90,72/18614,0.005124633,0.015041132,0.007365941,29072/5156/2263,3
GO:0048588,developmental cell growth,May-90,231/18614,0.005270139,0.015453866,0.007568065,6416/999/27086/8239/6794,5
GO:0022412,cellular process involved in reproduction in multicellular organism,Jul-90,438/18614,0.005321128,0.015573727,0.007626764,207/675/1788/472/4292/4436/639,7
GO:0042246,tissue regeneration,Mar-90,73/18614,0.005325782,0.015573727,0.007626764,861/1027/4851,3
GO:0060415,muscle tissue morphogenesis,Mar-90,73/18614,0.005325782,0.015573727,0.007626764,2263/4089/4851,3
GO:0051783,regulation of nuclear division,Apr-90,145/18614,0.00537799,0.015711875,0.007694418,5925/472/324/701,4
GO:0062012,regulation of small molecule metabolic process,Jun-90,331/18614,0.005386309,0.015721661,0.00769921,7157/207/9611/208/672/6794,6
GO:2001234,negative regulation of apoptotic signaling pathway,May-90,233/18614,0.005463234,0.015864293,0.00776906,5925/207/4193/672/7494,5
GO:0003177,pulmonary valve development,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,4853/4851,2
GO:0003283,atrial septum development,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,4193/4853,2
GO:0032891,negative regulation of organic acid transport,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,207/208,2
GO:0038095,Fc-epsilon receptor signaling pathway,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,4214/6416,2
GO:0072311,glomerular epithelial cell differentiation,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,4853/171023,2
GO:2000178,negative regulation of neural precursor cell proliferation,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,7157/4763,2
GO:2000629,negative regulation of miRNA metabolic process,Feb-90,23/18614,0.005475287,0.015864293,0.00776906,9611/2099,2
GO:0007224,smoothened signaling pathway,Apr-90,146/18614,0.00550939,0.015948498,0.007810297,5925/3169/1387/2263,4
GO:0051145,smooth muscle cell differentiation,Mar-90,74/18614,0.005531625,0.015983619,0.007827496,6926/2263/4851,3
GO:2000573,positive regulation of DNA biosynthetic process,Mar-90,74/18614,0.005531625,0.015983619,0.007827496,4609/545/472,3
GO:0016358,dendrite development,May-90,234/18614,0.005561637,0.016055675,0.007862783,5728/387/1523/6794/80243,5
GO:0045667,regulation of osteoblast differentiation,Apr-90,147/18614,0.005642921,0.01627548,0.007970426,1021/2263/4851/4221,4
GO:0030968,endoplasmic reticulum unfolded protein response,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,595/5295/7494,3
GO:0042058,regulation of epidermal growth factor receptor signaling pathway,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,55294/1956/868,3
GO:0042698,ovulation cycle,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,3480/2099/5156,3
GO:0046323,glucose import,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,207/5295/208,3
GO:0048662,negative regulation of smooth muscle cell proliferation,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,5728/387/1027,3
GO:0072078,nephron tubule morphogenesis,Mar-90,75/18614,0.005742194,0.016471716,0.008066527,4609/2625/4089,3
GO:0002053,positive regulation of mesenchymal cell proliferation,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,4609/2263,2
GO:0002320,lymphoid progenitor cell differentiation,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,2625/4851,2
GO:0003323,type B pancreatic cell development,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,207/1021,2
GO:0030539,male genitalia development,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,6926/5156,2
GO:0044030,regulation of DNA methylation,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,4609/672,2
GO:0060571,morphogenesis of an epithelial fold,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,1956/2263,2
GO:0140747,regulation of ncRNA transcription,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,546/6597,2
GO:1900543,negative regulation of purine nucleotide metabolic process,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,7157/9611,2
GO:2001026,regulation of endothelial cell chemotaxis,Feb-90,24/18614,0.005954354,0.016935835,0.008293815,2260/4851,2
GO:0002637,regulation of immunoglobulin production,Mar-90,76/18614,0.005957517,0.016935835,0.008293815,7494/4292/4436,3
GO:0003407,neural retina development,Mar-90,77/18614,0.006177622,0.01753004,0.008584809,4851/6597/639,3
GO:0072088,nephron epithelium morphogenesis,Mar-90,77/18614,0.006177622,0.01753004,0.008584809,4609/2625/4089,3
GO:0045834,positive regulation of lipid metabolic process,Apr-90,151/18614,0.006198667,0.017574,0.008606337,207/3480/208/5156,4
GO:0042445,hormone metabolic process,May-90,241/18614,0.00628588,0.017805303,0.008719611,2625/3480/2099/3169/5156,5
GO:0003012,muscle system process,Jul-90,452/18614,0.006292424,0.017807899,0.008720882,5290/6416/6926/27086/387/4089/4851,7
GO:0007612,learning,Apr-90,152/18614,0.006343084,0.017919212,0.008775394,4763/3845/673/23152,4
GO:0034614,cellular response to reactive oxygen species,Apr-90,152/18614,0.006343084,0.017919212,0.008775394,207/1956/27086/5156,4
GO:0002437,inflammatory response to antigenic stimulus,Mar-90,78/18614,0.006402535,0.018033359,0.008831294,2625/4853/4851,3
GO:0003148,outflow tract septum morphogenesis,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,2263/4089,2
GO:0010226,response to lithium ion,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,999/1027,2
GO:0045649,regulation of macrophage differentiation,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,5925/841,2
GO:0045662,negative regulation of myoblast differentiation,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,6926/4851,2
GO:0045980,negative regulation of nucleotide metabolic process,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,7157/9611,2
GO:0060706,cell differentiation involved in embryonic placenta development,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,841/639,2
GO:0099633,protein localization to postsynaptic specialization membrane,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,2064/3265,2
GO:0099645,neurotransmitter receptor localization to postsynaptic specialization membrane,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,2064/3265,2
GO:2000001,regulation of DNA damage checkpoint,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,675/672,2
GO:2000209,regulation of anoikis,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,5290/4851,2
GO:2000679,positive regulation of transcription regulatory region DNA binding,Feb-90,25/18614,0.006451885,0.018033359,0.008831294,2625/5925,2
GO:0006352,DNA-templated transcription initiation,Apr-90,153/18614,0.006489722,0.018107126,0.008867419,7157/2099/9439/6597,4
GO:0007292,female gamete generation,Apr-90,153/18614,0.006489722,0.018107126,0.008867419,675/8239/472/4292,4
GO:0045913,positive regulation of carbohydrate metabolic process,Mar-90,79/18614,0.006632284,0.018441192,0.009031018,207/208/6794,3
GO:0061333,renal tubule morphogenesis,Mar-90,79/18614,0.006632284,0.018441192,0.009031018,4609/2625/4089,3
GO:1903201,regulation of oxidative stress-induced cell death,Mar-90,79/18614,0.006632284,0.018441192,0.009031018,207/55294/27086,3
GO:0035148,tube formation,Apr-90,154/18614,0.006638596,0.018441192,0.009031018,2625/29072/2263/4851,4
GO:0046488,phosphatidylinositol metabolic process,Apr-90,154/18614,0.006638596,0.018441192,0.009031018,5290/5728/5295/472,4
GO:0030010,establishment of cell polarity,Apr-90,155/18614,0.006789721,0.01881145,0.009212341,2625/3480/387/6794,4
GO:0050770,regulation of axonogenesis,Apr-90,155/18614,0.006789721,0.01881145,0.009212341,5728/999/6794/673,4
GO:0060041,retina development in camera-type eye,Apr-90,155/18614,0.006789721,0.01881145,0.009212341,5156/4851/6597/639,4
GO:0070661,leukocyte proliferation,Jun-90,348/18614,0.006832861,0.018876499,0.009244197,7157/2064/896/4763/472/868,6
GO:0002292,T cell differentiation involved in immune response,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,2625/27086/4221,3
GO:0048644,muscle organ morphogenesis,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,2263/4089/4851,3
GO:0048844,artery morphogenesis,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,4763/4851/639,3
GO:0051865,protein autoubiquitination,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,4193/675/672,3
GO:0070227,lymphocyte apoptotic process,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,7157/207/27086,3
GO:0072028,nephron morphogenesis,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,4609/2625/4089,3
GO:0090049,regulation of cell migration involved in sprouting angiogenesis,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,55294/387/4851,3
GO:2000142,regulation of DNA-templated transcription initiation,Mar-90,80/18614,0.006866893,0.018876499,0.009244197,7157/2099/9439,3
GO:0008643,carbohydrate transport,Apr-90,156/18614,0.00694311,0.019037803,0.009323191,207/5295/208/673,4
GO:0072010,glomerular epithelium development,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,4853/171023,2
GO:1903306,negative regulation of regulated secretory pathway,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,4851/673,2
GO:1904262,negative regulation of TORC1 signaling,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,472/6794,2
GO:1904353,regulation of telomere capping,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,472/2072,2
GO:2000647,negative regulation of stem cell proliferation,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,7157/4763,2
GO:2000773,negative regulation of cellular senescence,Feb-90,26/18614,0.006967692,0.019037803,0.009323191,5728/1021,2
GO:0007043,cell-cell junction assembly,Apr-90,157/18614,0.007098778,0.019333289,0.009467896,80139/999/387/324,4
GO:0048592,eye morphogenesis,Apr-90,157/18614,0.007098778,0.019333289,0.009467896,4763/4853/4851/639,4
GO:0010833,telomere maintenance via telomere lengthening,Mar-90,81/18614,0.007106389,0.019333289,0.009467896,545/472/2072,3
GO:0014855,striated muscle cell proliferation,Mar-90,81/18614,0.007106389,0.019333289,0.009467896,861/2263/4851,3
GO:0031016,pancreas development,Mar-90,81/18614,0.007106389,0.019333289,0.009467896,207/1021/4221,3
GO:0045017,glycerolipid biosynthetic process,May-90,250/18614,0.007311494,0.019874198,0.00973279,5290/5728/55294/5295/472,5
GO:0061097,regulation of protein tyrosine kinase activity,Mar-90,82/18614,0.007350795,0.019946756,0.009768323,55294/2065/868,3
GO:1901184,regulation of ERBB signaling pathway,Mar-90,82/18614,0.007350795,0.019946756,0.009768323,55294/1956/868,3
GO:0050808,synapse organization,Jul-90,466/18614,0.00739077,0.020038044,0.009813028,5728/2064/999/207/3480/4763/387,7
GO:0001835,blastocyst hatching,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,54880/84295,2
GO:0009651,response to salt stress,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,7157/677,2
GO:0035188,hatching,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,54880/84295,2
GO:0046639,negative regulation of alpha-beta T cell differentiation,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,865/861,2
GO:0071684,organism emergence from protective structure,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,54880/84295,2
GO:1904666,regulation of ubiquitin protein ligase activity,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,5728/1027,2
GO:1904753,negative regulation of vascular associated smooth muscle cell migration,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,4763/387,2
GO:2000737,negative regulation of stem cell differentiation,Feb-90,27/18614,0.007501591,0.02020003,0.009892356,6926/4851,2
GO:0050871,positive regulation of B cell activation,Mar-90,83/18614,0.007600136,0.020447985,0.010013784,7494/4292/4436,3
GO:0061515,myeloid cell development,Mar-90,84/18614,0.007854433,0.021114212,0.010340049,55294/4853/27086,3
GO:0050730,regulation of peptidyl-tyrosine phosphorylation,May-90,255/18614,0.007929182,0.021297056,0.010429592,7157/55294/1956/2065/868,5
GO:0003401,axis elongation,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,2099/2263,2
GO:0033522,histone H2A ubiquitination,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,675/672,2
GO:0035116,embryonic hindlimb morphogenesis,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,6926/4851,2
GO:0036037,"CD8-positive, alpha-beta T cell activation",Feb-90,28/18614,0.008053401,0.021421997,0.010490777,865/861,2
GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,1956/868,2
GO:0045686,negative regulation of glial cell differentiation,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,4763/4851,2
GO:0045830,positive regulation of isotype switching,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,4292/4436,2
GO:0048679,regulation of axon regeneration,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,3480/673,2
GO:0060479,lung cell differentiation,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,3845/3169,2
GO:0060487,lung epithelial cell differentiation,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,3845/3169,2
GO:1903055,positive regulation of extracellular matrix organization,Feb-90,28/18614,0.008053401,0.021421997,0.010490777,5925/861,2
GO:0005996,monosaccharide metabolic process,May-90,256/18614,0.008056946,0.021421997,0.010490777,7157/5290/207/208/6794,5
GO:0051236,establishment of RNA localization,Apr-90,163/18614,0.008081425,0.021469043,0.010513817,29072/545/472/677,4
GO:0050878,regulation of body fluid levels,Jun-90,361/18614,0.008115813,0.021542308,0.010549697,5290/595/7494/5156/2778/4778,6
GO:0030307,positive regulation of cell growth,Apr-90,164/18614,0.008253434,0.021889242,0.010719597,2064/207/1956/387,4
GO:0031667,response to nutrient levels,Jul-90,477/18614,0.00834911,0.022124442,0.010834779,7157/595/207/1030/3480/1788/7494,7
GO:0008306,associative learning,Mar-90,86/18614,0.008377988,0.022126839,0.010835953,4763/3845/673,3
GO:0008543,fibroblast growth factor receptor signaling pathway,Mar-90,86/18614,0.008377988,0.022126839,0.010835953,2260/2625/2263,3
GO:0021766,hippocampus development,Mar-90,86/18614,0.008377988,0.022126839,0.010835953,5728/3480/1021,3
GO:0034103,regulation of tissue remodeling,Mar-90,86/18614,0.008377988,0.022126839,0.010835953,7157/4763/861,3
GO:0003209,cardiac atrium morphogenesis,Feb-90,29/18614,0.008622938,0.022697983,0.011115654,4853/4851,2
GO:0010592,positive regulation of lamellipodium assembly,Feb-90,29/18614,0.008622938,0.022697983,0.011115654,5290/5295,2
GO:1902175,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,Feb-90,29/18614,0.008622938,0.022697983,0.011115654,207/55294,2
GO:1904385,cellular response to angiotensin,Feb-90,29/18614,0.008622938,0.022697983,0.011115654,57492/3480,2
GO:0010507,negative regulation of autophagy,Mar-90,87/18614,0.008647287,0.022724267,0.011128525,7157/5290/207,3
GO:0097194,execution phase of apoptosis,Mar-90,87/18614,0.008647287,0.022724267,0.011128525,7157/207/841,3
GO:1902904,negative regulation of supramolecular fiber organization,Apr-90,167/18614,0.008783844,0.023063968,0.011294883,5290/5295/4089/324,4
GO:0051051,negative regulation of transport,Jul-90,483/18614,0.008909044,0.023367578,0.011443567,5728/207/4763/208/2065/4851/673,7
GO:0033273,response to vitamin,Mar-90,88/18614,0.008921629,0.023367578,0.011443567,595/3480/1788,3
GO:0050672,negative regulation of lymphocyte proliferation,Mar-90,88/18614,0.008921629,0.023367578,0.011443567,2064/472/868,3
GO:0001894,tissue homeostasis,May-90,263/18614,0.008991684,0.023512139,0.011514362,5925/4763/3845/4851/6794,5
GO:0060249,anatomical structure homeostasis,May-90,263/18614,0.008991684,0.023512139,0.011514362,5925/4763/3845/4851/6794,5
GO:0007568,aging,Apr-90,169/18614,0.009149566,0.023905224,0.011706863,1030/3480/1788/4089,4
GO:0006112,energy reserve metabolic process,Mar-90,89/18614,0.009201032,0.023905261,0.011706881,4609/207/208,3
GO:0032945,negative regulation of mononuclear cell proliferation,Mar-90,89/18614,0.009201032,0.023905261,0.011706881,2064/472/868,3
GO:0005979,regulation of glycogen biosynthetic process,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,207/208,2
GO:0007176,regulation of epidermal growth factor-activated receptor activity,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,55294/868,2
GO:0010962,regulation of glucan biosynthetic process,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,207/208,2
GO:0060045,positive regulation of cardiac muscle cell proliferation,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,2263/4851,2
GO:0070168,negative regulation of biomineral tissue development,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,54880/4851,2
GO:1900101,regulation of endoplasmic reticulum unfolded protein response,Feb-90,30/18614,0.009210023,0.023905261,0.011706881,5295/7494,2
GO:1902905,positive regulation of supramolecular fiber organization,Apr-90,171/18614,0.0095251,0.024702799,0.012097452,5925/387/1027/673,4
GO:0008544,epidermis development,Jun-90,375/18614,0.009682841,0.025091325,0.01228772,4763/1956/2263/4089/4851/677,6
GO:0006402,mRNA catabolic process,May-90,268/18614,0.009703638,0.02512464,0.012304035,207/472/4292/677/4849,5
GO:0003298,physiological muscle hypertrophy,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,6416/27086,2
GO:0003301,physiological cardiac muscle hypertrophy,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,6416/27086,2
GO:0010390,histone monoubiquitination,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,675/672,2
GO:0010464,regulation of mesenchymal cell proliferation,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,4609/2263,2
GO:0035767,endothelial cell chemotaxis,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,2260/4851,2
GO:0048873,homeostasis of number of cells within a tissue,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,3845/4851,2
GO:0060674,placenta blood vessel development,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,207/4853,2
GO:0061049,cell growth involved in cardiac muscle cell development,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,6416/27086,2
GO:0061311,cell surface receptor signaling pathway involved in heart development,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,4853/4851,2
GO:0070570,regulation of neuron projection regeneration,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,3480/673,2
GO:0071276,cellular response to cadmium ion,Feb-90,31/18614,0.009814476,0.025184917,0.012333554,207/1956,2
GO:0045666,positive regulation of neuron differentiation,Mar-90,92/18614,0.010069799,0.025819161,0.012644157,2260/3169/387,3
GO:0030178,negative regulation of Wnt signaling pathway,Apr-90,174/18614,0.010107015,0.025893601,0.012680611,8312/4851/324/6794,4
GO:0051091,positive regulation of DNA-binding transcription factor activity,May-90,271/18614,0.010148979,0.025959071,0.012712673,5728/207/2099/3169/6597,5
GO:0090150,establishment of protein localization to membrane,May-90,271/18614,0.010148979,0.025959071,0.012712673,2064/1956/208/673/3265,5
GO:0032436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,Mar-90,93/18614,0.010369633,0.026479458,0.012967517,207/4193/8312,3
GO:0051781,positive regulation of cell division,Mar-90,93/18614,0.010369633,0.026479458,0.012967517,3480/2263/387,3
GO:0002313,mature B cell differentiation involved in immune response,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,4853/7494,2
GO:0007435,salivary gland morphogenesis,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,1956/2263,2
GO:0031057,negative regulation of histone modification,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,672/54880,2
GO:0031069,hair follicle morphogenesis,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,2263/4851,2
GO:0033032,regulation of myeloid cell apoptotic process,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,1029/4763,2
GO:0034390,smooth muscle cell apoptotic process,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,6416/1029,2
GO:0034391,regulation of smooth muscle cell apoptotic process,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,6416/1029,2
GO:0071353,cellular response to interleukin-4,Feb-90,32/18614,0.01043612,0.026479458,0.012967517,2625/7494,2
GO:0001764,neuron migration,Apr-90,176/18614,0.010507512,0.026596613,0.01302489,2260/2625/8239/387,4
GO:0010634,positive regulation of epithelial cell migration,Apr-90,176/18614,0.010507512,0.026596613,0.01302489,2260/2625/207/27086,4
GO:0030509,BMP signaling pathway,Apr-90,176/18614,0.010507512,0.026596613,0.01302489,4853/8239/4089/4851,4
GO:0051492,regulation of stress fiber assembly,Mar-90,94/18614,0.010674617,0.026976429,0.013210894,5295/387/673,3
GO:1900407,regulation of cellular response to oxidative stress,Mar-90,94/18614,0.010674617,0.026976429,0.013210894,207/55294/27086,3
GO:0046330,positive regulation of JNK cascade,Mar-90,95/18614,0.010984768,0.027715953,0.013573053,6416/8312/3265,3
GO:0048704,embryonic skeletal system morphogenesis,Mar-90,95/18614,0.010984768,0.027715953,0.013573053,29072/5156/2263,3
GO:0048566,embryonic digestive tract development,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,5156/2263,2
GO:0048710,regulation of astrocyte differentiation,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,4763/4851,2
GO:0048799,animal organ maturation,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,2625/387,2
GO:0090183,regulation of kidney development,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,4609/2625,2
GO:1901185,negative regulation of ERBB signaling pathway,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,1956/868,2
GO:1905207,regulation of cardiocyte differentiation,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,1956/4089,2
GO:1990776,response to angiotensin,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,57492/3480,2
GO:2000191,regulation of fatty acid transport,Feb-90,33/18614,0.011074778,0.027765926,0.013597526,207/208,2
GO:0043502,regulation of muscle adaptation,Mar-90,96/18614,0.0113001,0.028286009,0.013852221,27086/4089/4851,3
GO:0048477,oogenesis,Mar-90,96/18614,0.0113001,0.028286009,0.013852221,675/472/4292,3
GO:0051048,negative regulation of secretion,Apr-90,180/18614,0.011339055,0.028361082,0.013888986,4763/2065/4851/673,4
GO:0008593,regulation of Notch signaling pathway,Mar-90,97/18614,0.011620628,0.028996583,0.014200203,207/55294/4851,3
GO:0034109,homotypic cell-cell adhesion,Mar-90,97/18614,0.011620628,0.028996583,0.014200203,80139/5156/2778,3
GO:0099175,regulation of postsynapse organization,Mar-90,97/18614,0.011620628,0.028996583,0.014200203,5728/207/4763,3
GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,Feb-90,34/18614,0.011730275,0.029178137,0.014289114,4292/4849,2
GO:0007431,salivary gland development,Feb-90,34/18614,0.011730275,0.029178137,0.014289114,1956/2263,2
GO:0032212,positive regulation of telomere maintenance via telomerase,Feb-90,34/18614,0.011730275,0.029178137,0.014289114,545/472,2
GO:0045577,regulation of B cell differentiation,Feb-90,34/18614,0.011730275,0.029178137,0.014289114,7494/677,2
GO:0046890,regulation of lipid biosynthetic process,Apr-90,182/18614,0.011770286,0.029254661,0.014326589,207/55294/3480/672,4
GO:0034620,cellular response to unfolded protein,Mar-90,98/18614,0.011946366,0.029668998,0.014529498,595/5295/7494,3
GO:0031503,protein-containing complex localization,Apr-90,183/18614,0.011989805,0.029753524,0.014570892,2064/545/472/3265,4
GO:0046578,regulation of Ras protein signal transduction,Apr-90,184/18614,0.012211942,0.030281022,0.014829218,4763/3845/4853/4851,4
GO:0036473,cell death in response to oxidative stress,Mar-90,99/18614,0.012277329,0.030395515,0.014885288,207/55294/27086,3
GO:2001243,negative regulation of intrinsic apoptotic signaling pathway,Mar-90,99/18614,0.012277329,0.030395515,0.014885288,207/4193/7494,3
GO:0006301,postreplication repair,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,672/4436,2
GO:0007095,mitotic G2 DNA damage checkpoint signaling,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,672/472,2
GO:0007143,female meiotic nuclear division,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,472/4292,2
GO:0032205,negative regulation of telomere maintenance,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,472/2072,2
GO:0032228,"regulation of synaptic transmission, GABAergic",Feb-90,35/18614,0.012402437,0.030396057,0.014885553,4763/3845,2
GO:0033146,regulation of intracellular estrogen receptor signaling pathway,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,3169/672,2
GO:0035137,hindlimb morphogenesis,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,6926/4851,2
GO:0060416,response to growth hormone,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,207/5295,2
GO:0062098,regulation of programmed necrotic cell death,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,7157/841,2
GO:0070670,response to interleukin-4,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,2625/7494,2
GO:0071425,hematopoietic stem cell proliferation,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,675/861,2
GO:1905898,positive regulation of response to endoplasmic reticulum stress,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,5295/7494,2
GO:2000352,negative regulation of endothelial cell apoptotic process,Feb-90,35/18614,0.012402437,0.030396057,0.014885553,2625/673,2
GO:0072659,protein localization to plasma membrane,May-90,285/18614,0.012413843,0.030400465,0.014887712,999/207/5295/1956/208,5
GO:0001936,regulation of endothelial cell proliferation,Apr-90,185/18614,0.012436707,0.030409382,0.014892079,2260/207/4763/4893,4
GO:0099173,postsynapse organization,Apr-90,185/18614,0.012436707,0.030409382,0.014892079,5728/207/3480/4763,4
GO:0030101,natural killer cell activation,Mar-90,100/18614,0.012613528,0.030794137,0.015080501,2625/841/639,3
GO:0034446,substrate adhesion-dependent cell spreading,Mar-90,100/18614,0.012613528,0.030794137,0.015080501,5295/387/673,3
GO:0007565,female pregnancy,Apr-90,187/18614,0.012894163,0.031454998,0.015404138,207/2099/4221/639,4
GO:0043255,regulation of carbohydrate biosynthetic process,Mar-90,101/18614,0.012954976,0.031579001,0.015464864,207/208/6794,3
GO:0002068,glandular epithelial cell development,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,207/1021,2
GO:0035520,monoubiquitinated protein deubiquitination,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,8239/171023,2
GO:0046320,regulation of fatty acid oxidation,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,207/208,2
GO:0048730,epidermis morphogenesis,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,2263/4851,2
GO:0060218,hematopoietic stem cell differentiation,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,7157/1021,2
GO:0070873,regulation of glycogen metabolic process,Feb-90,36/18614,0.013091091,0.031763965,0.015555445,207/208,2
GO:0002040,sprouting angiogenesis,Apr-90,188/18614,0.013126876,0.031826387,0.015586014,207/55294/387/4851,4
GO:0042472,inner ear morphogenesis,Mar-90,102/18614,0.013301685,0.032225521,0.015781478,2625/6926/2263,3
GO:0002700,regulation of production of molecular mediator of immune response,Apr-90,189/18614,0.013362259,0.032322772,0.015829104,2625/7494/4292/4436,4
GO:0071466,cellular response to xenobiotic stimulus,Apr-90,189/18614,0.013362259,0.032322772,0.015829104,7157/4609/5925/673,4
GO:0051495,positive regulation of cytoskeleton organization,Apr-90,190/18614,0.013600321,0.032873504,0.016098808,387/1027/673/3265,4
GO:0150115,cell-substrate junction organization,Mar-90,103/18614,0.013653666,0.032926981,0.016124997,5728/5295/387,3
GO:1902882,regulation of response to oxidative stress,Mar-90,103/18614,0.013653666,0.032926981,0.016124997,207/55294/27086,3
GO:1903076,regulation of protein localization to plasma membrane,Mar-90,103/18614,0.013653666,0.032926981,0.016124997,207/5295/1956,3
GO:0009303,rRNA transcription,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,7157/6597,2
GO:0044319,"wound healing, spreading of cells",Feb-90,37/18614,0.013796065,0.032943962,0.016133313,5728/387,2
GO:0045746,negative regulation of Notch signaling pathway,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,207/55294,2
GO:0045920,negative regulation of exocytosis,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,4851/673,2
GO:0048854,brain morphogenesis,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,5728/4763,2
GO:0055023,positive regulation of cardiac muscle tissue growth,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,2263/4851,2
GO:0060323,head morphogenesis,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,5156/673,2
GO:0070536,protein K63-linked deubiquitination,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,672/8239,2
GO:0090505,epiboly involved in wound healing,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,5728/387,2
GO:1902745,positive regulation of lamellipodium organization,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,5290/5295,2
GO:1903146,regulation of autophagy of mitochondrion,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,7157/55294,2
GO:1904358,positive regulation of telomere maintenance via telomere lengthening,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,545/472,2
GO:2000279,negative regulation of DNA biosynthetic process,Feb-90,37/18614,0.013796065,0.032943962,0.016133313,7157/4221,2
GO:0050773,regulation of dendrite development,Mar-90,104/18614,0.01401093,0.033431812,0.016372223,387/1523/6794,3
GO:0000578,embryonic axis specification,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,6926/4089,2
GO:0002335,mature B cell differentiation,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,4853/7494,2
GO:0032885,regulation of polysaccharide biosynthetic process,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,207/208,2
GO:0033028,myeloid cell apoptotic process,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,1029/4763,2
GO:0033260,nuclear DNA replication,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,675/546,2
GO:0043368,positive T cell selection,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,6794/673,2
GO:0045191,regulation of isotype switching,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,4292/4436,2
GO:0051385,response to mineralocorticoid,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,595/3480,2
GO:0090504,epiboly,Feb-90,38/18614,0.01451719,0.034406284,0.016849441,5728/387,2
GO:0043433,negative regulation of DNA-binding transcription factor activity,Apr-90,194/18614,0.014579571,0.034502441,0.016896531,5925/1029/2099/4221,4
GO:0045664,regulation of neuron differentiation,Apr-90,194/18614,0.014579571,0.034502441,0.016896531,2260/3169/387/4851,4
GO:0051056,regulation of small GTPase mediated signal transduction,May-90,298/18614,0.014804506,0.035008563,0.017144389,4763/3845/4853/4851/80243,5
GO:0043488,regulation of mRNA stability,Apr-90,195/18614,0.014831182,0.035019299,0.017149647,207/4292/677/4849,4
GO:0120032,regulation of plasma membrane bounded cell projection assembly,Apr-90,195/18614,0.014831182,0.035019299,0.017149647,5290/5295/324/3265,4
GO:0032526,response to retinoic acid,Mar-90,107/18614,0.015114519,0.035661698,0.017464242,2263/472/171023,3
GO:0030279,negative regulation of ossification,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,54880/4851,2
GO:0032350,regulation of hormone metabolic process,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,2625/3480,2
GO:0036297,interstrand cross-link repair,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,545/2072,2
GO:0042307,positive regulation of protein import into nucleus,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,999/5295,2
GO:0045616,regulation of keratinocyte differentiation,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,4851/677,2
GO:0046329,negative regulation of JNK cascade,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,9611/4221,2
GO:0046621,negative regulation of organ growth,Feb-90,39/18614,0.015254296,0.035804594,0.017534221,5728/27086,2
GO:0006403,RNA localization,Apr-90,197/18614,0.015342628,0.035958574,0.017609628,29072/545/472/677,4
GO:0060491,regulation of cell projection assembly,Apr-90,197/18614,0.015342628,0.035958574,0.017609628,5290/5295/324/3265,4
GO:0032231,regulation of actin filament bundle assembly,Mar-90,108/18614,0.015493011,0.036284149,0.017769069,5295/387/673,3
GO:0018107,peptidyl-threonine phosphorylation,Mar-90,109/18614,0.015876831,0.037073279,0.018155522,207/8312/6794,3
GO:0030038,contractile actin filament bundle assembly,Mar-90,109/18614,0.015876831,0.037073279,0.018155522,5295/387/673,3
GO:0043149,stress fiber assembly,Mar-90,109/18614,0.015876831,0.037073279,0.018155522,5295/387/673,3
GO:0060840,artery development,Mar-90,109/18614,0.015876831,0.037073279,0.018155522,4763/4851/639,3
GO:0010762,regulation of fibroblast migration,Feb-90,40/18614,0.016007216,0.037240317,0.018237323,207/673,2
GO:0016233,telomere capping,Feb-90,40/18614,0.016007216,0.037240317,0.018237323,472/2072,2
GO:0035136,forelimb morphogenesis,Feb-90,40/18614,0.016007216,0.037240317,0.018237323,6926/546,2
GO:0042092,type 2 immune response,Feb-90,40/18614,0.016007216,0.037240317,0.018237323,2625/4221,2
GO:1901532,regulation of hematopoietic progenitor cell differentiation,Feb-90,40/18614,0.016007216,0.037240317,0.018237323,1021/4851,2
GO:0006368,transcription elongation by RNA polymerase II,Mar-90,110/18614,0.016265987,0.037814536,0.01851853,9439/29072/8312,3
GO:0001935,endothelial cell proliferation,Apr-90,201/18614,0.01639867,0.038095001,0.018655879,2260/207/4763/4893,4
GO:0046651,lymphocyte proliferation,May-90,306/18614,0.016419875,0.038116277,0.018666298,7157/2064/896/472/868,5
GO:0006367,transcription initiation at RNA polymerase II promoter,Mar-90,111/18614,0.016660487,0.038618154,0.018912078,7157/2099/9439,3
GO:2001252,positive regulation of chromosome organization,Mar-90,111/18614,0.016660487,0.038618154,0.018912078,545/472/546,3
GO:0031062,positive regulation of histone methylation,Feb-90,41/18614,0.016775783,0.038771787,0.018987315,672/4089,2
GO:0032965,regulation of collagen biosynthetic process,Feb-90,41/18614,0.016775783,0.038771787,0.018987315,861/4851,2
GO:0060421,positive regulation of heart growth,Feb-90,41/18614,0.016775783,0.038771787,0.018987315,2263/4851,2
GO:1990000,amyloid fibril formation,Feb-90,41/18614,0.016775783,0.038771787,0.018987315,4193/8239,2
GO:0042177,negative regulation of protein catabolic process,Mar-90,112/18614,0.017060336,0.039400659,0.019295286,1956/8239/4089,3
GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,Apr-90,204/18614,0.017219984,0.039711391,0.019447457,4609/207/387/841,4
GO:1902075,cellular response to salt,Apr-90,204/18614,0.017219984,0.039711391,0.019447457,5290/999/1027/673,4
GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,May-90,311/18614,0.017487037,0.040231213,0.019702025,2625/4292/4851/4436/3265,5
GO:0000302,response to reactive oxygen species,Apr-90,205/18614,0.017499377,0.040231213,0.019702025,207/1956/27086/5156,4
GO:0002714,positive regulation of B cell mediated immunity,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,4292/4436,2
GO:0002891,positive regulation of immunoglobulin mediated immune response,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,4292/4436,2
GO:0007595,lactation,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,595/7494,2
GO:0010591,regulation of lamellipodium assembly,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,5290/5295,2
GO:0014912,negative regulation of smooth muscle cell migration,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,4763/387,2
GO:0043551,regulation of phosphatidylinositol 3-kinase activity,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,5295/5156,2
GO:0050999,regulation of nitric-oxide synthase activity,Feb-90,42/18614,0.017559831,0.040231213,0.019702025,207/1956,2
GO:2000241,regulation of reproductive process,Apr-90,206/18614,0.017781596,0.040709819,0.019936407,2099/1027/4851/6794,4
GO:0032943,mononuclear cell proliferation,May-90,313/18614,0.017926507,0.041011908,0.020084346,7157/2064/896/472/868,5
GO:0043487,regulation of RNA stability,Apr-90,207/18614,0.018066647,0.041272832,0.020212126,207/4292/677/4849,4
GO:0044703,multi-organism reproductive process,Apr-90,207/18614,0.018066647,0.041272832,0.020212126,207/2099/4221/639,4
GO:0030198,extracellular matrix organization,May-90,314/18614,0.018148967,0.041430974,0.020289571,5925/4763/861/5156/4851,5
GO:0008608,attachment of spindle microtubules to kinetochore,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,5925/324,2
GO:0010463,mesenchymal cell proliferation,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,4609/2263,2
GO:0016601,Rac protein signal transduction,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,4763/3845,2
GO:0031670,cellular response to nutrient,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,1030/7494,2
GO:0033574,response to testosterone,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,3480/27086,2
GO:0044786,cell cycle DNA replication,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,675/546,2
GO:0048713,regulation of oligodendrocyte differentiation,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,4763/4851,2
GO:0071548,response to dexamethasone,Feb-90,43/18614,0.018359197,0.041670372,0.020406809,5290/3480,2
GO:0043062,extracellular structure organization,May-90,315/18614,0.01837325,0.041672375,0.02040779,5925/4763/861/5156/4851,5
GO:0048167,regulation of synaptic plasticity,Apr-90,209/18614,0.018645279,0.042259071,0.020695107,4763/3845/673/3265,4
GO:0006979,response to oxidative stress,Jun-90,434/18614,0.018698432,0.042322382,0.020726111,7157/207/55294/1956/27086/5156,6
GO:0010633,negative regulation of epithelial cell migration,Mar-90,116/18614,0.018713341,0.042322382,0.020726111,5728/387/4851,3
GO:0042752,regulation of circadian rhythm,Mar-90,116/18614,0.018713341,0.042322382,0.020726111,7157/55294/8239,3
GO:0045229,external encapsulating structure organization,May-90,317/18614,0.01882731,0.042549722,0.020837444,5925/4763/861/5156/4851,5
GO:0046474,glycerophospholipid biosynthetic process,Apr-90,210/18614,0.018938875,0.042771306,0.020945959,5290/5728/5295/472,4
GO:0001709,cell fate determination,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,2625/4853,2
GO:0002347,response to tumor cell,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,4853/4851,2
GO:0032881,regulation of polysaccharide metabolic process,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,207/208,2
GO:0032924,activin receptor signaling pathway,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,4089/4221,2
GO:0090051,negative regulation of cell migration involved in sprouting angiogenesis,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,387/4851,2
GO:1903539,protein localization to postsynaptic membrane,Feb-90,44/18614,0.019173717,0.043117015,0.021115259,2064/3265,2
GO:0006401,RNA catabolic process,May-90,319/18614,0.019288733,0.043344852,0.021226836,207/472/4292/677/4849,5
GO:0002377,immunoglobulin production,Apr-90,212/18614,0.019534663,0.043835231,0.021466984,7494/4292/4436/5395,4
GO:0061013,regulation of mRNA catabolic process,Apr-90,212/18614,0.019534663,0.043835231,0.021466984,207/4292/677/4849,4
GO:0030510,regulation of BMP signaling pathway,Mar-90,118/18614,0.019572076,0.043856975,0.021477632,4853/4089/4851,3
GO:0035967,cellular response to topologically incorrect protein,Mar-90,118/18614,0.019572076,0.043856975,0.021477632,595/5295/7494,3
GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,Jun-90,439/18614,0.019660607,0.044024176,0.021559514,207/55294/4193/8239/8312/324,6
GO:0042098,T cell proliferation,Apr-90,213/18614,0.019836871,0.044387453,0.021737418,7157/2064/896/868,4
GO:0005978,glycogen biosynthetic process,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,207/208,2
GO:0008631,intrinsic apoptotic signaling pathway in response to oxidative stress,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,207/55294,2
GO:0009250,glucan biosynthetic process,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,207/208,2
GO:0031295,T cell costimulation,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,5290/207,2
GO:0048483,autonomic nervous system development,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,2625/4763,2
GO:0061098,positive regulation of protein tyrosine kinase activity,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,55294/2065,2
GO:0062237,protein localization to postsynapse,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,2064/3265,2
GO:1902116,negative regulation of organelle assembly,Feb-90,45/18614,0.02000323,0.044490587,0.021787925,672/4089,2
GO:0018210,peptidyl-threonine modification,Mar-90,119/18614,0.020009515,0.044490587,0.021787925,207/8312/6794,3
GO:0045216,cell-cell junction organization,Apr-90,214/18614,0.020141962,0.04475363,0.021916742,80139/999/387/324,4
GO:0042180,cellular ketone metabolic process,Apr-90,216/18614,0.020760827,0.046030515,0.022542058,207/9611/208/672,4
GO:0044706,multi-multicellular organism process,Apr-90,216/18614,0.020760827,0.046030515,0.022542058,207/2099/4221/639,4
GO:0010712,regulation of collagen metabolic process,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,861/4851,2
GO:0010830,regulation of myotube differentiation,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,7494/4851,2
GO:0016574,histone ubiquitination,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,675/672,2
GO:0032467,positive regulation of cytokinesis,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,3480/387,2
GO:0035272,exocrine system development,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,1956/2263,2
GO:0045910,negative regulation of DNA recombination,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,4292/4436,2
GO:0070266,necroptotic process,Feb-90,46/18614,0.020847575,0.046030515,0.022542058,7157/841,2
GO:0043500,muscle adaptation,Mar-90,121/18614,0.020900549,0.046115297,0.022583578,27086/4089/4851,3
GO:0072676,lymphocyte migration,Mar-90,122/18614,0.021354148,0.047083292,0.023057624,2625/207/387,3
GO:0002440,production of molecular mediator of immune response,May-90,328/18614,0.021457401,0.047278006,0.023152979,2625/7494/4292/4436/5395,5
GO:0001754,eye photoreceptor cell differentiation,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,4851/639,2
GO:0016578,histone deubiquitination,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,672/171023,2
GO:0031294,lymphocyte costimulation,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,5290/207,2
GO:0032369,negative regulation of lipid transport,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,207/208,2
GO:0045646,regulation of erythrocyte differentiation,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,1021/677,2
GO:0061383,trabecula morphogenesis,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,387/4851,2
GO:0090199,regulation of release of cytochrome c from mitochondria,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,7157/207,2
GO:1901976,regulation of cell cycle checkpoint,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,675/672,2
GO:1902459,positive regulation of stem cell population maintenance,Feb-90,47/18614,0.021706593,0.047529176,0.023275982,8289/6597,2
GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,Mar-90,123/18614,0.021813138,0.04763062,0.023325661,2625/4292/4436,3
GO:0042471,ear morphogenesis,Mar-90,123/18614,0.021813138,0.04763062,0.023325661,2625/6926/2263,3
GO:0043244,regulation of protein-containing complex disassembly,Mar-90,123/18614,0.021813138,0.04763062,0.023325661,5290/3480/324,3
GO:0061157,mRNA destabilization,Mar-90,123/18614,0.021813138,0.04763062,0.023325661,4292/677/4849,3
GO:0043280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,Mar-90,124/18614,0.022277519,0.048611082,0.023805813,4609/387/841,3
GO:0021795,cerebral cortex cell migration,Feb-90,48/18614,0.022580125,0.049203523,0.024095943,1956/387,2
GO:0032008,positive regulation of TOR signaling,Feb-90,48/18614,0.022580125,0.049203523,0.024095943,5290/8239,2
GO:0006605,protein targeting,May-90,333/18614,0.02272842,0.049492581,0.024237501,2064/55294/208/8239/3265,5
